
<html lang="en"     class="pb-page"  data-request-id="5f476532-ac95-4d34-8ded-a1fdf6739d72"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm800093c;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2008.51.issue-13;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Trithiocarbonates as a Novel Class of HDAC Inhibitors: SAR Studies, Isoenzyme Selectivity, and Pharmacological Profiles" /></meta><meta name="dc.Creator" content="Florian  Dehmel" /></meta><meta name="dc.Creator" content="Steffen  Weinbrenner" /></meta><meta name="dc.Creator" content="Heiko  Julius" /></meta><meta name="dc.Creator" content="Thomas  Ciossek" /></meta><meta name="dc.Creator" content="Thomas  Maier" /></meta><meta name="dc.Creator" content="Thomas  Stengel" /></meta><meta name="dc.Creator" content="Kamal  Fettis" /></meta><meta name="dc.Creator" content="Carmen  Burkhardt" /></meta><meta name="dc.Creator" content="Heike  Wieland" /></meta><meta name="dc.Creator" content="Thomas  Beckers" /></meta><meta name="dc.Description" content="Inhibitors of histone deacetylases (HDAC) are currently developed for the treatment of cancer. These include compounds with a sulfur containing head group like depsipeptide, alkylthiols, thiocarbox..." /></meta><meta name="Description" content="Inhibitors of histone deacetylases (HDAC) are currently developed for the treatment of cancer. These include compounds with a sulfur containing head group like depsipeptide, alkylthiols, thiocarbox..." /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 18, 2008" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm800093c" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2008 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm800093c" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm800093c" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm800093c" /></link>
        
    
    

<title>Trithiocarbonates as a Novel Class of HDAC Inhibitors: SAR Studies, Isoenzyme Selectivity, and Pharmacological Profiles | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm800093c" /></meta><meta property="og:title" content="Trithiocarbonates as a Novel Class of HDAC Inhibitors: SAR Studies, Isoenzyme Selectivity, and Pharmacological Profiles" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0026.jpeg" /></meta><meta property="og:description" content=" Inhibitors of histone deacetylases (HDAC) are currently developed for the treatment of cancer. These include compounds with a sulfur containing head group like depsipeptide, alkylthiols, thiocarboxylates, and trithiocarbonates with a carbonyl group in the α-position. In the present investigation, we report on the synthesis and comprehensive SAR analysis of HDAC inhibitors bearing a tri- or dithiocarbonate motif. Such trithiocarbonates are readily accessible from either preformed or in situ prepared α-halogenated methylaryl ketones. A HDAC isotype selectivity and a substrate competitive mode-of-action is shown for defined analogues. Exploration of the head group showed the necessity of the dithio-α-carbonyl motif for potent HDAC inhibition. Highly potent, substrate competitive HDAC6 selective inhibitors were identified (12ac:IC50 = 65 nM and Ki = 110 nM). Trithiocarbonate analogues with an aminoquinoline-substituted pyridinyl-thienoacetyl cap demonstrate a cytotoxicity profile and potency comparable to that of suberoylanilide hydroxamic acid (SAHA) as an approved cancer drug." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm800093c"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm800093c">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-13/achre4.2021.54.issue-13/20210706/achre4.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-26/aamick.2021.13.issue-26/20210707/aamick.2021.13.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-13/accacs.2021.11.issue-13/20210702/accacs.2021.11.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-13/acncdm.2021.12.issue-13/20210707/acncdm.2021.12.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-27/acsodf.2021.6.issue-27/20210713/acsodf.2021.6.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-27/ascecg.2021.9.issue-27/20210712/ascecg.2021.9.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-27/ancham.2021.93.issue-27/20210713/ancham.2021.93.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-27/bichaw.2021.60.issue-27/20210713/bichaw.2021.60.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-13/cmatex.2021.33.issue-13/20210713/cmatex.2021.33.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-13/enfuem.2021.35.issue-13/20210701/enfuem.2021.35.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-13/esthag.2021.55.issue-13/20210706/esthag.2021.55.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-26/iecred.2021.60.issue-26/20210707/iecred.2021.60.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-13/inocaj.2021.60.issue-13/20210705/inocaj.2021.60.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-26/jafcau.2021.69.issue-26/20210707/jafcau.2021.69.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-13/jmcmar.2021.64.issue-13/20210708/jmcmar.2021.64.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-13/joceah.2021.86.issue-13/20210702/joceah.2021.86.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-26/jpcafh.2021.125.issue-26/20210708/jpcafh.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-26/jpcbfk.2021.125.issue-26/20210708/jpcbfk.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-26/jpccck.2021.125.issue-26/20210708/jpccck.2021.125.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-26/jpclcd.2021.12.issue-26/20210708/jpclcd.2021.12.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-26/jacsat.2021.143.issue-26/20210707/jacsat.2021.143.issue-26.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-27/langd5.2021.37.issue-27/20210713/langd5.2021.37.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-13/mamobx.2021.54.issue-13/20210713/mamobx.2021.54.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-13/orlef7.2021.23.issue-13/20210702/orlef7.2021.23.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-13/orgnd7.2021.40.issue-13/20210712/orgnd7.2021.40.issue-13.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm800093c&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm800093c&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm800093c&amp;href=/doi/10.1021/jm800093c" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2008</span><span class="cit-fg-volume">, 51</span><span class="cit-fg-issue">, 13</span><span class="cit-fg-pageRange">, 3985-4001</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/51/13" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm800085p" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm8000345" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Trithiocarbonates as a Novel Class of HDAC Inhibitors: SAR Studies, Isoenzyme Selectivity, and Pharmacological Profiles</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Florian++Dehmel">Florian Dehmel</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steffen++Weinbrenner">Steffen Weinbrenner</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Heiko++Julius">Heiko Julius</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas++Ciossek">Thomas Ciossek</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas++Maier">Thomas Maier</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas++Stengel">Thomas Stengel</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kamal++Fettis">Kamal Fettis</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carmen++Burkhardt">Carmen Burkhardt</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Heike++Wieland">Heike Wieland</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas++Beckers">Thomas Beckers</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Nycomed GmbH, Therapeutic Area Oncology, Byk-Gulden-Strasse 2, D-78467 Konstanz, Germany</span></div><div class="corresp-info"><strong>*</strong> To whom correspondence should be addressed. Phone: +761-5155916. Fax: +761-5155595. E-mail: <a href="/cdn-cgi/l/email-protection#6c380403010d1f422e090f07091e1f2c03020f0318091f18420809"><span class="__cf_email__" data-cfemail="17437f787a7664395572747c726564577879747863726463397372">[email protected]</span></a>. Address: Oncotest GmbH, Institute for Experimental Oncology, Am Flughafen 12−14, D-79108 Freiburg, Germany.</div><div class="corresp-fn" id="afn1">†Nycomed GmbH, Therapeutic Area Oncology.</div><div class="corresp-fn" id="afn2">‡Present address: Henkel KGaA, D-40589 Düsseldorf, Germany.</div><div class="corresp-fn" id="afn3">§Present address: Boehringer Ingelheim Pharma.</div><div class="corresp-fn" id="afn4">∥Present address: Oncotest GmbH, Institute for Experimental Oncology.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm800093c&amp;href=/doi/10.1021%2Fjm800093c" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2008</span></span><span class="cit-volume">, 51</span><span class="cit-issue">, 13</span><span class="cit-pageRange">, 3985–4001</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 18, 2008</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>30 January 2008</li><li><span class="item_label"><b>Published</b> online</span>18 June 2008</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 1 July 2008</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm800093c" title="DOI URL">https://doi.org/10.1021/jm800093c</a></div><div class="article_header-article-copyright"><strong>Copyright © 2008 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3985%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DFlorian%2BDehmel%252C%2BSteffen%2BWeinbrenner%252C%2BHeiko%2BJulius%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D51%26issueNum%3D13%26contentID%3Djm800093c%26title%3DTrithiocarbonates%2Bas%2Ba%2BNovel%2BClass%2Bof%2BHDAC%2BInhibitors%253A%2BSAR%2BStudies%252C%2BIsoenzyme%2BSelectivity%252C%2Band%2BPharmacological%2BProfiles%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4001%26publicationDate%3DJuly%2B2008">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm800093c"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2610</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">28</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm800093c" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Trithiocarbonates as a Novel Class of HDAC Inhibitors: SAR Studies, Isoenzyme Selectivity, and Pharmacological Profiles&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Florian&quot;,&quot;last_name&quot;:&quot;Dehmel&quot;},{&quot;first_name&quot;:&quot;Steffen&quot;,&quot;last_name&quot;:&quot;Weinbrenner&quot;},{&quot;first_name&quot;:&quot;Heiko&quot;,&quot;last_name&quot;:&quot;Julius&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;Ciossek&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;Maier&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;Stengel&quot;},{&quot;first_name&quot;:&quot;Kamal&quot;,&quot;last_name&quot;:&quot;Fettis&quot;},{&quot;first_name&quot;:&quot;Carmen&quot;,&quot;last_name&quot;:&quot;Burkhardt&quot;},{&quot;first_name&quot;:&quot;Heike&quot;,&quot;last_name&quot;:&quot;Wieland&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;Beckers&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2008&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;18&quot;,&quot;issue&quot;:&quot;13&quot;,&quot;volume&quot;:&quot;51&quot;,&quot;pages&quot;:&quot;3985-4001&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm800093c&quot;},&quot;abstract&quot;:&quot;Inhibitors of histone deacetylases (HDAC) are currently developed for the treatment of cancer. These include compounds with a sulfur containing head group like depsipeptide, alkylthiols, thiocarboxylates, and trithiocarbonates with a carbonyl group in the α-position. In the present investigation, we report on the synthesis and comprehensive SAR analysis of HDAC inhibitors bearing a tri- or dithiocarbonate motif. Such trithiocarbonates are readily accessible from either preformed or in situ prepared α-halogenated methylaryl ketones. A HDAC isotype selectivity and a substrate competitive mode-of-action is shown for defined analogues. Exploration of the head group showed the necessity of the dithio-α-carbonyl motif for potent HDAC inhibition. Highly potent, substrate competitive HDAC6 selective inhibitors were identified (12ac:IC50 = 65 nM and Ki = 110 nM). Trithiocarbonate analogues with an aminoquinoline-substituted pyridinyl-thienoacetyl cap demonstrate a cytotoxicity profile and potency comparable to that of&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm800093c&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800093c" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm800093c&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800093c" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm800093c&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800093c" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm800093c&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm800093c&amp;href=/doi/10.1021/jm800093c" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm800093c" /></input><a href="/doi/pdf/10.1021/jm800093c" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm800093c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm800093c%26sid%3Dliteratum%253Aachs%26pmid%3D18558669%26genre%3Darticle%26aulast%3DDehmel%26date%3D2008%26atitle%3DTrithiocarbonates%2Bas%2Ba%2BNovel%2BClass%2Bof%2BHDAC%2BInhibitors%253A%2BSAR%2BStudies%252C%2BIsoenzyme%2BSelectivity%252C%2Band%2BPharmacological%2BProfiles%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D51%26issue%3D13%26spage%3D3985%26epage%3D4001%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290808" title="Toxicity">Toxicity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/51/13" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_null" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0026.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800093c&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Inhibitors of histone deacetylases (HDAC) are currently developed for the treatment of cancer. These include compounds with a sulfur containing head group like depsipeptide, alkylthiols, thiocarboxylates, and trithiocarbonates with a carbonyl group in the α-position. In the present investigation, we report on the synthesis and comprehensive SAR analysis of HDAC inhibitors bearing a tri- or dithiocarbonate motif. Such trithiocarbonates are readily accessible from either preformed or in situ prepared α-halogenated methylaryl ketones. A HDAC isotype selectivity and a substrate competitive mode-of-action is shown for defined analogues. Exploration of the head group showed the necessity of the dithio-α-carbonyl motif for potent HDAC inhibition. Highly potent, substrate competitive HDAC6 selective inhibitors were identified (12ac:IC<sub>50</sub> = 65 nM and <i>K</i><sub>i</sub> = 110 nM). Trithiocarbonate analogues with an aminoquinoline-substituted pyridinyl-thienoacetyl cap demonstrate a cytotoxicity profile and potency comparable to that of suberoylanilide hydroxamic acid (SAHA) as an approved cancer drug.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71075" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71075" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Posttranslational modification of proteins by reversible lysine acetylation is one important modification modulating protein function.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The modification of core histone proteins H3 and H4 by acetylation of <i>N</i>-terminal lysine residues is well described and part of the so-called histone code important in epigenetic processes.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Nevertheless, a raising number of nonhistone proteins modified by lysine acetylation have been reported, including the signal transducer and activator of transcription 1 and 3 (STAT1, STAT3),<a class="ref internalNav" href="#fn1" aria-label="a">a</a><div class="NLM_fn" id="fn1">a<p class="last">Abbreviations: APL, acute promyelocytic leukemia; AML, acute myelogenous leukemia; AMC, 7-amino-4-methylcoumarin, ATCC, American Tissue Type Collection; CBP, cAMP binding protein; CTCL, cutaneous T-cell lymphoma; FACS, flourescence activated cell sorting; HDAC, histone deacetylase; HAT, histone acetyltransferase; HTS, high throughput screening; NSCLC, nonsmall cell lung cancer; PVDF, polyvinylidendiflouride; rHDAC, recombinant HDAC; SAR, structure−activity relationship; SAHA, suberoylanilide hydroxamic acid; SDS, disodiumdodecylsulfate; SDS-PAGE, SDS polyacrylamide gel electrophoresis; STAT, signal transducers and activators of transcription; TSA, trichostatin A; VPA, valproic acid.</p></div> heat shock protein 90 (Hsp90), the tumor suppressor protein p53, and α-tubulin.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The status of H3/H4 core histone acetylation correlates with the transcriptional activity of chromatin with histone acetyltransferases (HATs) and histone deacetylases (HDACs) as key players regulating reversible histone acetylation.<a onclick="showRef(event, 'cit1b'); return false;" href="javascript:void(0);" class="ref cit1b">(1b)</a> Up to now, 11 different HDAC isoenzymes belonging to the class I (HDAC 1, 2, 3, 8), class II (HDAC 4−7, 9, 10), and class IV (HDAC11) family have been described.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> There is clear evidence for a pathophysiological relevance of HDAC mediated histone acetylation and cancer.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> These include (i) mutations of cAMP binding protein (CBP) as a HAT are associated with Rubinstein−Taybi syndrome, a cancer predisposition,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> (ii) aberrant recruitment of HDAC1 by transcription factors in acute promyelocytic leukemia (APL) mediated by the PML-retinoic acid receptor α fusion gene in non-Hodgkin lymphoma by the overexpressed BCL6 protein and in acute myelogenous leukemia (AML M2 subtype) by the AML-ETO fusion protein,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> (iii) overexpression of HDAC2 in colon carcinoma upon constitutive activation of the wnt/β-catenin/TCF signaling pathway,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> and finally (iv) a high expression of HDAC1, 2, and 3 in gastric, prostate, and colorectal cancer correlating with survival and staging.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> As a consequence, the identification of HDAC inhibitors is currently one major topic in oncology drug discovery programs. Inhibition of HDAC class I/II enzymes is well established as an experimental clinical approach for solid and hematological tumor therapy.<a onclick="showRef(event, 'cit4b ref10'); return false;" href="javascript:void(0);" class="ref cit4b ref10">(4b, 10)</a> HDAC inhibitors affect the transcriptional regulation and induce or repress genes involved in differentiation, proliferation, cell cycle regulation, protein turnover, and apoptosis.<a onclick="showRef(event, 'cit4b'); return false;" href="javascript:void(0);" class="ref cit4b">(4b)</a> HDAC inhibitors of divergent chemical structure are currently in clinical development.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> These include short chain fatty acids, hydroxamic acids, cyclic tetrapeptides/peptolides, ketones, and benzamides.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Various agents are currently in clinical development, namely the hydroxamate analogues (<i>E</i>)-3-(4-(((2-(1<i>H</i>-indol-3-yl)ethyl)(2-hydroxyethyl)amino)methyl)phenyl)-<i>N-</i>hydroxyacrylamide (LBH589), <i>N-</i>hydroxy-3-(3-(<i>N-</i>phenylsulfamoyl)phenyl)acrylamide <b>(</b>PXD101, Belinostat), <i>N-</i>(2-(4-(hydroxycarbamoyl)phenoxy)ethyl)-3-(isopropylamino)benzofuran-2-carboxamide (PCI024781) and <i>N</i><sup>1</sup>-hydroxy-<sup>8</sup>-phenyloctanediamide (suberoylanilide hydroxamic acid/SAHA, Vorinostat), the benzamide analogues (4-(2-aminophenylcarbamoyl)benzylamino)methyl nicotinate (MS275 or SNDX275) and <i>N-</i>(2-aminophenyl)-4-((4-(pyridin-3-yl)pyrimidin-2-ylamino)methyl)benzamide <b>(</b>MGCD0103), the cyclic peptolide depsipeptide/FK228 (rhomidepsin) and valproic acid (VPA). As shown for SAHA and the natural product trichostatin A (TSA), the hydroxamic acid head group complexes the Zn<sup>2+</sup> in the active site, thereby inhibiting the enzyme in a substrate competitive manner.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> So far, HDAC class I isotype selectivity has been shown only for benzamide analogues with MGCD0103 as a prominent example.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Selective HDAC6 inhibitors have been rarely described with the hydroxamate analogue Tubacin as one example.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Obviously, isotype selective inhibitors will open new avenues for treating cancer and noncancer diseases like rheumatoid arthritis, Crohn’s disease or muscle dystrophia, displaying a different overall safety profile.</div><div class="NLM_p">The structural basis of HDAC inhibition is well established, with the Zn<sup>2+</sup> complexing head group, a linker/spacer, and the cap group of high structural variability.<a onclick="showRef(event, 'cit13a ref16'); return false;" href="javascript:void(0);" class="ref cit13a ref16">(13a, 16)</a> Nevertheless, the identification of new head groups bearing druglike properties proved to be difficult.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Besides the well-studied benzamides and hydroxamates,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> compounds with a free thiol head group were described as potent and occasionally isotype-selective HDAC inhibitors,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> but in general cellular activity was very weak.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Depsipeptide is a remarkable exception by acting as a prodrug, liberating the reduced sulfhydryl group only intracellular.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> This concept has also been exploited at similar structures bearing a disulfide moiety derived from thio-pyridine.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Different head groups containing sulfur including thiocarboxylates,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> thioglycolamides,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and α-thio-substituted acetyl compounds<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> have been described. Recently, it was found that a trithiocarbonate group in α-position to the carbonyl moiety represents a promising new head group for HDAC inhibition.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> In the present study, we report on the exploition of this novel structural motif for HDAC inhibition and its biological activity in detail.</div><div id="sec1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p">The HDAC inhibitors containing the acetyl trithiocarbonate moiety are typically prepared from an α-halo-acetophenone and conversion with sodium ethyl trithiocarbonate (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The advanced hit compound <b>2</b> as well as its methoxy analogue <b>3a</b> were obtained in a clean reaction.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0001.jpeg" id="gs1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800093c&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) EtSNa, CS<sub>2</sub>, THF, rt.</p></p></figure><div class="NLM_p">Analogues of the trithiocarbonate headgroup were accessible from α-bromo-4-methoxy-acetophenone <b>1a</b> in similar conversions, as dithiobutyrate prepared from <i>n</i>-propyl Grignard and carbondisulfide provided access to its dithiocarboxate analogue <b>3b</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). The corresponding xanthogenate <b>3c</b>, the functionalized trithiocarbonates (<b>3j</b> and <b>3k</b>), and the dithiocarbamate <b>3m</b> were prepared from the requisite alcoholate, thiolate, or amine and carbondisulfide followed by addition of the electrophilic bromo-acetophenone. The synthesis of other trithiocarbonate analogues required 2-mercapto-acetophenone <b>4</b> as precursor, which was prepared in two steps using potassium thioacteate followed by saponification. The thiol <b>4</b> was used to prepare the functionalized trithiocarbonate <b>3l</b>, using commercially available methoxyethyl bromide (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>), but the yield for this conversion was found to be rather low. The <i>O</i>-ethyl thiocarbonate <b>3h</b> and the <i>N</i>-ethyl carbamates <b>3d</b> and <b>3i</b> were prepared in moderate to good yield from <b>4</b> by simple addition of ethyl chloroformiate, ethyl isothiocyanate, or ethyl isocyanate, respectively.</div><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0002.jpeg" id="gs2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800093c&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>n</i>PrMgCl, CS<sub>2</sub>, CuI, THF, −20 °C; (b) EtOH, KOH, CS<sub>2</sub>, H<sub>2</sub>O, rt; (c) KSAc, THF, 50 °C, then NaOH, MeOH, rt; (d) EtNCS, THF, rt; (e) EtO(C═O)Cl, DIPEA, THF, rt; (f) EtNCO, THF, rt; (g) RC<sub>2</sub>H<sub>4</sub>SH, NaH, THF, 0 °C, CS<sub>2</sub>; (h) morpholine, NaOAc, CS<sub>2</sub>, THF, rt; (i) CS<sub>2</sub>, NaOH, THF, then EtOC<sub>2</sub>H<sub>4</sub>Br, rt.</p></p></figure><div class="NLM_p">Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a> illustrates the preparation of nitrogen analogues of the trithiocarbonate moiety. The addition of ethyl isothiocyanate to amino-acetophenone <b>5</b> resulted in thiourea <b>3f</b>, while conversion with carbondisulfide and ethyl bromide provided the <i>S</i>-ethyl carbamate <b>3g</b> in high yields. It is noteworthy that all <i>N</i>-ethyl derivatives (<b>3d</b>, <b>3i</b>, and <b>3f</b>) exist in an equilibrium with a cyclized species, the ratio being dependent on temperature and solvent environment.</div><figure id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0003.jpeg" id="gs3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800093c&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) EtNCS, NEt<sub>3</sub>, THF, rt; (b) EtBr, CS<sub>2</sub>, 1 M NaOH, ethyl acetate/EtOH, rt.</p></p></figure><div class="NLM_p">The preparation of the <i>S</i>-ethyl dithiocarbonate <b>3e</b> proved to be more cumbersome (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). 2-Hydroxy-acetophenone <b>6</b> was converted into the dioxolane to allow the installation of the required functionality using sodium hydride, carbon sulfide, and ethyl iodide before the protecting group was removed under acid catalysis to yield <b>3e</b>.</div><figure id="sch4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0004.jpeg" id="gs4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800093c&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HOC<sub>2</sub>H<sub>4</sub>OH, amberlyst 15, PhH, 80 °C; (b) NaH, imidazole, THF, 0 °C, then CS<sub>2</sub>, then EtI; (c) cat. HCl, THF/H<sub>2</sub>O, 60 °C.</p></p></figure><div class="NLM_p">A one-pot procedure was elaborated to access substituted acetophenone trithiocarbonates, which brominated precursors are not commercially available (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>).</div><figure id="sch5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0005.jpeg" id="gs5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800093c&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) PTT, THF, rt; then EtS(C═S)SNa.</p></p></figure><div class="NLM_p">The acetophenone was brominated in situ with phenyltrimethylammonium tribromide (PTT) in tetrahydrofuran. Decolorization of the orange solution and formation of whitish precipitate indicated the completion of the bromination reaction and a solution sodium ethyl trithiocarbonate solution (stock solution, stored under nitrogen for several weeks) was added to yield <b>8a</b> and <b>8e</b>−<b>g</b>. Chlorides of type <b>9</b> or <b>10</b> instead of bromo compounds also represented suitable electrophiles for the preparation of trithiocarbonates (<b>8h</b>−<b>j</b>, Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a>) as well as their CH<sub>2</sub>-, O-, and NH-analogues (<b>8b</b>−<b>d</b>, Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>), which were prepared using similar procedures as described in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>.</div><figure id="sch6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0006.jpeg" id="gs6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800093c&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) i. <i>n</i>-PrMgCl, CS<sub>2</sub>, CuI, THF, −20 °C, then HCl, H<sub>2</sub>O, ii. <b>9</b>, NEt<sub>3</sub>, DMF, rt; (b) EtOH, KOH, CS<sub>2</sub>, H<sub>2</sub>O, rt; (c) EtNH<sub>2</sub>, aq NaOH, CS<sub>2</sub>, DMF, 10 °C to rt.</p></p></figure><figure id="sch7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0007.jpeg" id="gs7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 7. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800093c&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) EtS(C═S)SNa, THF, rt.</p></p></figure><div class="NLM_p">A wide range of trithiocarbonates of type <b>12</b> was accessible from substituted acetophenones <b>7</b> using the in situ bromination with PTT followed by addition of sodium ethyl trithiocarbonate (Scheme <a class="ref internalNav" href="#sch8" aria-label="8">8</a>, method a and Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). This methodolgy was also successful with certain heterocyclic ethanones such as pyrroles (<b>13</b>, Scheme <a class="ref internalNav" href="#sch9" aria-label="9">9</a>).</div><figure id="sch8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0008.jpeg" id="gs8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 8. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800093c&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) PTT, THF, rt; then EtS(C═S)SNa (method a); (b) TBDMSOTf, NEt<sub>3</sub>, THF; then NBS, 0 °C, then EtS(C═S)SNa, rt (method b); (c) NaHMDS, THF, −78 °C, then TMSCl, then Br<sub>2</sub>, then EtS(C═S)SNa, warm to rt (method c).</p></p></figure><figure id="sch9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0009.jpeg" id="gs9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 9. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800093c&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) PTT, THF, rt; then EtS(C═S)SNa.</p></p></figure><div class="NLM_p">The presence of six-membered nitrogen bearing heterocycles, especially pyridine groups, however, prevented the application of this methodology because no bromide formation with PTT was observed for these substrates. To circumvent this obstacle, alternative bromination methods were examined. NBS bromination of silylenolethers in situ prepared from the acetophenone and TBDMSOTf followed by addition of sodium ethyl trithiocarbonate was successful for the preparation of <b>12ag</b> (Scheme <a class="ref internalNav" href="#sch8" aria-label="8">8</a>, method b, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><div class="NLM_p">More general applicable was the preparation of silylenolethers using NaHMDS as base and TMSCl in tetrahydrofuran at low temperature. Addition of bromine to the reaction mixture followed by the addition of solution of sodium ethyl trithiocarbonate and warming to rt provided trithiocarbonates bearing pyridine and quinoline substituents (Scheme <a class="ref internalNav" href="#sch8" aria-label="8">8</a>, method c and Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Purification of the resulting products was sometimes difficult and required purification by preparative HPLC.</div><div class="NLM_p">Several trithiocarbonates containing sulfonamide moieties were prepared from 2-bromo-acetyl-benzenesulfonyl chlorides <b>14</b> by subsequent nucleophilic displacement with amines and then sodium ethyl trithiocarbonate (Scheme <a class="ref internalNav" href="#sch10" aria-label="10">10</a>, method d and Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><figure id="sch10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0010.jpeg" id="gs10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 10. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800093c&amp;id=sch10"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) RR’NH, DIPEA, THF, rt; then EtS(C═S)SNa (method d).</p></p></figure><div class="NLM_p">Outlined in Scheme <a class="ref internalNav" href="#sch11" aria-label="11">11</a> is the preparation of trithiocarbonate possessing a thiophene core structure. These compounds were derived from 5-acetyl-thiophene-2-carboxylic acid (<b>15</b>), which was converted into the amide using <i>iso</i>-butyl chloroformiate and <i>N</i>-methyl morpholine and subsequent addition of the requisite amine. The reaction mixture was directly treated with PTT followed by addition of sodium ethyl trithiocarbonate, therefore giving access to compounds <b>16a</b>−<b>e</b> in a four-step one-pot sequence (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><figure id="sch11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0011.jpeg" id="gs11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 11. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800093c&amp;id=sch11"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NMM, IBCF, THF, 0 °C, then RR’NH, rt, then PTT, then EtS(C═S)SNa. NMM: <i>N</i>-methyl-morpholine; IBCF: <i>i</i>-butylchloroformiate.</p></p></figure><div class="NLM_p">Its C1-homologues (<b>18a</b>−<b>e</b>) were prepared in similar sequence from commercially available chloro-acetyl thiophene carboxylic acid <b>17</b>, thus the bromination step was omitted in the sequence as shown in Scheme <a class="ref internalNav" href="#sch12" aria-label="12">12</a> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><figure id="sch12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0012.jpeg" id="gs12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 12. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800093c&amp;id=sch12"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NMM, IBCF, THF, 0 °C, then RR’NH, rt, then EtS(C═S)SNa. NMM: <i>N</i>-methyl-morpholine; IBCF: <i>i</i>-butylchloroformiate.</p></p></figure><div class="NLM_p">Finally, two related trithiocarbonates bearing a 2′-pyridinyl-2,5-thieno-acetyl core unit were prepared from commercially available 5-acetyl-2-thienyl-boronic acid (<b>19</b>) and respective 2-bromopyridine <b>20</b> using Suzuki-coupling conditions to yield the coupling products <b>21</b> in acceptable yield (Scheme <a class="ref internalNav" href="#sch13" aria-label="13">13</a>).</div><figure id="sch13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0013.jpeg" id="gs13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 13. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800093c&amp;id=sch13"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Pd(dppf)Cl<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O, rt; (b) NaHMDS, THF, −78 °C, then TMSCl, then Br<sub>2</sub>, then EtS(C═S)SNa, warm to rt; NaHMDS: sodium hexamethyldisilazide.</p></p></figure><div class="NLM_p last">The conversion into the trithiocarbonates <b>22</b> and <b>23</b> required again low temperature α-acetyl deprotonation using sodium hexamethyldisilazide (NaHDMS) followed by silylenolether formation, its subsequent bromination, and finally substitution with sodium ethyl trithiocarbonate.</div></div><div id="sec1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Biological Results and Discussion</h3><div class="NLM_p">The prepared trithiocarbonates and their analogues were examined for their HDAC inhibiting properties. For this purpose, the compounds were tested using a HDAC isoenzyme mixture purified from HeLa cervical carcinoma nuclei, containing at least HDAC isoenzymes 1, 2, 3, 5, and 8, as well as the recombinant isoforms rHDAC1 and rHDAC6 purified from HEK293 cells.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Their cellular activity in HeLa cervical carcinoma cells was evaluated by different assays, namely (i) an enzymatic HDAC activity assay,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> (ii) by quantification of histone H3 hyperacetylation using a single cell imaging assay,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and finally (iii) using the Alamar blue proliferation/cytotoxicity assay.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Recently, we reported about HDAC inhibitors bearing ethyl trithiocarbonate as a preferred head group<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> found in compounds <b>2</b> or <b>3a</b>. The lead compound <b>2</b> now was more deeply studied for its biochemical properties. Recombinant HDAC isoenzymes were inhibited with IC<sub>50</sub> = 6.99 µM for rHDAC1 and IC<sub>50</sub> = 1.25 µM for rHDAC6 (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>B/C). A substrate competitive mode-of-action was demonstrated in enzyme kinetic studies using rHDAC1 with a <i>K</i><sub>i</sub> value of 7 µM calculated from a Lineweaver−Burk plot (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A). Cellular HDAC activity in HeLa cells was concentration dependently inhibited, evident by an EC<sub>50</sub> of 4.8 µM for induction of histone H3 hyperacetylation and an IC<sub>50</sub> of 81.2 µM for inhibition of cellular HDAC activity (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A/B). A broad cytotoxicity was observed for compound <b>2</b> with a mean IC<sub>50</sub> of 8.31 µM over a panel of 21 different tumor cell lines representing 15 different cancer entities (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>A) and first evidence for a proliferation-dependent cytotoxicity (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>B). Compound <b>2</b> induced potent apoptosis in RKO colon carcinoma cells, evident by a massive population of cells in a subG1 cell cycle state (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>A). These experiments with the initial HTS hit compound <b>2</b> proved the HDAC inhibitory mode-of-action with similarities to the hydroxamate analogue SAHA in biochemical and cellular assays.</div><figure id="fig1" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0015.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Inhibition of HDAC enzymatic activity. Trithiocarbonate analogues, namely <b>2</b> as initial HTS hit, <b>3b</b> (dithiobutyrate analogue), <b>12ac</b> (phenylamide analogue), <b>18a</b> and <b>22</b> (thiophene analogues) were tested for inhibition of HeLa nuclear extract HDAC activity (A), rHDAC1 (B), and rHDAC6 (C) as class I and IIb representatives, respectively. SAHA was included as a reference HDAC inhibitor with the hydroxamate head group. IC<sub>50</sub> values calculated from the concentration−effect curves using Graphpad prism nonlinear curve fitting are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800093c&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0016.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Enzyme kinetic analysis of rHDAC1 and rHDAC6 inhibition. The initial hit <b>2</b> and the thiophene analogue <b>18d</b> were tested for inhibition of rHDAC1 enzymatic activity at various substrate concentrations up to 100 µM. Respective Lineweaver−Burk plots with calculated <i>K</i><sub>i</sub> values are shown in (A). A similar analysis was done for isoenzyme selective analogues <b>12ac</b> and <b>13</b> regarding inhibition of rHDAC6 at various substrate concentrations up to 100 µM. Respective Lineweaver−Burk plots with calculated <i>K</i><sub>i</sub> values are shown in (B). Ac-GGK(Ac)-AMC was used as the substrate for both, rHDAC1 and rHDAC6 assays.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800093c&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0018.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Inhibition of HDAC activity in HeLa cells. The inhibition of cellular HDAC activity by selected analogues <b>2</b>, <b>8c</b>, <b>18a</b>, <b>18c</b>, <b>22</b>, and SAHA as reference was measured in two independent assays in HeLa cells. The induction of histone H3 hyperacetylation was quantified by single-cell image analysis using the Cellomics Array Scan (A). The inhibition of HDAC enzymatic activity was quantified with the cell permeable HDAC substrate Boc-K(Ac)-AMC. After cell lysis, only the deacetylated substrate Boc-K-AMC is cleaved by trypsin with subsequent release of the fluorophore AMC.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800093c&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the basis of the published results for affix variations on ethyl trithiocarbonates,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> special emphasis was laid on the relevance of the trithiocarbonate moiety itself acting as the HDAC inhibitory head group. For the methoxy trithiocarbonate <b>3a</b>, a submicromolar inhibition of the nuclear extract HDAC isoenzyme mixture was determined (IC<sub>50</sub> = 0.375 µM, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). When the ethyl trithiocarbonate is exchanged for a dithiobutyrate (Z = CH<sub>2</sub>, <b>3b</b>), the HDAC inhibition is slightly enhanced (IC<sub>50</sub> = 0.123 µM). Similar HDAC inhibition is observed for the dithiocarbamate <b>3d</b> (Z = NH, IC<sub>50</sub> = 0.195 µM), while the dithiocarbonate <b>3c</b> is less active (Z = O, IC<sub>50</sub> = 0.811 µM). Thus, the nuclear extract is inhibited by all four ethyl derivatives <b>3a</b>−<b>3d</b>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Enzymatic and Cellular Assay Results for Compounds <b>3</b><a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0014.gif" alt="" id="_i6" /></img><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col width="9.98003992015968%" align="left" /></col><col width="9.98003992015968%" align="left" /></col><col width="9.98003992015968%" align="left" /></col><col width="9.98003992015968%" align="left" /></col><col width="10.379241516966067%" align="left" /></col><col width="9.880239520958083%" align="left" /></col><col width="9.98003992015968%" align="left" /></col><col width="9.98003992015968%" align="left" /></col><col width="9.880239520958083%" align="left" /></col><col width="9.98003992015968%" align="left" /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">compd</th><th align="center" valign="middle">X</th><th align="center" valign="middle">Y</th><th align="center" valign="middle">Z</th><th align="center" valign="middle">R</th><th align="center" valign="middle">HDAC nuc IC<sub>50</sub> [µM]</th><th align="center" valign="middle">rHDAC1 IC<sub>50</sub> [µM]</th><th align="center" valign="middle">rHDAC6 IC<sub>50</sub> [µM]</th><th align="center" valign="middle">cell HDAC IC<sub>50</sub> [µM]</th><th align="center" valign="middle">HeLa cytotoxicity IC<sub>50</sub> [µM]</th></tr></thead><tbody><tr valign="top"><td align="left"><b>3a</b></td><td align="left">S</td><td align="left">S</td><td align="left">S</td><td align="left">C<sub>2</sub>H<sub>5</sub></td><td align="left">0.375</td><td align="left">4.56</td><td align="left">1.22</td><td align="left">4.67</td><td align="left">1.96</td></tr><tr valign="top"><td align="left"><b>3b</b></td><td align="left">S</td><td align="left">S</td><td align="left">CH<sub>2</sub></td><td align="left">C<sub>2</sub>H<sub>5</sub></td><td align="left">0.123</td><td align="left">0.422</td><td align="left">0.110</td><td align="left">3.41</td><td align="left">5.71</td></tr><tr valign="top"><td align="left"><b>3c</b></td><td align="left">S</td><td align="left">S</td><td align="left">O</td><td align="left">C<sub>2</sub>H<sub>5</sub></td><td align="left">0.811</td><td align="left">1.38</td><td align="left">0.448</td><td align="left">4.72</td><td align="left">4.64</td></tr><tr valign="top"><td align="left"><b>3d</b></td><td align="left">S</td><td align="left">S</td><td align="left">NH</td><td align="left">C<sub>2</sub>H<sub>5</sub></td><td align="left">0.195</td><td align="left">0.215</td><td align="left">0.094</td><td align="left">nd</td><td align="left">7.80</td></tr><tr valign="top"><td align="left"><b>3e</b></td><td align="left">O</td><td align="left">S</td><td align="left">S</td><td align="left">C<sub>2</sub>H<sub>5</sub></td><td align="left">16% @</td><td align="left">6% @</td><td align="left">16% @</td><td align="left">28% @</td><td align="left">2.99</td></tr><tr valign="top"><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left">32 µM</td><td align="left">32 µM</td><td align="left">32 µM</td><td align="left">50 µM</td><td align="left"> </td></tr><tr valign="top"><td align="left"><b>3f</b></td><td align="left">NH</td><td align="left">S</td><td align="left">NH</td><td align="left">C<sub>2</sub>H<sub>5</sub></td><td align="left">−6% @</td><td align="left">nd</td><td align="left">nd</td><td align="left">nd</td><td align="left">5.81</td></tr><tr valign="top"><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left">30 µM</td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left"> </td></tr><tr valign="top"><td align="left"><b>3g</b></td><td align="left">NH</td><td align="left">S</td><td align="left">S</td><td align="left">C<sub>2</sub>H<sub>5</sub></td><td align="left">−3% @</td><td align="left">−17% @</td><td align="left">−8% @</td><td align="left">nd</td><td align="left">26% @</td></tr><tr valign="top"><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left">32 µM</td><td align="left">32 µM</td><td align="left">32 µM</td><td align="left"> </td><td align="left">50 µM</td></tr><tr valign="top"><td align="left"><b>3 h</b></td><td align="left">S</td><td align="left">O</td><td align="left">O</td><td align="left">C<sub>2</sub>H<sub>5</sub></td><td align="left">2.81</td><td align="left">21.2</td><td align="left">5.36</td><td align="left">9.79</td><td align="left">18.5</td></tr><tr valign="top"><td align="left"><b>3i</b></td><td align="left">S</td><td align="left">O</td><td align="left">NH</td><td align="left">C<sub>2</sub>H<sub>5</sub></td><td align="left">0.115</td><td align="left">0.368</td><td align="left">0.132</td><td align="left">3.18</td><td align="left">13.3</td></tr><tr valign="top"><td align="left"><b>3j</b></td><td align="left">S</td><td align="left">S</td><td align="left">S</td><td align="left">C<sub>2</sub>H<sub>4</sub>OPh</td><td align="left">0.128</td><td align="left">9.72</td><td align="left">4.57</td><td align="left">11.6</td><td align="left">5.46</td></tr><tr valign="top"><td align="left"><b>3k</b></td><td align="left">S</td><td align="left">S</td><td align="left">S</td><td align="left">C<sub>2</sub>H<sub>4</sub>NHAc</td><td align="left">0.467</td><td align="left">7.51</td><td align="left">1.64</td><td align="left">3.47</td><td align="left">11.1</td></tr><tr valign="top"><td align="left"><b>3l</b></td><td align="left">S</td><td align="left">S</td><td align="left">S</td><td align="left">C<sub>2</sub>H<sub>4</sub>OCH<sub>3</sub></td><td align="left">0.293</td><td align="left">8.94</td><td align="left">2.13</td><td align="left">5.53</td><td align="left">7.88</td></tr><tr valign="top"><td align="left"><b>3m</b></td><td align="left">S</td><td align="left">S</td><td align="left">bond</td><td align="left">−<i>N</i>-morpholinyl</td><td align="left">2% @</td><td align="left">0% @</td><td align="left">−2% @</td><td align="left">0% @</td><td align="left">−8% @</td></tr><tr valign="top"><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left"> </td><td align="left">32 µM</td><td align="left">32 µM</td><td align="left">32 µM</td><td align="left">32 µM</td><td align="left">50 µM</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">Biochemical and cellular assays were done in replicate and mean values are shown. IC<sub>50</sub> values were calculated from respective concentration−effect curves. Inhibition of cellular HDAC enzymatic activity and cytotoxicity was quantified in HeLa cervical carcinoma cells. nd: not determined.</p></div></div></div><div class="NLM_p">While the nuclear extract HDACs and rHDAC1 were almost equipotently inhibited by all dithio analogues <b>3b</b>−<b>3d</b> (1.1−3.4-fold difference, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), the trithiocarbonate <b>3a</b> inhibited rHDAC1 about 12-fold less potently (IC<sub>50</sub> = 4.56 µM) as the nuclear extract. This indicates the presence of another, not tested HDAC isoform(s) or HDAC multiprotein complex distinct to rHDAC1 and present in the nuclear extract, preferentially inhibited by trithiocarbonate representative <b>3a</b> compared to other dithio analogues <b>3b</b>−<b>3d</b>. In contrast, <b>3a</b> exhibited a slightly more potent rHDAC6 inhibition (IC<sub>50</sub> = 1.22 µM), a cytosolic isoenzyme not present in the nuclear extract. About 10 times more potent rHDAC6 inhibition was found for all dithio analogues <b>3b</b>−<b>3d</b>, especially for dithiocarboxylate <b>3b</b> and dithiocarbamate <b>3d</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><div class="NLM_p">For the trithiocarbonate <b>3a</b>, its enzymatic inhibition of rHDAC1 correlated well with cellular HDAC inhibition (IC<sub>50</sub> = 4.67 µM) and is also expressed by inhibition of proliferation/cytotoxicity toward HeLa cells (IC<sub>50</sub> = 1.96 µM). A direct correlation between rHDAC1 inhibition and cellular activity, however, is not found for dithiocarboxylate <b>3b</b> or dithiocarbamate <b>3d</b> and is less distinct for the dithiocarbonate <b>3c</b>.</div><div class="NLM_p">The replacement of the phenacyl bound sulfur in the headgroup for oxygen (X = O, <b>3e</b>) or nitrogen (X = NH, <b>3g</b> or <b>3f</b>) results in a complete loss of any HDAC inhibitory activity (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Finally, substitution of the central sulfur for oxygen was probed for the N- and O-analogues (Y = O, <b>3h</b> and <b>3i</b>). These compounds exhibited HDAC inhibition in a similar range as the corresponding sulfur analogues (Y = S, <b>3c</b> and <b>3d</b>) for the isoenzyme mixture, rHDAC1, and rHDAC6 (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The cellular HDAC inhibition and cytotoxicity of derivatives <b>3h</b> and <b>3i</b> was about 2-fold weaker compared to the sulfur analogues, resulting in a less pronounced correlation between rHDAC1 inhibition and cellular HDAC activity.</div><div class="NLM_p">In a next step, substitution of the ethyl group of the trithiocarbonates were investigated with the option to improve physicochemical properties of such compounds. Introduction of phenoxy- (<b>3j</b>) and methoxy-groups (<b>3l</b>) were tolerated as the nuclear extract (IC<sub>50</sub> = 0.128 and 0.293 µM, respectively, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) was inhibited in a similar range as the unsubstituted ethyl derivative <b>3a</b> (IC<sub>50</sub> = 0.375 µM). Similarily, the <i>N</i>-acetamide substitutent (<b>3k</b>) was found to be an active HDAC inhibitor. All three substituted ethyl derivatives <b>3j</b>−<b>3l</b> showed slightly decreased rHDAC1 and rHDAC6 activity compared to <b>3a</b>. The inhibition of cellular HDAC activity was found to be similar to <b>3a</b> and correlating well with rHDAC1 inhibition (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Interestingly, the most sterically demanding phenoxy derivative <b>3j</b> showed the lowest activity in both test systems. In contrast to cellular HDAC inhibitory activity, the cytotoxicity of the substituted derivatives <b>3j</b>−<b>3l</b> was significantly weaker compared to their unsubstituted parent compound <b>3a</b>. While variations of the ethyl moiety of trithiocarbonates were compatible with HDAC inhibition, a variation of dithiocarbamates toward more bulky, secondary dithiocarbamates lead to completely inactive compounds (<b>3m</b>).</div><div class="NLM_p">These results for the variation of the head group were reconfirmed in the structurally related <i>N</i>-acetamide series <b>8a</b>−<b>8d</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Again, all four analogues inhibit the nuclear extract in a similar range (IC<sub>50</sub> values from 87 to 386 nM, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) but more potently than the methoxy compounds <b>3a</b>−<b>3d</b>. Again, the differences for the nontrithiocarbonates <b>8b</b>−<b>8d</b> between inhibition of nuclear extract and rHDAC1 are subtle (1.4−1.9 times), while <b>8a</b> inhibits rHDAC1 about 5 times less potently. Potent rHDAC6 inhibition is found for all <i>N</i>-acetamide analogues <b>8a</b>−<b>8d</b>, especially dithiocarboxylate <b>8b</b> and dithiocarbamate <b>8d</b>, showing low nanomolar inhibition (IC<sub>50</sub> = 23 and 18 nM, respectively, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Enzymatic and Cellular Assay Results for Compounds <b>8</b><a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0017.gif" alt="" id="_i8" /></img><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">compd</th><th align="center" valign="middle">X</th><th align="center" valign="middle">R</th><th align="center" valign="middle" char=".">HDAC nuc IC<sub>50</sub> [µM]</th><th align="center" valign="middle" char=".">HDAC1 IC<sub>50</sub> [µM]</th><th align="center" valign="middle" char=".">rHDAC6 IC<sub>50</sub> [µM]</th><th align="center" valign="middle" char=".">cell HDAC IC<sub>50</sub> [µM]</th><th align="center" valign="middle" char=".">HeLa cytotoxicity IC<sub>50</sub> [µM]</th></tr></thead><tbody><tr valign="top"><td align="left"><b>8a</b></td><td align="left">S</td><td align="left">4-AcNH</td><td align="char" char=".">0.318</td><td align="char" char=".">1.68</td><td align="char" char=".">0.180</td><td align="char" char=".">0.857</td><td align="char" char=".">1.46</td></tr><tr valign="top"><td align="left"><b>8b</b></td><td align="left">CH<sub>2</sub></td><td align="left">4-AcNH</td><td align="char" char=".">0.087</td><td align="char" char=".">0.164</td><td align="char" char=".">0.023</td><td align="char" char=".">1.37</td><td align="char" char=".">6.41</td></tr><tr valign="top"><td align="left"><b>8c</b></td><td align="left">O</td><td align="left">4-AcNH</td><td align="char" char=".">0.386</td><td align="char" char=".">0.536</td><td align="char" char=".">0.090</td><td align="char" char=".">26.2</td><td align="char" char=".">3.61</td></tr><tr valign="top"><td align="left"><b>8d</b></td><td align="left">NH</td><td align="left">4-AcNH</td><td align="char" char=".">0.094</td><td align="char" char=".">0.141</td><td align="char" char=".">0.018</td><td align="char" char=".">1.12</td><td align="char" char=".">11.0</td></tr><tr valign="top"><td align="left"><b>8e</b></td><td align="left">S</td><td align="left">3-AcNH</td><td align="char" char=".">0.506</td><td align="char" char=".">2.93</td><td align="char" char=".">0.329</td><td align="char" char=".">3.28</td><td align="char" char=".">9.38</td></tr><tr valign="top"><td align="left"><b>8f</b></td><td align="left">S</td><td align="left">3-AcNHCH<sub>2</sub></td><td align="char" char=".">6.59</td><td align="char" char=".">38.24</td><td align="char" char=".">0.816</td><td align="char" char=".">6.82</td><td align="char" char=".">11.3</td></tr><tr valign="top"><td align="left"><b>8g</b></td><td align="left">S</td><td align="left">4-AcNHCH<sub>2</sub></td><td align="char" char=".">0.719</td><td align="char" char=".">7.12</td><td align="char" char=".">0.346</td><td align="char" char=".">2.07</td><td align="char" char=".">17.9</td></tr><tr valign="top"><td align="left"><b>8h</b></td><td align="left">S</td><td align="left">4-MeSO<sub>2</sub>NH</td><td align="char" char=".">1.26</td><td align="char" char=".">6.11</td><td align="char" char=".">1.09</td><td align="char" char=".">8.95</td><td align="char" char=".">45.8</td></tr><tr valign="top"><td align="left"><b>8i</b></td><td align="left">S</td><td align="left">4-AcN(Me)CH<sub>2</sub></td><td align="char" char=".">0.384</td><td align="char" char=".">0.946</td><td align="char" char=".">0.256</td><td align="char" char=".">6.33</td><td align="char" char=".">21.5</td></tr><tr valign="top"><td align="left"><b>8j</b></td><td align="left">S</td><td align="left">4-AcNHCH<sub>2</sub>CH<sub>2</sub></td><td align="char" char=".">0.587</td><td align="char" char=".">0.607</td><td align="char" char=".">0.102</td><td align="char" char=".">1.48</td><td align="char" char=".">12.8</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">Biochemical and cellular assays were done in replicate and mean values are shown. IC<sub>50</sub> values were calculated from respective concentration−effect curves. Inhibition of cellular HDAC enzymatic activity and cytotoxicity was quantified in HeLa cervical carcinoma cells.</p></div></div></div><div class="NLM_p">The complete inhibition of nuclear extract HDACs, rHDAC1, and rHDAC6 is exemplified for <b>8b</b> in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>. As seen before, a good correlation between enzymatic and cellular activity is found only for the trithiocarbonate <b>8a</b>, whereas for the dithio analogues <b>8b</b>−<b>8d</b>, this correlation is less distinct (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Respective concentration−effect curves for cellular HDAC inhibition and histone H3 hyperacetylation exemplified for <b>8c</b> are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a> (IC<sub>50</sub> values of 2.9 and 28 µM, respectively), verified by Western blotting for histone H3 hyperacetylation and p21<sup>waf</sup> induction in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> for <b>8b</b> and <b>8c</b>.</div><figure id="fig4" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0019.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Induction of p21<sup>waf</sup> expression, histone H3, and α-tubulin hyperacetylation. The induction of histone H3 K<sup>1−20</sup> hyperacetylation and p21<sup>waf1</sup> as a HDAC inhibitor marker gene was analyzed in HeLa cells, treated with analogues <b>8b</b>, <b>8c</b>, <b>12az</b>, <b>18a</b>, <b>18c</b>, <b>22</b>, and <b>23</b> at concentrations of 5 and 50 µM for 24 h (A). As a control, rehybridization was done with a β-actin specific antibody. The induction of histone H3 K<sup>1−20</sup> and α-tubulin hyperacetylation was studied in A549 NSCLC cells treated for 24 h with the HDAC6 selective analogues <b>12ac</b> and <b>13</b> (B). The natural product HC-toxin was included as HDAC inhibitor with weak, µM inhibition of HDAC6. As a control, rehybridization was done with antibodies specific for histone H3 or α-tubulin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800093c&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Having identified an amide substitutent at the phenacyl moiety to be beneficial for HDAC inhibition, several small analogues of <b>8a</b> were tested. Introduction of the <i>N</i>-acetyl substituent in <i>meta</i>-position (<b>8e</b>) instead of <i>para</i>-position (<b>8a</b>) lead to a decrease in enzymatic (about 2-fold) and cellular (about 5-fold) activity. Even more prominent was this difference between the <i>meta</i>- and <i>para</i>-position in the case of C1-homologues (<b>8f</b> and <b>8g</b>). While <i>para</i>-analogue <b>8g</b> exhibited slightly reduced HDAC activity compared to <b>8a</b> (about 2−4 times, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), the <i>meta</i>-derivative <b>8f</b> was more than 10-fold less active in nuclear extract and rHDAC1 inhibition (IC<sub>50</sub> values of 6.59 and 38.2 µM, respectively). Interestingly, rHDAC6 inhibition by <b>8f</b> and the cellular HDAC inhibition were found to be less reduced (about 2−3 times). Other <i>para</i>-<i>N</i>-acetyl derivatives were also studied. The <i>N</i>-methylsulfonamide <b>8h</b> proved to be a weaker HDAC inhibitor in the overall profile. <i>N-</i>acetyl-methylation of the C1-homologue (<b>8i</b>) or C2-homologenation (<b>8j</b>) resulted in potent rHDAC1 inhibitors in submicromolar range (IC<sub>50</sub> values of 0.946 and 0.607 µM, respectively, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), but their cellular activity, especially cytotoxicity toward Hela cells, were surprisingly modest.</div><div class="NLM_p">Next, trithiocarbonates with a phenylacetyl moiety as the core bearing larger amide substituents were studied in detail for their HDAC inhibitory effects (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Simple phenyl amide derivatives <b>12aa</b>−<b>12ad</b> proved to be effective HDAC inhibitors in regard to the HDAC isoenzyme mixture displaying submicromolar activity. In general, those compounds possess a remarkable selectivity for rHDAC6 over rHDAC1. The complete inhibition of nuclear extract, rHDAC1, and rHDAC6 is shown for <b>12ac</b> in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>. A substrate competitive mode-of-action for inhibition of rHDAC6 was determined with a <i>K</i><sub>i</sub> value of 0.11 µM (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B). In A549 NSCLC cells, α-tubulin hyperacetylation as a hallmark for cellular HDAC6 inhibition was strongly induced by <b>12ac</b> at 10 µM concentration, whereas the effect on histone H3 hyperacetylation was weak (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B). This nicely proved the HDAC6 selectivity also in a cellular context.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Enzymatic and Cellular Assay Results for Compounds <b>12</b><a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0020.gif" alt="" id="gr21" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_topbot"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0021.gif" alt="" id="_i10" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">Biochemical and cellular assays were done in replicate and mean values are shown. IC50 values were calculated from respective concentration−effect curves. Inhibition of cellular HDAC enzymatic activity and cytotoxicity was quantified in HeLa cervical carcinoma cells.</p></div></div></div><div class="NLM_p">The differences in activity between acetyl benzoic acid derived anilides <b>12aa</b> and <b>12ab</b> and the inverse amides <b>12ac</b> and <b>12ad</b> are marginal except for rHDAC6 inhibition, which was more effectively inhibited by <b>12ac</b> and <b>12ad</b>. As seen before for small amides, the position of ring substitution has a strong influence on rHDAC1 inhibition: <i>meta</i>-substituted derivatives <b>12aa</b> and <b>12ac</b> inhibit rHDAC1 with low micromolar activity (IC<sub>50</sub> values of 1.67 and 1.22 µM, respectively). The corresponding <i>para</i>-substituted derivatives, however, strongly loose their rHDAC1 inhibitory activity in case of the aniline derivative <b>12ad</b> (IC<sub>50</sub> = 10.4 µM) or almost completely in case of benzoic acid derivative <b>12ab</b> (IC<sub>50</sub> = 27.9 µM). Structural rigidity of the phenyl amide moiety might be an explanation for this remarkable isoenzyme selectivity, as the corresponding structurally more flexible <i>para</i>- and <i>meta</i>-substituted sulfonamide derivates <b>12ae</b> and <b>12af</b> do not discriminate in their rHDAC1 activity. The conformationally restricted amino-quinazoline <b>12ag</b> also inhibited the HDAC nuclear extract and rHDAC6 in submicromolar concentration, but rHDAC1 inhibition is also significantly reduced (IC<sub>50</sub> = 25.8 µM). The amides of 3-pyridine-carboxylic acid and 3-quinoline-carboxylic acid, <b>12ah</b>−<b>12ak</b>, were found to be strong HDAC inhibitors (IC<sub>50</sub> as low as 36 nM) and preferential inhibition of rHDAC6. rHDAC6 selectivity, however, is less prominent for the <i>para</i>-substituted derivatives <b>12ai</b> and <b>12ak</b>, as their rHDAC1 inhibition is in the micromolar range. For these compounds, the rHDAC1 inhibition correlates well with cellular HDAC inhibition resulting in submicromolar cellular activity, albeit their cytotoxic activity is weak. More evidence for the dependence of rHDAC1 inhibition on structural flexibility of the core phenyl substitution is provided by compounds <b>12al</b>−<b>12an</b>. A more than 8-fold difference in rHDAC1 inhibition between <i>meta</i>- and <i>para</i>-substituted benzylamides <b>12al</b> and <b>12am</b> was observed, but the constitutional <i>para</i>-isomer <b>12an</b>, which possess a less rigid connection to the phenyl core, again retained rHDAC1 inhibition (IC<sub>50</sub> = 0.523 µM). Another pair of <i>meta</i>- and <i>para</i>-substituted phenyl with potent HDAC inhibitory properties are phenoxy-ethylamino carboxamides <b>12ao</b> and <b>12ap</b>, which are low submicromolar HDAC inhibitors in the enzymatic assays as well as potent inhibitors of cellular HDAC activity, but again weakly cytotoxic. A final example for the loss of rHDAC1 inhibitory efficacy by the structural rigidity of <i>para</i>-substituted phenyl analogues represents the bis-phenyl urea <b>12aq</b>, which is 30-fold more active toward rHDAC6 (IC<sub>50</sub> = 0.606 µM) and 470-fold more active toward the nuclear extract isoenzyme mixture (IC<sub>50</sub> = 0.040 µM) compared to rHDAC1 (IC<sub>50</sub> = 18.8 µM).</div><div class="NLM_p">The next series of trithiocarbonates that were probed for HDAC inhibition were phenylsulfonamides (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Four 4-chloro-phenyl derivatives were compared and, as expected, the <i>para</i>-4-chloro-aniline carboxamide <b>12ar</b> was inactive in the rHDAC1 enzyme assay, while the corresponding sulfonamide <b>12as</b> exhibited submicromolar rHDAC1 and cellular HDAC inhibiton, besides a very potent inhibition of nuclear HDACs (IC<sub>50</sub> = 8 nM). The constitutional analogue <b>12at</b> was considerably less potent toward rHDAC1 (IC<sub>50</sub> = 2.49 µM), and the <i>meta</i>-substituted analogue <b>12au</b> has even lower enzymatic inhibitory activity that is also reflected in low cellular HDAC inhibition. The biochemical discrimination between <i>meta</i>- and <i>para</i>-substituted benzene sulfonamides was probed for the 4-methoxy-aniline sulfonamides <b>12av</b> and <b>12aw</b>. Both isomers were found to be potent inhibitors of the nuclear extract, but in contrast to the carboxamides (e.g., <b>12aa</b> and <b>12ab</b>), the <i>para</i>-substituted sulfonamide showed slightly enhanced activity at rHDAC1 and rHDAC6 (about 2-fold) and clearly superior cellular HDAC inhibition. Interestingly, all activity was 10-fold reduced by methylation of the sulfonamide moiety (<b>12ax</b>). Several other amino-aryl sulfonamides were low submicromolar HDAC inhibitors with cytotoxic activity of IC<sub>50</sub> = 7.7 and 9.18 µM for <b>12ay</b>−<b>12az</b>, respectively. The cellular activity of <b>12az</b> as HDAC inhibitor was proven by a strong induction of p21<sup>waf1</sup> and histone H3 hyperacetylation at 50 µM concentration in HeLa cells (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A).</div><div class="NLM_p">The HDAC inhibitory activity of the structurally related pyrrole-<i>N</i>-sulfonamide <b>13</b> was also studied in more detail (Scheme <a class="ref internalNav" href="#sch9" aria-label="9">9</a>). Nuclear HDACs were very potently inhibited with an IC<sub>50</sub> of 9 nM, while rHDAC1 inhibition was about 200-fold weaker (IC<sub>50</sub> = 2.1 µM). Compound <b>13</b> was found to be a very potent and selective HDAC6 inhibitor in biochemical (IC<sub>50</sub> = 56 nM) and cellular (EC<sub>50</sub> ≈ 5 µM) assays (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B), displaying a substrate competitive mode-of-action as determined by Lineweaver−Burk enzyme kinetic analysis (<i>K</i><sub>i</sub> = 0.14 µM, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B).</div><div class="NLM_p">Trithiocarbonates bearing a 2,5-disubstituted thiophene core instead of benzene as in compounds of type <b>16</b> were also potent HDAC inhibitors (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). The HDAC isoenzyme mixture was inhibited with IC<sub>50</sub> values from 19 to 63 nM, while the inhibition of rHDAC6 was weaker, especially for the sterically more demanding 3,5-dimethylbenzyl amine derivative <b>16d</b>. Remarkably, rHDAC1 was inhibited by all benzyl amine derivatives <b>16a</b>−<b>16d</b> with IC<sub>50</sub> values between 0.34 and 0.73 µM (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>), but as seen for the phenyl compounds <b>12</b>, the rigidified aniline amide <b>16e</b> was almost inactive (IC<sub>50</sub> = 31.6 µM). Noteworthy, the two enantiomers <b>16b</b> and <b>16c</b> had almost identical inhibitory activity. The activity of the amides <b>16</b> in biochemical assays was reflected in potent cellular enzymatic HDAC inhibition (IC<sub>50</sub> values from 0.41 to 1.45 µM), but very weak cytotoxicity was determined.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Enzymatic and Cellular Assay Results for Compounds <b>16</b> and <b>18</b><a class="ref internalNav" href="#tbl4-fn4" aria-label="d">d</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0022.gif" alt="" id="gr23" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_topbot"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0023.gif" alt="" id="_i12" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>a</sup><p class="last">Preparation according to Scheme <a class="ref internalNav" href="#sch11" aria-label="11">11</a>.</p></div><div class="footnote" id="tbl4-fn2"><sup>b</sup><p class="last">Preparation according to Scheme <a class="ref internalNav" href="#sch12" aria-label="12">12</a>.</p></div><div class="footnote" id="tbl4-fn3"><sup>c</sup><p class="last">Preparation according to Scheme <a class="ref internalNav" href="#sch13" aria-label="13">13</a>.</p></div><div class="footnote" id="tbl4-fn4"><sup>d</sup><p class="last">Biochemical and cellular assays were done in replicate and mean values are shown. IC50 values were calculated from respective concentration-effect curves. Inhibition of cellular HDAC enzymatic activity and cytotoxicity was quantified in HeLA cervical carcinoma cells.</p></div></div></div><div class="NLM_p">If the structural rigidity in the thienyl carboxamide bond was reduced by introduction of a methylene linker as in aryl-bearing amides <b>18a</b>−<b>18d</b>, potent HDAC inhibitors were obtained. For all derivatives, also reasonable rHDAC1 inhibitory activity was found, even for aniline derived carboxamides as <b>18c</b> (IC<sub>50</sub> = 0.25 µM, Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>), which was more active as its benzylamine analogue <b>18b</b> (IC<sub>50</sub> = 0.89 µM). rHDAC6 inhibition was also observed for <b>18a</b>−<b>18d</b>. Complete inhibition of nuclear extract, rHDAC1, and rHDAC6 isoenzymes is shown for <b>18a</b> in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, and the substrate competitive mode-of-action for rHDAC1 was proven for <b>18d</b> exemplarily (<i>K</i><sub>i</sub> = 0.46 µM, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A). Compound <b>18a</b> displays potent cytotoxicity toward HeLa cells (IC<sub>50</sub> = 0.71 µM) and was studied together with the close analogue <b>18c</b> in more detail. Histone H3 hyperacetylation is induced by <b>18a</b> and <b>18c</b> with EC<sub>50</sub> values of 2.4 and 0.76 µM, respectively (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A), also seen in respective Western Blot experiments for p21<sup>waf1</sup> and acetylated histone H3 (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A). Inhibition of cellular HDAC enzymatic activity was up to 10-fold weaker for both analogues. Compound <b>18a</b> was also characterized using the 21 tumor cell line panel, depicting a mean cytotoxicity of IC<sub>50</sub> = 1.41 µM, quite comparable to SAHA (mean IC<sub>50</sub> = 3.3 µM)<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> with some preferential activity toward hematological tumors (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). <figure id="fig5" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0024.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Cytotoxicity profile for selected trithiocarbonate analogues. The overall cytotoxicity profile was studied for <b>2</b> as the initial HTS hit and the potent thiophene analogues <b>18a</b> and <b>22</b>. A selection of 21 different solid and hematological tumor cell lines representing 15 different histotypes was treated for 72 h with the HDAC inhibitors before quantification of metabolic activity, correlating with cell viability/cell number. Mean graph blots with the deviation from the mean IC<sub>50</sub> expressed in log IC<sub>50</sub> [M] are shown in (A). In this graphic representation, the mean IC<sub>50</sub> value for a given compound is defined as “0” and deviations of individual IC<sub>50</sub> values (log IC<sub>50</sub> [M]) to higher and lower potency are expressed as negative and positive values, respectively. Mean IC<sub>50</sub> values were determined as 8.31 µM (−5.08) for <b>2</b>, 1.41 µM (−5.85) for <b>18a</b>, and 2.37 µM (−5.57) for <b>22</b>. Individual concentration−effect curves are shown for proliferating and arrested, nonproliferating RKO p21<sup>waf1</sup> colon carcinoma cells in (B). RKO p21<sup>waf1</sup> cells were arrested by induction of the cdk inhibitory p21<sup>waf1</sup> protein.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800093c&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div class="NLM_p">Finally, the two pyridinyl-thienoacetyl derivatives <b>22</b> and <b>23</b> were studied. Both compounds exhibited potent HDAC inhibition in the enzymatic assays. While the amino-quinoline substituted derivative <b>22</b> was a very potent inhibitor of the nuclear extract (IC<sub>50</sub> = 8 nM, Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>), inhibition of rHDAC1 and rHDAC6 with IC<sub>50</sub> values of 0.56 and 0.44 µM, respectively, was significantly weaker. The concentration-dependent activity of derivative <b>22</b> in the biochemical HDAC assays is shown in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, with a partial inhibition of rHDAC6 only. The 5-amino-pyridinyl bearing trithiocarbonate <b>23</b> was also active in the HeLa nuclear extract and rHDAC1 assays but with diminished potency. Nevertheless, rHDAC6 was potently inhibited with IC<sub>50</sub> = 43 nM. For both compounds, the activity in the cellular HDAC activity assay and cytotoxicity were in the same range. Respective cellular data for histone H3 hyperacetylation, p21<sup>waf1</sup> induction, and HDAC enzymatic activity are shown for analogues <b>22</b> and <b>23</b> in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A/B and Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A. Compound <b>22</b> was characterized using the 21 tumor cell line panel, depicting a mean cytotoxicity of IC<sub>50</sub> = 2.37 µM and a selectivity pattern similar to <b>18a</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>).</div><div class="NLM_p">HDAC inhibitors are well-known for affecting cell cycle regulation, depleting cells in the S-phase while transiently arresting in G1 and G2/M as shown for 5 µM SAHA treated RKO colon carcinoma cells in Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>. For most cytotoxic trithiocarbonate analogues, a partial proliferation-dependent cytotoxicity was seen in the RKO p21<sup>waf1</sup> cell system, highlighted for compounds <b>18a</b> and <b>22</b> in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>B. This was unexpected, although a partial proliferation-dependent cytotoxicity was seen for selected benzamide analogues in previous studies as well (data not shown). We therefore investigated the effects on RKO cell cycle distribution by compounds <b>2</b>, <b>8c</b>, <b>18a</b>, and <b>22</b> in more detail. All analogues induced depletion of S-phase cells and apoptosis after 24 h at 10 µM concentration (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>A). At 1 µM concentration, a partial arrest in G1 is evident for the thiophene analogues <b>18a</b> and <b>22</b>, a partial arrest in G2/M seen for <b>22</b> at the higher concentration of 10 µM. Recently, the interaction of HDAC3 with the mitotic kinase Aurora B and a HDAC3 dependent phosphorylation of histone H3 at residue S<sup>10</sup> by Aurora B was shown.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> In this study, hydroxamate analogues induced a strong reduction of histone H3 S<sup>10</sup> phosphorylation, a marker for mitotic arrest. This has been explained by dissociation of inactive HDAC3 from the Aurora B complex and subsequent hyperacetylation of histone H3 at residue K<sup>9</sup>.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> We therefore investigated the effect of selected trithiocarbonates on histone H3 S<sup>10</sup> phosphorylation. In contrast to the study by Li et al. using hydroxamates like TSA, compounds <b>8c</b> and <b>18a</b> induced histone H3 S<sup>10</sup> phosphorylation and in parallel H3 K<sup>1−20</sup> hyperacetylation (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>B). Compound <b>22</b> behaved as expected, only inducing histone H3 hyperacetylation, whereas compound <b>2</b> showed the opposite effect. All analogues induced α-tubulin hyperacetylation as evidence for cellular HDAC6 inhibition. Interestingly, this α-tubulin hyperacetylation was strongly reduced for compounds <b>2</b> and <b>18a</b> at the 10 µM concentration, inducing strong histone H3 S<sup>10</sup> phosphorylation and most likely mitotic arrest. From these experiments, we conclude that selected trithiocarbonate analogues show unique cellular properties with similarities to antimitotic agents like taxol, arresting RKO colon carcinoma cells transiently in mitosis before execution of apoptosis. We hypothesize that a new lysine specific protein deacetylase or a hypothetical mitotic HDAC complex are targeted by these antimitotic trithiocarbonate analogues.</div><figure id="fig6" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0025.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Cell cycle analysis and induction of histone H3S<sup>10</sup> phosphorylation. The effects of selected analogues <b>2</b>, <b>8c</b>, <b>18a</b>, and <b>22</b> on the cell division cycle of RKO colon carcinoma cells was studied by flow cytometry. RKO cells were treated for 24 h with the trithiocarbonate analogues at 1 and 10 µM concentration. The percentage of cells in apoptosis (subG1), G1(2N), S, and G2/M (4N) was determined and is shown in a column diagram in (A). 10 nM taxol as a tubulin interacting, antimitotic agent and 5 μM SAHA were included as control agents. The phosphorylation of histone H3 at residue S<sup>10</sup> in RKO cells treated for 24 h with <b>2</b>, <b>8c</b>, <b>18a</b>, and <b>22</b> at 1, 3, and 10 µM concentration was analyzed by Western blotting (B). Hyperacetylation of histone H3 K<sup>1−20</sup> as well as α-tubulin was analyzed in parallel. As a control, rehybridization was done with a β-actin specific antibody.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800093c&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40053" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40053" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Biological Methods</h3><div id="sec2_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> Biochemical HDAC Assay</h4><div class="NLM_p last">HDAC activity was isolated from HeLa nuclear extracts according to a method originally described by Dignam et al.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Mass cultures of HEK293 cell lines with stable expression of human rHDAC1 and rHDAC6 (kindly provided by E.Verdin, Gladstone Institute for Immunology, San Francisco) were lysed and flag-tagged proteins purified by M2-agarose affinity chromatography (Sigma art. no. A-2220). Fractions from the purification were analyzed by Western blotting and for specific activity in the biochemical enzyme assay. The HDAC enzyme activity assay was done essentially as described.<a onclick="showRef(event, 'ref14 ref32'); return false;" href="javascript:void(0);" class="ref ref14 ref32">(14, 32)</a> About 4 ng/well HDAC1 or 3 ng/well HDAC6 were incubated with 6 or 10 µM Ac-NH-GGK(Ac)-AMC, respectively, as a substrate for 2 or 3 h at 30 °C. For enzyme kinetic studies, rHDAC1 (specific activity 0.39 µmol/min/mg) and rHDAC6 (specific activity 0.78 µmol/min/mg) enzymes were incubated with different substrate and inhibitor concentrations. For both enzymes, the substrate Ac-GGK(Ac)-AMC was used up to 100 µM final concentration (<i>K</i><sub>m</sub> values of 32.3 and 7.3 µM for rHDAC1 and rHDAC6, respectively). For trithiocarbonate analogues, the concentrations were selected based on IC<sub>50</sub> values, namely <sup>1</sup>/<sub>4</sub>, <sup>1</sup>/<sub>2</sub>, 1, 2, and 4 times the EC<sub>50</sub> concentration. Substrate concentration (mol/L) was plotted versus enzyme velocity (µmol/min), and <i>K</i><sub>i</sub> values were calculated from Lineweaver−Burk plots using GraphPad prism algorithms. A substrate competitive bindung mode is evident by a point of intersection on the <i>y</i>-axis.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> Cellular Histone H3/Tubulin Hyperacetylation, p21, and Phosphohistone H3 Induction Assays</h4><div class="NLM_p">Histone H3 hyperacetylation was quantified using a single-cell based high content assay (HCS) format on the Cellomics “ArrayScan II” platform (Thermo Fisher Scientific, Waltham, MA) as described.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Briefly, HeLa cells in 96-well microtiter plates were treated with test compound for 24 h, fixed, permeabilized, and stained with a polyclonal rabbit antibody specific for histone H3K(Ac)<sup>1−20</sup> (Calbiochem, Darmstadt/Germany). Data analysis was done with the Cellomics algorithm “mitotic index”, calculating normalized nuclear fluorescence intensity, correlating with the level of histone H3 hyperacetylation.</div><div class="NLM_p last">In parallel to the histone H3 hyperacetylation assay, the cellular efficacy and mode-of-action of HDAC inhibitors was studied in treated HeLa, RKO, or A549 cell lysates by Western blotting using antibodies specific for acetylated or phosphorylated histone H3, acetylated α-tubulin, and p21<sup>waf1</sup>. After treatment with compound for 24 h, cells were lysed (50 mM Tris HCl pH 8, 150 mM NaCl, 1 v/v NP-40, 0.5% w/v Na-desoxycholate, 0.2% w/v disodiumdodecylsulfate (SDS), 0.02% NaN<sub>3</sub>, 1 mM Na-vanadate, 20 mM NaF, 100 µg/mL PMSF, protease inhibitor mix/Roche and 50U/mL benzonase) and respective equal amounts of protein separated by SDS-PAGE before transfer to polyvinylidendifluoride/PVDF membrane (Biorad) by semidry blotting. The following antibodies were used for Western blot analysis: Acetylated histone H3 K<sup>1−20</sup> (Calbiochem no. 382158), histone H3 (Cell Signaling no. 9715), phosphorylated histone H3 S<sup>10</sup> (Cell Signaling no. 9701), p21 (Santa Cruz no. SC-397), acetylated α-tubulin (Sigma T-6793), and β-actin (Sigma A-5441).</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> Cellular HDAC Enzymatic Activity Assay</h4><div class="NLM_p last">A 96-well microtiter plate assay was established using Boc-K(Ac)-AMC as substrate as described recently.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> HeLa cells were seeded into white 96-well tissue culture plates at a density of 5 × 10<sup>3</sup> cells/well and cultivated for 24 h under standard cell culture conditions. After treatment with trithiocarbonate analogues for 3 h, 10 µL/well of a 2 mM stock solution of the substrate Boc-K(Ac)-AMC in culture medium were added and incubation continued for additional 3 h before addition of 100µL/well lysis/developer buffer mix (50 mM Tris HCl pH 8.0, 137 mM NaCl, 2.7 mM KCl, 1 mM MgCl<sub>2</sub>, 1 vol % Nonidet P40, 2.0 mg/mL trypsin, 10 µM TSA). After final incubation for 3 h under cell culture conditions, AMC fluorescence was measured at an excitation of λ = 355 nm and emission of λ = 460 nm on the Perkin-Elmer Wallac Victor II V multilabel plate reader (Perkin-Elmer, Wellesley, MA).</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> Proliferation Assay and Tumor Cell Lines</h4><div class="NLM_p last">The antiproliferative activity of trithiocarbonate analogues on diverse tumor cell lines was evaluated by using the Alamar Blue (Resazurin) cell viability assay.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Cells were seeded into 96-well flat bottom plates at respective densities to allow proliferation during 72 h cultivation with test compound. The assay was done essentially done as described.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The following human tumor cell lines were used: H460 (nonsmall cell lung cancer, ATCC HTB-177), A549 (nonsmall cell lung cancer, ATCC CCL-185), MCF7 (breast carcinoma, ATCC HTB-22), MDA-MB468 (breast carcinoma, ATCC HTB-132), MDA-MB435 (HTB129), MDA-MB231 (breast carcinoma, ATCC HTB-26), SK-BR-3 (breast carcinoma, ATCC HTB-30), SK-OV-3 (ovarian carcinoma, ATCC HTB-77), HCT-15 (colon carcinoma, ATCC CCL-225), PC3 (prostate carcinoma, ATCC CRL-1435), AsPC1 (pancreatic carcinoma, ATCC CRL-1682), HeLa (cervical carcinoma, ATCC CCL-2), Cal27 (tongue carcinoma, ATCC CRL-2095), A-431 (vulva carcinoma, ATCC CRL-2592), Hec1A (endometrial carcinoma, ATCC HTB-112), Saos-2 (osteosarcoma, ATCC HTB-85), U87MG (glioblastoma, ATCC HTB-14), K562 (chronic myeloid leukemia, DSMZ ACC 10), EOL1 (acute hypereosinophilic myeloid leukemia, DSMZ ACC386), and CCRF-CEM and CCRF-CEM VCR1000 (acute lymphoblastic T-cell leukemia sensitive and resistant toward vincristine and DSMZ 240).<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The human colon adenocarcinoma cell line RKO and transfectant RKOp21<sup>waf1</sup> were described recently.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> p21<sup>waf1</sup> expression was induced by treatment with 10 µM ponasterone A for 24 h and RKO cells with/without p21<sup>waf1</sup> expression (2 × 10<sup>4</sup> cells/well induced, 6 × 10<sup>3</sup> cells/well not induced) were treated with the compounds as described.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> All cell lines were cultivated at 37 °C, 5% CO<sub>2</sub> in medium as stated on the ATCC, DSMZ, and ECACC information sheets or as published.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Flow Cytometric Analysis</h4><div class="NLM_p last">RKO colon carcinoma cells were seeded at 5 × 10<sup>5</sup> cells/10 cm cell culture dish 24 h before treatment to allow logarithmic proliferation during the experiment. After about 24 h, cells were treated with test compound for 24 and 48 h. Further procedure and flow cytomteric analysis was done as described using the Becton Dickinson FACS Canto device.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Chemical Procedures</h3><div class="NLM_p">Reagents and solvents were used as purchased from the supplier. Usually, reactions were run under nitrogen atmosphere (N<sub>2</sub>-balloon). Unless otherwise stated, preparations were typically performed on a 0.5 mmol scale. NMR spectra were recorded on a Bruker DPX200, a Bruker AV400, a Bruker AVII300, or on a Bruker AV600 in the solvent given. Mass spectra were recorded on a LCQ classic by Thermofinnigan and GC-MS spectra on a Trace MS (Thermofinnigan). Reaction progress was monitored by analytical LC-MS on an Agilent 1100.</div><div id="sec2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Preparation of Ethyl Trithiocarbonates (Procedure A)</h4><div class="NLM_p last">A 0.5 M solution of sodium ethyl trithiocarbonate was prepared by adding carbon disulfide (1.3 equiv) to a suspension of sodium thioethanolate (1.2 equiv) in tetrahydrofuran at room temperature and stirring of the resulting yellow solution for 30 min. Phenacyl bromide or chloride (1.0 equiv) was dissolved in ethyl acetate at room temperature and a 0.5 M solution of sodium ethyl trithiocarbonate (1.2 equiv) was added via syringe. After 1−3 h, the reaction mixture was diluted with half-saturated brine, and the aqueous phase was extracted with dichloromethane three times. The organic layer was dried via filtration through IST phase separator cartridge and evaporated to leave a yellowish residue, which was purified by chromatography (silica, hexanes to hexanes/ethyl acetate 1:1) providing the title compounds.</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Ethyl 2-(4-Methylphenyl)-2-oxoethyl Trithiocarbonate (<b>2</b>)</h4><div class="NLM_p last"><b>2</b> was prepared from 2-bromo-1-<i>p</i>-tolyl-ethanone using general procedure A; yellow solid (59%). <sup>1</sup>H NMR (DMSO-<i>d<sub>6</sub></i>, 400 MHz, rt) δ (ppm) : 7.94 (d, <i>J</i> = 8.2 Hz, 2H), 7.37 (d, <i>J</i> = 8.2 Hz, 2H), 5.10 (s, 2H), 3.38 (q, <i>J</i> = 7.3 Hz, 2H), 2.38 (s, 3H), 1.29 (t, <i>J</i> = 7.3 Hz, 3H). LC-MS (<i>m</i>/<i>e</i>): 271 [M + H]<sup>+</sup>.</div></div><div id="sec2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Ethyl 2-(4-Methoxyphenyl)-2-oxoethyl Trithiocarbonate (<b>3a</b>)</h4><div class="NLM_p last"><b>3a</b> was prepared from 2-bromo-1-(4-methoxy-phenyl)-ethanone using general procedure A; yellow solid (79%). <sup>1</sup>H NMR (DMSO-<i>d<sub>6</sub></i>, 200 MHz, rt) δ (ppm): 8.02 (d, <i>J</i> = 8.9 Hz, 2H), 7.08 (d, <i>J</i> = 8.9 Hz, 2H), 5.08 (s, 2H), 3.86 (s, 3H), 3.38 (q, <i>J</i> = 7.4 Hz, 2H), 1.29 (t, <i>J</i> = 7.4 Hz, 3H). LC-MS (<i>m</i>/<i>e</i>): 287 [M + H]<sup>+</sup>.</div></div><div id="sec2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 2-(4-Methoxyphenyl)-2-oxoethyl Dithiobutyrate (<b>3b</b>)</h4><div class="NLM_p last">A solution of 1-propylmagnesium bromide (1.0 equiv) in diethyl ether (2 M) was diluted with tetrahydrofuran (0.2 M) and cooled to −20 °C under a nitrogen atmosphere. Copper iodide (0.1 equiv) and, 5 min later, carbon disulfide (1.0 equiv) was added to yield a dark solution. After 20 min, 2-bromo-1-(4-methoxy-phenyl)-ethanone was added and the mixture was stirred for 5 min. The reaction mixture was then poured into brine and the aqueous phase was extracted with ethyl acetate. The organic phases were dried over anhydrous magnesium sulfate and evaporated. Chromatographical purification (silica, hexanes/ethyl acetate) provided <b>3b</b> as pale-yellow oil (13%). <sup>1</sup>H NMR (DMSO-<i>d<sub>6</sub></i>, 200 MHz, rt) δ (ppm): 8.01 (d, <i>J</i> = 9.6 Hz, 2H), 6.97 (d, <i>J</i> = 9.6 Hz, 2H), 4.76 (s, 2H), 3.89 (s, 3H), 3.06 (t, <i>J</i> = 7.5 Hz, 2H), 1.92 (quin, <i>J</i> = 7.2 Hz, 2H), 1.00 (t, <i>J</i> = 7.4 Hz, 3H). LC-MS (<i>m</i>/<i>e</i>): 269 [M + H]<sup>+</sup>.</div></div><div id="sec2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> <i>O</i>-Ethyl <i>S</i>-2-(4-methoxy-phenyl)-2-oxoethyl Dithiocarbonate (<b>3c</b>)</h4><div class="NLM_p last">A 0.5 M solution of sodium ethanolate (1.0 equiv) was added carbon disulfide (1.15 equiv) in tetrahydrofuran at room temperature, and the resulting solution was stirred for 30 min. 4-Methoxy-phenacylbromide (1.0 equiv) was added via syringe. After 1 h, the reaction mixture was diluted with half-saturated brine and the aqueous phase was extracted with dichloromethane three times. The organic layer was dried via filtration through an IST phase separator cartridge and evaporated to leave a yellowish residue, which was purified by chromatography (silica gel, hexanes to hexanes/ethyl acetate 1:1), providing <b>3c</b> as whitish solid (93%). <sup>1</sup>H NMR (DMSO-<i>d<sub>6</sub></i>, 200 MHz, rt) δ (ppm): 8.00 (d, <i>J</i> = 8.9 Hz, 2H), 7.08 (d, <i>J</i> = 8.9 Hz, 2H), 4.88 (s, 2H), 4.22 (q, <i>J</i> = 7.1 Hz, 2H), 3.86 (s, 3H), 1.21 (t, <i>J</i> = 7.3 Hz, 3H). GC-MS: 271 [M]<sup>+</sup>, 135 [M-119]<sup>+</sup>.</div></div><div id="sec2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> <i>N</i>-Ethyl <i>S</i>-2-(4-Methoxy-phenyl)-2-oxoethyl Dithiocarbamate (<b>3d</b>)</h4><div class="NLM_p last">A solution of 2-mercapto-1-(4-methoxy-phenyl)-ethanone <b>4</b> (1.0 equiv) in tetrahydrofuran (0.2 M) was treated with ethylthioisocyanate (1.2 equiv) at 0 °C. The reaction mixture was allowed to warm to rt overnight, poured into saturated sodium bicarbonate solution, and extracted with ethyl acetate. The organic phases were dried over anhydrous magnesium sulfate and evaporated to yield <b>3i</b> as pale-white powder (71%). <b>3d</b> exists in solution in equilibrium with a cyclized hemiaminal with the ratio being dependent on the solvent. <sup>1</sup>H NMR (DMSO-<i>d<sub>6</sub></i>, 400 MHz, rt) open chain δ (ppm): 10.05 (bs, 1H), 8.01 (d, <i>J</i> = 8.9 Hz, 2H), 7.08 (d, <i>J</i> = 8.9 Hz, 2H), 4.84 (s, 2H), 3.86 (s, 3H), 3.66 (m, 2H), 1.15 (t, <i>J</i> = 7.2 Hz, 3H). Cyclized hemiaminal δ (ppm): 7.57 (s, 1H), 7.36 (d, <i>J</i> = 8.8 Hz, 2H), 6.99 (d, <i>J</i> = 8.8 Hz, 2H), 3.69 (s, 3H), 3.57 (s, 2H), 3.57 (qd, <i>J</i> = 7.1, 6.5 Hz, 1H), 3.22 (qd, <i>J</i> = 7.1, 6.5 Hz, 1H), 0.98 (t, <i>J</i> = 7.1 Hz, 2H). LC-MS (<i>m</i>/<i>e</i>): 270 [M + H]<sup>+</sup>.</div></div><div id="sec2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> <i>S-</i>Ethyl <i>O</i>-2-(4-Methoxy-phenyl)-2-oxoethyl Dithiocarbonate (<b>3e</b>)</h4><div class="NLM_p last">A mixture of 2-hyxdroxy-1-(4′-methoxyphenyl)-ethanone (<b>6</b>) (0.50 g, 3.0 mmol), ethyleneglycol (4 mL), and amberlyst 15 (0.80 g) in benzene was refluxed in a Dean−Stark apparatus for 3 h. The mixture was extracted with saturated bicarbonate solution and brine, and the solvents were removed under reduced pressure to leave the product, which was used without further purification. A solution of the dioxolane (0.6 g, 2.9 mmol) in tetrahydrofuran (19 mL) was added dropwise to a suspension of NaH (60% in mineral oil, 0.28 g, 7.1 mmol) and imidazole (10 mg) in tetrahydrofuran (25 mL) at 0 °C. After stirring for 30 min at rt, carbon disulfide (430 µL, 7.1 mmol) was added. The mixture was again stirred for 30 min, before ethyl iodide (575 µL, 7.1 mmol) was added and the mixture was stirred for further 1 h. Then the reaction mixture was poured onto ice and extracted with ethyl acetate. The organic phases were dried over anhydrous magnesium sulfate and evaporated. The residue was purified using chromatography (silica, dichloromethane/hexanes 4:1) to yield the product as whitish solid (0.65 g, 72%). The mixture of the resulting dioxolane (0.30 g, 0.95 mmol) in tetrahydrofuran/H<sub>2</sub>O (3:1, 4 mL) was treated with a few drops of conc HCl and stirred at 60 °C for 4 h. The reaction mixture was poured into water and extracted with dichloromethane. The organic phases were dried over anhydrous magnesium sulfate and evaporated. The residue was purified using chromatography (silica, dichloromethane/hexanes 3:2) to yield <b>3e</b> as a colorless solid (0.20 g, 78%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 200 MHz, rt) δ (ppm): 7.92 (d, <i>J</i> = 9.2 Hz, 2H), 6.97 (d, <i>J</i> = 9.2 Hz, 2H), 5.84 (s, 2H), 3.88 (s, 3H), 3.19 (q, <i>J</i> = 7.1 Hz, 2H), 1.39 (t, <i>J</i> = 7.1 Hz, 3H). LC-MS (<i>m</i>/<i>e</i>): 271 [M + H]<sup>+</sup>.</div></div><div id="sec2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Preparation of Trithiocarbonates (Procedure B)</h4><div class="NLM_p last">A 0.5 M solution of alkyl sodium trithiocarbonate is prepared by adding carbon disulfide (1.15 equiv) to a suspension of the requisite sodium thiolate (1.0 equiv) in tetrahydrofuran at room temperature and stirring of the resulting yellow solution for 30 min. Phenacyl bromide (1.0 equiv) was dissolved in ethyl acetate at room temperature, and a 0.5 M solution of sodium alkyl trithiocarbonate (1.2 equiv) was added via syringe. After 1−3 h, the reaction mixture was diluted with half-saturated brine and the aqueous phase was extracted with dichloromethane three times. The organic layer was dried via filtration through an IST phase separator cartridge and evaporated to leave a yellowish residue, which was purified by chromatography (silica gel, hexanes to hexanes/ethyl acetate 1:1), providing the title compounds.</div></div><div id="sec2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Preparation of Trithiocarbonates Using PTT in Situ Bromination, Method a (Procedure C)</h4><div class="NLM_p last">A solution of phenylethanone <b>7</b> (1.0 equiv) in tetrahydrofuran (0.2−0.5 M) was treated with phenyltrimethylammonium tribromide (PTT, 1.1 equiv) at rt. The mixture was stirred at rt until the reaction was complete (TLC control and appearance of a white precipitate, 3 min to 16 h). To this reaction mixture, a 0.5 M solution of sodium ethyl trithiocarbonate (1.5−3 equiv) was added via syringe. After completion of the reaction, the reaction mixture was diluted with half-saturated brine and the aqueous phase was extracted with dichloromethane three times. The organic layer was dried via filtration through an IST phase separator cartridge and evaporated to leave a yellowish residue, which was purified by chromatography (silica, hexanes to hexanes/ethyl acetate 1:1), providing the title compounds.</div></div><div id="sec2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 2-(4-Acetylamino-phenyl)-2-oxoethyl Ethyl Trithiocarbonate (<b>8a</b>)</h4><div class="NLM_p last"><b>8a</b> was prepared from <i>N</i>-(4-acetyl-phenyl)-acetamide according to general procedure C; yellow solid (53%). <sup>1</sup>H NMR (DMSO-<i>d<sub>6</sub></i>, 200 MHz, rt) δ (ppm): 10.30 (s, 1H), 8.03 (d, <i>J</i> = 8.7 Hz, 2H), 7.76 (d, <i>J</i> = 8.7 Hz, 2H), 5.08 (s, 2H), 3.39 (q, <i>J</i> = 7.4 Hz, 2H), 2.10 (s, 3H), 1.29 (t, <i>J</i> = 7.4 Hz, 3H). LC-MS (<i>m</i>/<i>e</i>): 314 [M + H]<sup>+</sup>.</div></div><div id="sec2_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> <i>O</i>-Ethyl <i>S</i>-2-(4-Acetamido-phenyl)-2-oxoethyl Dithiocarbonate (<b>8c</b>)</h4><div class="NLM_p last">Ethyl chloroformiate (210 µL, 2.2 mmoL) was added a solution of 2-mercapto-1-(4-methoxy-phenyl)-ethanone (365 mg, 2.0 mmol) in 4 mL of tetrahydrofuran at rt. Diisopropylethylamine (346 µL, 2.5 mmol) was added, and the mixture was stirred overnight. The reaction mixture was treated with half-saturated brine, and the aqueous phase was extracted with ethyl acetate. The organic phases were dried over anhydrous magnesium sulfate and evaporated. The residue was purified using rotating preparative thin layer chromatography (hexanes/ethyl acetate gradient) to yield <b>8c</b> as whitish solid (93%). <sup>1</sup>H NMR (DMSO-<i>d<sub>6</sub></i>, 200 MHz, rt) δ (ppm): 8.00 (d, <i>J</i> = 8.9 Hz, 2H), 7.08 (d, <i>J</i> = 8.9 Hz, 2H), 4.53 (s, 2H), 4.22 (q, <i>J</i> = 7.1 Hz, 2H), 3.86 (s, 3H), 1.21 (t, <i>J</i> = 7.3 Hz, 3H). GC-MS (<i>m</i>/<i>e</i>): 254 [M]<sup>+</sup>, 135 [M-119]<sup>+</sup>.</div></div><div id="sec2_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 2-(3-Acetylamino-phenyl)-2-oxoethyl Ethyl Trithiocarbonate (<b>8e</b>)</h4><div class="NLM_p last"><b>8e</b> was prepared from <i>N</i>-(3-acetyl-phenyl) acetamide according to procedure C; yellow solid (70%). <sup>1</sup>H NMR (DMSO-<i>d<sub>6</sub></i>, 400 MHz, rt) δ (ppm): 10.15 (s, 1H), 8.19 (s, 1H), 7.90 (d, <i>J</i> = 8.1 Hz, 1H), 7.77 (d, <i>J</i> = 7.9 Hz, 1H), 7.50 (d, <i>J</i> = 7.0 Hz, 1H), 5.10 (s, 2H), 3.39 (q, <i>J</i> = 7.4 Hz, 2H), 2.07 (s, 3H), 1.29 (t, <i>J</i> = 7.3 Hz, 3H). LC-MS (<i>m</i>/<i>e</i>): 314 [M + H]<sup>+</sup>.</div></div><div id="sec2_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 2-[4-(Acetylamino-methyl)-phenyl]-2-oxoethyl Ethyl Trithiocarbonate (<b>8g</b>)</h4><div class="NLM_p last"><b>8g</b> was prepared from <i>N</i>-(4-acetyl-benzyl)-acetamide according to general procedure C; yellow solid (70%). <sup>1</sup>H NMR (DMSO-<i>d<sub>6</sub></i>, 200 MHz, rt) δ (ppm): 8.43 (t, <i>J</i> = 6.0 Hz, 1H), 8.00 (d, <i>J</i> = 8.3 Hz, 2H), 7.42 (d, <i>J</i> = 8.3 Hz, 2H), 5.10 (s, 2H), 4.34 (d, <i>J</i> = 6.0 Hz, 2H), 3.38 (q, <i>J</i> = 7.4 Hz, 2H), 1.90 (s, 3H), 1.29 (t, <i>J</i> = 7.4 Hz, 3H). LC-MS (<i>m</i>/<i>e</i>): 328 [M + H]<sup>+</sup>.</div></div><div id="sec2_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Ethyl 2-(4-Methanesulfonylamino-phenyl)-2-oxoethyl Trithiocarbonate (<b>8h</b>)</h4><div class="NLM_p last"><b>8h</b> was prepared from 2-chloro-1-(4-methanesulfonylamino-phenyl)-ethanone using general procedure A; yellow oil (64%). <sup>1</sup>H NMR (DMSO-<i>d<sub>6</sub></i>, 200 MHz, rt) δ (ppm): 10.35 (s, 1H), 8.04 (d, <i>J</i> = 8.8 Hz, 2H), 7.32 (d, <i>J</i> = 8.8 Hz, 2H), 5.08 (s, 2H), 3.38 (q, <i>J</i> = 7.3 Hz, 2H), 3.14 (s, 3H), 1.29 (t, <i>J</i> = 7.4 Hz, 3H). LC-MS (<i>m</i>/<i>e</i>): 350 [M + H]<sup>+</sup>.</div></div><div id="sec2_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Preparation of Arylamide Trithiocarbonates (Procedure D)</h4><div class="NLM_p last">A solution of the acetyl-aryl carboxylic acid (1.0 equiv) in tetrahydrofuran (0.3 M) was cooled to 0 °C, then isobutyl chloroformate (1.1 equiv) and <i>N</i>-methyl-morpholine (1.05 equiv) were added and the mixture was stirred for 45 min. The corresponding amine (1.2 equiv) was added, and the mixture was allowed to warm to rt slowly. After 18 h, phenyltrimethylammonium tribromide (PTT, 1.1 equiv) was added and the mixture was stirred at rt (1−18 h) until the orange solution became colorless and a white precipitate was observed. A solution of sodium ethyl trithiocarbonate (0.5 M in tetrahydrofuran, 2.0 equiv) was added and the mixture was stirred again for 2−18 h. After completion of the reaction, the reaction mixture was diluted with half-saturated brine, and the aqueous phase was extracted with dichloromethane. The organic layer was evaporated to leave a yellowish residue, which was purified either by chromatography (silica, hexanes/ethyl acetate gradient) or by washing the solid with a little ethyl acetate, providing the title compound as a pale-yellow solid.</div></div><div id="sec2_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Ethyl 2-oxo-2-(3-Phenylcarbamoyl-phenyl)-ethyl Trithiocarbonate (<b>12aa</b>)</h4><div class="NLM_p last"><b>12aa</b> was prepared from aniline and 3-acetyl-benzoic acid according to general procedure D; yellow solid (18%). <sup>1</sup>H NMR (DMSO-<i>d<sub>6</sub></i>, 400 MHz, rt) δ (ppm): 10.45 (s, 1H), 8.58 (s, 1H), 8.27 (t, <i>J</i> = 6.3 Hz, 2H), 7.79 (d, <i>J</i> = 7.7 Hz, 2H), 7.75 (t, <i>J</i> = 7.8 Hz, 1H), 7.39 (t, <i>J</i> = 7.6 Hz, 2H), 7.14 (t, <i>J</i> = 7.4 Hz, 1H), 5.23 (s, 2H), 3.40 (q, <i>J</i> = 7.4 Hz, 2H), 1.30 (t, <i>J</i> = 7.4 Hz, 3H). LC-MS (<i>m</i>/<i>e</i>): 376 [M + H]<sup>+</sup>.</div></div><div id="sec2_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Ethyl 2-oxo-2-(4-Phenylcarbamoyl-phenyl)-ethyl Trithiocarbonate (<b>12ab</b>)</h4><div class="NLM_p last"><b>12ab</b> was prepared from aniline and 4-acetyl-benzoic acid according to general procedure D; yellow solid (30%). <sup>1</sup>H NMR (DMSO-<i>d<sub>6</sub></i>, 200 MHz, rt) δ (ppm): 10.45 (s, 1H), 8.19 (d, <i>J</i> = 8.5 Hz, 2H), 8.10 (d, <i>J</i> = 8.5 Hz, 2H), 7.80 (d, <i>J</i> = 7.6 Hz, 2H), 7.38 (t, <i>J</i> = 7.6 Hz, 2H), 7.13 (t, <i>J</i> = 7.3 Hz, 1H), 5.18 (s, 2H), 3.39 (q, <i>J</i> = 7.3 Hz, 2H), 1.30 (t, <i>J</i> = 7.3 Hz, 3H). LC-MS (<i>m</i>/<i>e</i>): 376 [M + H]<sup>+</sup>.</div></div><div id="sec2_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Preparation of Pyrimidylamide Trithiocarbonates, Method c (Procedure E)</h4><div class="NLM_p last">A solution of the 1-(hetero)aryl-ethanone (1.0 equiv) in tetrahydrofuran (0.08 M) was treated with a solution of sodium hexamethyldisilazide (1.1−2.2 equiv) at −78 °C and then stirred for 0.5 h. Trimethylsilylchloride (1.1−2.2 equiv) was added, and the mixture was stirred for 1 h at −78 °C. After the addition of a solution of bromine (1.0 equiv) in tetrahydrofuran (0.5 M), the mixture was stirred again for 1 h at −78 °C and then allowed to warm to rt. A solution of sodium ethyl trithiocarbonate (0.5 M in tetrahydrofuran, 3.0 equiv) was added, and the mixture was stirred again for 2−18 h. The reaction mixture was poured into a 2:1 mixture of 5% sodium bicarbonate and 5% sodium bisulfite solution and extracted with ethyl acetate. The organic phases were washed with brine and dried with sodium sulfate. Evaporation in vacuo gave an oily residue, which was purified by chromatography (silica, hexanes/ethyl acetate gradient) or by preparative HPLC (acetonitrile/water gradient), providing the title compounds.</div></div><div id="sec2_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 2-(3-Benzylcarbamoyl-phenyl)-2-oxoethyl Ethyl Trithiocarbonate (<b>12al</b>)</h4><div class="NLM_p last"><b>12al</b> was prepared from benzylamine and 3-acetyl-benzoic acid according to general procedure D; yellow solid (63%). <sup>1</sup>H NMR (DMSO-<i>d<sub>6</sub></i>, 400 MHz, rt) δ (ppm): 9.30 (t, <i>J</i> = 5.9 Hz, 1H), 8.56 (s, 1H), 8.21 (d, <i>J</i> = 7.8 Hz, 2H), 7.70 (t, <i>J</i> = 7.7 Hz, 1H), 7.36−7.33 (m, 4H), 7.29−7.23 (m, 1H), 5.19 (s, 2H), 4.53 (d, <i>J</i> = 5.9 Hz, 2H), 3.38 (q, <i>J</i> = 7.4 Hz, 2H), 1.29 (t, <i>J</i> = 7.4 Hz, 3H). LC-MS (<i>m</i>/<i>e</i>): 390 [M + H]<sup>+</sup>.</div></div><div id="sec2_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 2-(4-Benzylcarbamoyl-phenyl)-2-oxoethyl Ethyl Trithiocarbonate (<b>12am</b>)</h4><div class="NLM_p last"><b>12am</b> was prepared from benzylamine and 4-acetyl-benzoic acid according to general procedure D; yellow solid (49%). <sup>1</sup>H NMR (DMSO-<i>d<sub>6</sub></i>, 200 MHz, rt) δ (ppm): 9.23 (t, <i>J</i> = 5.9 Hz, 1H), 8.16 (d, <i>J</i> = 8.5 Hz, 2H), 8.04 (d, <i>J</i> = 8.5 Hz, 2H), 7.36−7.23 (m, 5H), 5.16 (s, 2H), 4.50 (d, <i>J</i> = 5.9 Hz, 2H), 3.38 (q, <i>J</i> = 7.4 Hz, 2H), 1.29 (t, <i>J</i> = 7.4 Hz, 3H). LC-MS (<i>m</i>/<i>e</i>): 390 [M + H]<sup>+</sup>.</div></div><div id="sec2_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Preparation of Pyrimidylamide Trithiocarbonates, Method d (Procedure F)</h4><div class="NLM_p last">A solution of 4-(2-bromo-acetyl)-benzenesulfonic acid chloride (1.0 equiv) in tetrahydrofuran (0.08 M) was treated with the requisite arylamine (1.1−2.2 equiv) and diisopropylethylamine (1.1 equiv) at rt and then stirred for 0.5 h. A solution of sodium ethyl trithiocarbonate (0.5 M in tetrahydrofuran, 3.0 equiv) was added, and the mixture was stirred again for 18 h. The reaction mixture was poured into a 2:1 mixture of 5% sodium bicarbonate and extracted with ethyl acetate. The organic phases were washed with brine and dried with sodium sulfate. Evaporation in vacuo gave an oily residue, which was purified by chromatography (silica, hexanes/ethyl acetate gradient) or by preparative HPLC (acetonitrile/water gradient), providing the title compounds.</div></div><div id="sec2_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> Ethyl 2-oxo-2-[5-((<i>S</i>)-1-phenyl-ethylcarbamoyl)-thiophen-2-yl]-ethyl Trithiocarbonate (<b>16b</b>)</h4><div class="NLM_p last"><b>16b</b> was prepared from (<i>S</i>)-1-phenyl-ethylamine and 5-acetyl-thiophene-2-carboxylic acid according to general procedure E; yellow solid (6%). <sup>1</sup>H NMR (DMSO-<i>d<sub>6</sub></i>, 400 MHz, rt) δ (ppm): 9.15 (d, <i>J</i> = 8.0 Hz, 1H), 8.18 (d, <i>J</i> = 4.0 Hz, 1H), 8.01 (d, <i>J</i> = 4.0 Hz, 1H), 7.40 (d, <i>J</i> = 7.2 Hz, 2H), 7.35 (t, <i>J</i> = 7.2 Hz, 2H), 7.25 (t, <i>J</i> = 7.1 Hz, 1H), 5.13 (quint, <i>J</i> = 7.4 Hz, 1H), 5.07 (s, 2H), 4.48 (d, <i>J</i> = 6.0 Hz, 2H), 3.38 (q, <i>J</i> = 7.3 Hz, 2H), 1.50 (d, <i>J</i> = 7.1 Hz, 3H), 1.29 (t, <i>J</i> = 7.4 Hz, 3H). LC-MS (<i>m</i>/<i>e</i>): 410 [M + H]<sup>+</sup>.</div></div><div id="sec2_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> Ethyl 2-oxo-2-[5-((<i>R</i>)-1-Phenyl-ethylcarbamoyl)-thiophen-2-yl]-ethyl Trithiocarbonate (<b>16c</b>)</h4><div class="NLM_p last"><b>16c</b> was prepared from (<i>R</i>)-1-phenyl-ethylamine and 5-acetyl-thiophene-2-carboxylic acid according to general procedure D; yellow solid (44%). <sup>1</sup>H NMR (DMSO-<i>d<sub>6</sub></i>, 400 MHz, rt) δ (ppm): 9.15 (d, <i>J</i> = 8.0 Hz, 1H), 8.18 (d, <i>J</i> = 4.0 Hz, 1H), 8.01 (d, <i>J</i> = 4.0 Hz, 1H), 7.40 (d, <i>J</i> = 7.2 Hz, 2H), 7.35 (t, <i>J</i> = 7.2 Hz, 2H), 7.25 (t, <i>J</i> = 7.1 Hz, 1H), 5.13 (quint, <i>J</i> = 7.4 Hz, 1H), 5.07 (s, 2H), 4.48 (d, <i>J</i> = 6.0 Hz, 2H), 3.38 (q, <i>J</i> = 7.3 Hz, 2H), 1.50 (d, <i>J</i> = 7.1 Hz, 3H), 1.29 (t, <i>J</i> = 7.4 Hz, 3H). LC-MS (<i>m</i>/<i>e</i>): 410 [M + H]<sup>+</sup>.</div></div><div id="sec2_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 2-[5-(3,5-Dimethyl-benzylcarbamoyl)-thiophen-2-yl]-2-oxoethyl Ethyl Trithiocarbonate (<b>16d</b>)</h4><div class="NLM_p last"><b>16d</b> was prepared from 3,5-dimethyl-benzylanime and 5-acetyl-thiophene-2-carboxylic acid according to general procedure D; yellow solid (21%). <sup>1</sup>H NMR (DMSO-<i>d<sub>6</sub></i>, 400 MHz, rt) δ (ppm): 9.27 (t, <i>J</i> = 5.9 Hz, 1H), 8.16 (d, <i>J</i> = 4.1 Hz, 1H), 7.90 (d, <i>J</i> = 4.1 Hz, 1H), 6.92 (s, 2H), 6.90 (s, 1H), 5.07 (s, 2H), 4.40 (d, <i>J</i> = 5.9 Hz, 2H), 3.39 (q, <i>J</i> = 7.4 Hz, 2H), 2.25 (s, 6H), 1.29 (t, <i>J</i> = 7.4 Hz, 3H). LC-MS (<i>m</i>/<i>e</i>): 424 [M + H]<sup>+</sup>.</div></div><div id="sec2_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> Preparation of Thiophenylmethylamide Trithiocarbonates (Procedure G)</h4><div class="NLM_p last">A solution of [5-(2-chloro-ethanoyl)-thiophen-2-yl]-acetic acid (1.0 equiv) in tetrahydrofuran (0.2 M) was cooled to 0 °C, then isobutyl chloroformate (1.2 equiv) and <i>N</i>-methyl-morpholine (1.2 equiv) were added and the mixture was stirred for 45 min. The corresponding amine (1.2 equiv) was added, and the mixture was allowed to warm to rt slowly. After 1 h, a solution of sodium ethyl trithiocarbonate (0.5 M in tetrahydrofuran, 1.5 equiv) was added and the mixture was stirred again for 18 h. After completion of the reaction, the reaction mixture was diluted with half-saturated brine and the aqueous phase was extracted with dichloromethane. The organic layer was evaporated to leave a yellowish residue, which was purified by chromatography (silica, hexanes/ethyl acetate gradient) followed by preparative HPLC (acetonitrile/water gradient), providing the title compound as a pale-yellow solid.</div></div><div id="sec2_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 2-[5-(Benzylcarbamoyl-methyl)-thiophen-2-yl]-2-oxoethyl Ethyl Trithiocarbonate (<b>18a</b>)</h4><div class="NLM_p last"><b>18a</b> was prepared from benzylamine according to general procedure G; yellow solid (13%). <sup>1</sup>H NMR (DMSO-<i>d<sub>6</sub></i>, 200 MHz, rt) δ (ppm): 8.67 (t, <i>J</i> = 5.7 Hz, 1H), 8.00 (d, <i>J</i> = 3.8 Hz, 1H), 7.37−7.24 (m, 5H), 7.09 (d, <i>J</i> = 3.9 Hz, 1H), 5.01 (s, 2H), 4.20 (d, <i>J</i> = 5.8 Hz, 2H), 3.83 (s, 2H), 3.38 (q, <i>J</i> = 7.4 Hz, 2H), 1.29 (t, <i>J</i> = 7.3 Hz, 3H). LC-MS (<i>m</i>/<i>e</i>): 410 [M + H]<sup>+</sup>.</div></div><div id="sec2_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> Ethyl 2-oxo-2-{5-[(2-Phenoxy-ethylcarbamoyl)-methyl]-thiophen-2-yl}-ethyl Trithiocarbonate (<b>18d</b>)</h4><div class="NLM_p last"><b>18d</b> was prepared from 2-phenoxy-ethylamine according to general procedure G; yellow solid (17%). <sup>1</sup>H NMR (DMSO-<i>d<sub>6</sub></i>, 200 MHz, rt) δ (ppm): 8.46 (t, <i>J</i> = 5.5 Hz, 1H), 7.98 (d, <i>J</i> = 3.9 Hz, 1H), 7.29 (t, <i>J</i> = 8.1 Hz, 2H), 7.07 (d, <i>J</i> = 3.9 Hz, 1H), 6.97−6.91 (m, 3H), 5.00 (s, 2H), 4.00 (t, <i>J</i> = 5.5 Hz, 2H), 3.73 (s, 2H), 3.46 (t, <i>J</i> = 5.6 Hz, 2H), 3.38 (t, <i>J</i> = 7.4 Hz, 2H), 1.29 (t, <i>J</i> = 7.3 Hz, 3H). LC-MS (<i>m</i>/<i>e</i>): 440 [M + H]<sup>+</sup>.</div></div><div id="sec2_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> Preparation of Pyridinyl Acetylthiophenes (Procedure H)</h4><div class="NLM_p last">A solution of pyridinyl-bromide (1.0 equiv) and 5-acetyl-thienyl-2-boronic acid (1.05 equiv) in dioxane/water (10:1, 0.2 M) was charged with Pd(dppf)Cl<sub>2</sub> (0.01 equiv) and cesium carbonate (1.4 equiv), then purged with nitrogen and the mixture was stirred at 15 rt for 18 h. The reaction mixture was diluted with dichloromethane and filtered through a silica pad. Evaporation in vacuo and subsequent purification by flash chromatography (silica, hexanes/ethyl acetate gradient) yielded the desired product.</div></div><div id="sec2_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 2-(5-{5-[(3-Amino-quinolinyl)-methyl]-pyridin-2-yl}-thiophen-2-yl)-2-oxoethyl Ethyl Trithiocarbonate (<b>22</b>)</h4><div class="NLM_p">2-(5-{5-[(3-amino-quinolinyl)-methyl]-pyridin-2-yl}-thiophen-2-yl)-ethanone (<b>21a</b>) was prepared from (4-bromo-benzyl)-quinolin-3-yl-amine according to procedure H; yellow solid (51%). <sup>1</sup>H NMR (DMSO-<i>d<sub>6</sub></i>, 400 MHz, rt) δ (ppm): 8.68 (d, <i>J</i> = 1.6 Hz, 1H), 8.56 (d, <i>J</i> = 2.8 Hz, 1H), 8.04 (d, <i>J</i> = 8.2 Hz, 1H), 7.95−7.91 (m, 2H), 7.87 (d, <i>J</i> = 4.1 Hz, 1H), 7.79 (d, <i>J</i> = 8.0 Hz, 1H), 7.62 (d, <i>J</i> = 7.8 Hz, 1H), 7.38 (t, <i>J</i> = 6.7 Hz, 1H), 7.34 (t, <i>J</i> = 6.7 Hz, 1H), 7.08 (d, <i>J</i> = 1.6 Hz, 1H), 6.99 (t, <i>J</i> = 4.0 Hz, 1H), 5.07 (s, 2H), 4.48 (t, <i>J</i> = 4.0 Hz, 2H), 2.55 (s, 3H). LC-MS (<i>m</i>/<i>e</i>): 360 [M + H]<sup>+</sup>.</div><div class="NLM_p last"><b>22</b> was prepared from <b>21a</b> according to general procedure E: yellow solid (9%). <sup>1</sup>H NMR (DMSO-<i>d<sub>6</sub></i>, 400 MHz, rt) δ (ppm): 8.69 (s, 1H), 8.56 (d, <i>J</i> = 2.7 Hz, 1H), 8.18 (d, <i>J</i> = 4.1 Hz, 1H), 8.07 (d, <i>J</i> = 8.2 Hz, 1H), 7.95−7.91 (m, 2H), 7.79 (d, <i>J</i> = 7.9 Hz, 1H), 7.62 (d, <i>J</i> = 7.8 Hz, 1H), 7.38 (t, <i>J</i> = 6.7 Hz, 1H), 7.34 (t, <i>J</i> = 6.7 Hz, 1H), 7.09 (s, 1H), 6.98 (t, <i>J</i> = 6.0 Hz, 1H), 5.07 (s, 2H), 4.48 (t, <i>J</i> = 6.0 Hz, 2H), 3.39 (q, <i>J</i> = 7.4 Hz, 2H), 1.29 (t, <i>J</i> = 7.4 Hz, 3H). LC-MS (<i>m</i>/<i>e</i>): 496 [M + H]<sup>+</sup>.</div></div><div id="sec2_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 2-(5-(5-Amino-pyrid-2-yl)-thieno-2-yl)-2-oxoethyl Ethyl Trithiocarbonate (<b>23</b>)</h4><div class="NLM_p">2-(5-(5-Amino-pyrid-2-yl)-thieno-2-yl)-ethanone (<b>21b</b>) was prepared from 5-amino-2-bromo-pyridine according to general procedure H; yellowish solid (44%). <sup>1</sup>H NMR (DMSO-<i>d<sub>6</sub></i>, 400 MHz, rt) δ (ppm): 7.94 (d, <i>J</i> = 2.6 Hz, 1H), 7.85 (d, <i>J</i> = 4.0 Hz, 1H), 7.69 (d, <i>J</i> = 8.6 Hz, 1H), 7.53 (d, <i>J</i> = 4.1 Hz, 1H), 6.97 (dd, <i>J</i> = 8.6, 2.7 Hz, 1H), 5.78 (s, 2H), 2.56 (s, 3H). LC-MS (<i>m</i>/<i>e</i>): 219 [M + H]<sup>+</sup>.</div><div class="NLM_p last"><b>23</b> was prepared from <b>21b</b> according to general procedure E; yellow solid (10%). <sup>1</sup>H NMR (DMSO-<i>d<sub>6</sub></i>, 400 MHz, rt) δ (ppm): 8.09 (d, <i>J</i> = 4.0 Hz, 1H), 7.95 (d, <i>J</i> = 2.6 Hz, 1H), 7.73 (d, <i>J</i> = 8.6 Hz, 1H), 7.59 (d, <i>J</i> = 4.1 Hz, 1H), 6.98 (dd, <i>J</i> = 8.5, 2.7 Hz, 1H), 5.77 (s, 2H), 5.03 (s, 2H), 3.39 (q, <i>J</i> = 7.4 Hz, 2H), 1.29 (t, <i>J</i> = 7.4 Hz, 3H). LC-MS (<i>m</i>/<i>e</i>): 355 [M + H]<sup>+</sup>.</div></div></div><div id="sec2_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> HPLC Purity</h3><div class="NLM_p last">Purity of all compounds was determined by analytical HPLC using a HPLC equipment of the LiChroGraph series by Hitachi (pressure gradient pump L-7100), a reversed phase column by Waters (Xterra, 100 mm × 2.1 mm inner diameter), and as eluent a 10 mM ammoniumacetate/acetonitrile gradient (buffer to pH 7,4). The purity of the compounds was determined using a diode array detector (Hitachi L-7455, cell: 10 mm, 8 µL) at λ = 230−330 nm. All compounds possessed a purity of greater than 95% as determined as average value of two independent injections (see Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> for key compounds). Tracings of key compounds are given as <a class="ref internalNav" href="#note1" aria-label="Supporting Information">Supporting Information</a>. <div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Purity of Key Compounds as Determined by Analytical HPLC</div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle">no.</th><th align="center" valign="middle"> </th><th align="center" valign="middle" char=".">purity (%)</th></tr></thead><tbody><tr valign="top"><td align="left"><b>2</b></td><td align="left">ethyl 2-(4-methylphenyl)-2-oxoethyl trithiocarbonate</td><td align="char" char=".">100/100</td></tr><tr valign="top"><td align="left"><b>3a</b></td><td align="left">ethyl 2-(4-methoxyphenyl)-2-oxoethyl trithiocarbonate</td><td align="char" char=".">99.1/98.9</td></tr><tr valign="top"><td align="left"><b>3b</b></td><td align="left">2-(4-methoxyphenyl)-2-oxoethyl dithiobutyrate</td><td align="char" char=".">96.0/95.9</td></tr><tr valign="top"><td align="left"><b>3c</b></td><td align="left"><i>O</i>-ethyl <i>S</i>-2-(4-methoxy-phenyl)-2-oxoethyl dithiocarbonate</td><td align="char" char=".">97.8/98.1</td></tr><tr valign="top"><td align="left"><b>3d</b></td><td align="left"><i>N</i>-ethyl <i>S</i>-2-(4-methoxy-phenyl)-2-oxoethyl dithiocarbamate</td><td align="char" char=".">96.8/96.8</td></tr><tr valign="top"><td align="left"><b>3e</b></td><td align="left"><i>S-</i>ethyl <i>O</i>-2-(4-methoxy-phenyl)-2-oxoethyl dithiocarbonate</td><td align="char" char=".">98.3/98.1</td></tr><tr valign="top"><td align="left"><b>8a</b></td><td align="left">2-(4-acetylamino-phenyl)-2-oxoethyl ethyl trithiocarbonate</td><td align="char" char=".">95.2/95.7</td></tr><tr valign="top"><td align="left"><b>8c</b></td><td align="left"><i>O</i>-ethyl <i>S</i>-2-(4-acetamido-phenyl)-2-oxoethyl dithiocarbonate</td><td align="char" char=".">100/100</td></tr><tr valign="top"><td align="left"><b>8e</b></td><td align="left">2-(3-acetylamino-phenyl)-2-oxoethyl ethyl trithiocarbonate</td><td align="char" char=".">96.7/95.9</td></tr><tr valign="top"><td align="left"><b>8g</b></td><td align="left">2-[4-(acetylamino-methyl)-phenyl]-2-oxoethyl ethyl trithiocarbonate</td><td align="char" char=".">99.7/99.7</td></tr><tr valign="top"><td align="left"><b>8h</b></td><td align="left">ethyl 2-(4-methanesulfonylamino-phenyl)-2-oxoethyl trithiocarbonate</td><td align="char" char=".">98.6/98.9</td></tr><tr valign="top"><td align="left"><b>12aa</b></td><td align="left">ethyl 2-oxo-2-(3-phenylcarbamoyl-phenyl)-ethyl trithiocarbonate</td><td align="char" char=".">97.8/98.1</td></tr><tr valign="top"><td align="left"><b>12ab</b></td><td align="left">ethyl 2-oxo-2-(4-phenylcarbamoyl-phenyl)-ethyl trithiocarbonate</td><td align="char" char=".">98.0/97.5</td></tr><tr valign="top"><td align="left"><b>12al</b></td><td align="left">2-(3-benzylcarbamoyl-phenyl)-2-oxoethyl ethyl trithiocarbonate</td><td align="char" char=".">99.5/99.8</td></tr><tr valign="top"><td align="left"><b>12am</b></td><td align="left">2-(4-benzylcarbamoyl-phenyl)-2-oxoethyl ethyl trithiocarbonate</td><td align="char" char=".">97.4/97.9</td></tr><tr valign="top"><td align="left"><b>16b</b></td><td align="left">ethyl 2-oxo-2-[5-((<i>S</i>)-1-phenyl-ethylcarbamoyl)-thiophen-2-yl]-ethyl trithiocarbonate</td><td align="char" char=".">95.2/95.3</td></tr><tr valign="top"><td align="left"><b>16c</b></td><td align="left">ethyl 2-oxo-2-[5-((<i>R</i>)-1-phenyl-ethylcarbamoyl)-thiophen-2-yl]-ethyl trithiocarbonate</td><td align="char" char=".">99.4/99.3</td></tr><tr valign="top"><td align="left"><b>16d</b></td><td align="left">2-[5-(3,5-dimethyl-benzylcarbamoyl)-thiophen-2-yl]-2-oxoethyl ethyl trithiocarbonate</td><td align="char" char=".">96.5/97.0</td></tr><tr valign="top"><td align="left"><b>18a</b></td><td align="left">2-[5-(benzylcarbamoyl-methyl)-thiophen-2-yl]-2-oxoethyl ethyl trithiocarbonate</td><td align="char" char=".">99.5/99.5</td></tr><tr valign="top"><td align="left"><b>18d</b></td><td align="left">ethyl 2-oxo-2-{5-[(2-phenoxy-ethylcarbamoyl)-methyl]-thiophen-2-yl}-ethyl trithiocarbonate</td><td align="char" char=".">98.7/98.7</td></tr><tr valign="top"><td align="left"><b>22</b></td><td align="left">2-(5-{5-[(3-amino-quinolinyl)-methyl]-pyridin-2-yl}-thiophen-2-yl)-2-oxoethyl ethyl trithiocarbonate</td><td align="char" char=".">95.7/95.7</td></tr><tr valign="top"><td align="left"><b>23</b></td><td align="left">2-(5-(5-amino-pyrid-2-yl)-thieno-2-yl)-2-oxoethyl ethyl trithiocarbonate</td><td align="char" char=".">98.5/98.6</td></tr></tbody></table></div></div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="note1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i53"><a href="/doi/suppl/10.1021/jm800093c">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57416" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57416" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">All information about chemical synthesis and analytics of additional compounds as presented in the manuscript but not shown in the Experimental Section. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm800093c/suppl_file/jm800093c-file003.pdf">jm800093c-file003.pdf (1.69 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm800093c" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66204" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66204" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas Beckers</span> - <span class="hlFld-Affiliation affiliation">Nycomed GmbH, Therapeutic Area Oncology, Byk-Gulden-Strasse 2, D-78467 Konstanz, Germany</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#b7e3dfd8dad6c499f5d2d4dcd2c5c4f7d8d9d4d8c3d2c4c399d3d2"><span class="__cf_email__" data-cfemail="2d794542404c5e036f484e46485f5e6d42434e4259485e59034948">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Florian Dehmel</span> - <span class="hlFld-Affiliation affiliation">Nycomed GmbH, Therapeutic Area Oncology, Byk-Gulden-Strasse 2, D-78467 Konstanz, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steffen Weinbrenner</span> - <span class="hlFld-Affiliation affiliation">Nycomed GmbH, Therapeutic Area Oncology, Byk-Gulden-Strasse 2, D-78467 Konstanz, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Heiko Julius</span> - <span class="hlFld-Affiliation affiliation">Nycomed GmbH, Therapeutic Area Oncology, Byk-Gulden-Strasse 2, D-78467 Konstanz, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas Ciossek</span> - <span class="hlFld-Affiliation affiliation">Nycomed GmbH, Therapeutic Area Oncology, Byk-Gulden-Strasse 2, D-78467 Konstanz, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas Maier</span> - <span class="hlFld-Affiliation affiliation">Nycomed GmbH, Therapeutic Area Oncology, Byk-Gulden-Strasse 2, D-78467 Konstanz, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas Stengel</span> - <span class="hlFld-Affiliation affiliation">Nycomed GmbH, Therapeutic Area Oncology, Byk-Gulden-Strasse 2, D-78467 Konstanz, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kamal Fettis</span> - <span class="hlFld-Affiliation affiliation">Nycomed GmbH, Therapeutic Area Oncology, Byk-Gulden-Strasse 2, D-78467 Konstanz, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carmen Burkhardt</span> - <span class="hlFld-Affiliation affiliation">Nycomed GmbH, Therapeutic Area Oncology, Byk-Gulden-Strasse 2, D-78467 Konstanz, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Heike Wieland</span> - <span class="hlFld-Affiliation affiliation">Nycomed GmbH, Therapeutic Area Oncology, Byk-Gulden-Strasse 2, D-78467 Konstanz, Germany</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i54">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56620" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56620" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 34 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cohen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, T. P.</span><span> </span><span class="NLM_article-title">AcK-Knowledge reversible acetylation</span> <span class="citation_source-journal">Sci. STKE 3</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_fpage">pe42</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1126%2Fstke.2452004pe42" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&pages=pe42&author=T.+Cohenauthor=T.+P.+Yao&title=AcK-Knowledge+reversible+acetylation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1126%2Fstke.2452004pe42&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fstke.2452004pe42%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DT.%26aulast%3DYao%26aufirst%3DT.%2BP.%26atitle%3DAcK-Knowledge%2520reversible%2520acetylation%26jtitle%3DSci.%2520STKE%25203%26date%3D2004%26spage%3Dpe42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Yang, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seto, E.</span><span> </span><span class="NLM_article-title">HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">5310</span><span class="NLM_x">–</span> <span class="NLM_lpage">5318</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1038%2Fsj.onc.1210599" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=17694074" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovFekurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=5310-5318&author=X.+J.+Yangauthor=E.+Seto&title=HATs+and+HDACs%3A+from+structure%2C+function+and+regulation+to+novel+strategies+for+therapy+and+prevention"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention</span></div><div class="casAuthors">Yang, X.-J.; Seto, E.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">5310-5318</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The acetylation of the ε-NH2 group of a Lys residue was 1st discovered with histones in 1968, but the responsible enzymes, histone acetyltransferases (HATs) and histone deacetylases (HDACs), were not identified until the mid-1990s.  In the past decade, knowledge about this modification has exploded, with targets rapidly expanding from histones to transcription factors and other nuclear proteins, and then to the cytoskeleton, metabolic enzymes, and signaling regulators in the cytoplasm.  Thus, protein Lys acetylation has emerged as a major post-translational modification to rival phosphorylation.  Here, various aspects of the enzymes governing Lys acetylation, esp. about their intimate links to cancer are reviewed.  For central themes are highlighted: (1) multisubunit enzymic complexes; (2) non-histone substrates in diverse cellular processes; (3) interplay of Lys acetylation with other regulatory mechanisms, such as noncoding RNA-mediated gene silencing and activation; and (4) novel therapeutic strategies and preventive measures to combat cancer and other human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuGSkc-b3umrVg90H21EOLACvtfcHk0lirstkDfMHmlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovFekurc%253D&md5=de49d71791356a55d90fd797cbecaf4b</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1210599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1210599%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DX.%2BJ.%26aulast%3DSeto%26aufirst%3DE.%26atitle%3DHATs%2520and%2520HDACs%253A%2520from%2520structure%252C%2520function%2520and%2520regulation%2520to%2520novel%2520strategies%2520for%2520therapy%2520and%2520prevention%26jtitle%3DOncogene%26date%3D2007%26volume%3D26%26spage%3D5310%26epage%3D5318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Strahl, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allis, C. D.</span><span> </span><span class="NLM_article-title">The language of covalent histone modifications</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">403</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1038%2F47412" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=10638745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A280%3ADC%252BD3c7gt1arsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=403&publication_year=2000&pages=41-45&author=B.+D.+Strahlauthor=C.+D.+Allis&title=The+language+of+covalent+histone+modifications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The language of covalent histone modifications</span></div><div class="casAuthors">Strahl B D; Allis C D</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">403</span>
        (<span class="NLM_cas:issue">6765</span>),
    <span class="NLM_cas:pages">41-5</span>
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Histone proteins and the nucleosomes they form with DNA are the fundamental building blocks of eukaryotic chromatin.  A diverse array of post-translational modifications that often occur on tail domains of these proteins has been well documented.  Although the function of these highly conserved modifications has remained elusive, converging biochemical and genetic evidence suggests functions in several chromatin-based processes.  We propose that distinct histone modifications, on one or more tails, act sequentially or in combination to form a 'histone code' that is, read by other proteins to bring about distinct downstream events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSyzhdlYh9sX7t7lRqEFUJVfW6udTcc2eax-fo0XfnGGbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c7gt1arsQ%253D%253D&md5=2eb7d093151c6122ccd70fa2adcfd94b</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2F47412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F47412%26sid%3Dliteratum%253Aachs%26aulast%3DStrahl%26aufirst%3DB.%2BD.%26aulast%3DAllis%26aufirst%3DC.%2BD.%26atitle%3DThe%2520language%2520of%2520covalent%2520histone%2520modifications%26jtitle%3DNature%26date%3D2000%26volume%3D403%26spage%3D41%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zhang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dent, S. Y. J.</span><span> </span><span class="NLM_article-title">Histone modifying enzymes and cancer: going beyond histones</span> <span class="citation_source-journal">Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">1137</span><span class="NLM_x">–</span> <span class="NLM_lpage">1148</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1002%2Fjcb.20615" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1KgtbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2005&pages=1137-1148&author=K.+Zhangauthor=S.+Y.+J.+Dent&title=Histone+modifying+enzymes+and+cancer%3A+going+beyond+histones"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Histone modifying enzymes and cancer: Going beyond histones</span></div><div class="casAuthors">Zhang, Ke; Dent, Sharon Y. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1137-1148</span>CODEN:
                <span class="NLM_cas:coden">JCEBD5</span>;
        ISSN:<span class="NLM_cas:issn">0730-2312</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Mutations in the mol. pathways that regulate cell proliferation, differentiation, and cell death all contribute to cancer formation.  Enzymes that covalently modify histones affect these pathways by controlling the dynamic remodeling of chromatin structure.  Here, the authors review several connections between histone-modifying enzymes and cancer that are likely mediated via both histone and non-histone substrates.  The authors propose that multiple protein modifications, including phosphorylation, methylation, and acetylation, cross-regulate one another to coordinate intermol. signaling, and that miscues in this regulation can lead to oncogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmU2D4BWPAyLVg90H21EOLACvtfcHk0lirstkDfMHmlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1KgtbbK&md5=8b6cccbd9c896ec68cd063914f8996da</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1002%2Fjcb.20615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.20615%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DDent%26aufirst%3DS.%2BY.%2BJ.%26atitle%3DHistone%2520modifying%2520enzymes%2520and%2520cancer%253A%2520going%2520beyond%2520histones%26jtitle%3DCell.%2520Biochem.%26date%3D2005%26volume%3D96%26spage%3D1137%26epage%3D1148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Johnstone, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Licht, J. D.</span><span> </span><span class="NLM_article-title">Histone deacetylase inhibitors in cancer therapy: is transcription the primary target?</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=13-18&author=R.+W.+Johnstoneauthor=J.+D.+Licht&title=Histone+deacetylase+inhibitors+in+cancer+therapy%3A+is+transcription+the+primary+target%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohnstone%26aufirst%3DR.%2BW.%26aulast%3DLicht%26aufirst%3DJ.%2BD.%26atitle%3DHistone%2520deacetylase%2520inhibitors%2520in%2520cancer%2520therapy%253A%2520is%2520transcription%2520the%2520primary%2520target%253F%26jtitle%3DCancer%2520Cell%26date%3D2003%26volume%3D4%26spage%3D13%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">de Ruijter, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Gennip, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, H. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Kuilenburg, A. B.</span><span> </span><span class="NLM_article-title">Histone deacetylases (HDACs): characterization of the classical HDAC family</span> <span class="citation_source-journal">J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">370</span><span class="NLM_x">, </span> <span class="NLM_fpage">737</span><span class="NLM_x">–</span> <span class="NLM_lpage">749</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1042%2FBJ20021321" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhvFKiu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=2003&pages=737-749&author=A.+J.+de+Ruijterauthor=A.+H.+van+Gennipauthor=H.+N.+Caronauthor=S.+Kempauthor=A.+B.+van+Kuilenburg&title=Histone+deacetylases+%28HDACs%29%3A+characterization+of+the+classical+HDAC+family"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylases (HDACs): characterization of the classical HDAC family</span></div><div class="casAuthors">de Ruijter, Annemieke J. M.; van Gennip, Albert H.; Caron, Huib N.; Kemp, Stephan; van Kuilenburg, Andre B. P.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">370</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">737-749</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review, with refs.  Transcriptional regulation in eukaryotes occurs within a chromatin setting, and is strongly influenced by the post-translational modification of histones, the building blocks of chromatin, such as methylation, phosphorylation and acetylation.  Acetylation is probably the best understood of these modifications: hyperacetylation leads to an increase in the expression of particular genes, and hypoacetylation has the opposite effect.  Many studies have identified several large, multisubunit enzyme complexes that are responsible for the targeted deacetylation of histones.  The aim of this review is to give a comprehensive overview of the structure, function and tissue distribution of members of the classical histone deacetylase (HDAC) family, in order to gain insight into the regulation of gene expression through HDAC activity.  SAGE (serial anal. of gene expression) data show that HDACs are generally expressed in almost all tissues investigated.  Surprisingly, no major differences were obsd. between the expression pattern in normal and malignant tissues.  However, significant variation in HDAC expression was obsd. within tissue types.  HDAC inhibitors have been shown to induce specific changes in gene expression and to influence a variety of other processes, including growth arrest, differentiation, cytotoxicity and induction of apoptosis.  This challenging field has generated many fascinating results which will ultimately lead to a better understanding of the mechanism of gene transcription as a whole.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN1-6ct5EQtrVg90H21EOLACvtfcHk0lifz73moQqSLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhvFKiu7o%253D&md5=8a521cd3ddcf046b4b806ebf9f1476b4</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1042%2FBJ20021321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20021321%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BRuijter%26aufirst%3DA.%2BJ.%26aulast%3Dvan%2BGennip%26aufirst%3DA.%2BH.%26aulast%3DCaron%26aufirst%3DH.%2BN.%26aulast%3DKemp%26aufirst%3DS.%26aulast%3Dvan%2BKuilenburg%26aufirst%3DA.%2BB.%26atitle%3DHistone%2520deacetylases%2520%2528HDACs%2529%253A%2520characterization%2520of%2520the%2520classical%2520HDAC%2520family%26jtitle%3DJ.%2520Biochem.%26date%3D2003%26volume%3D370%26spage%3D737%26epage%3D749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bolden, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peart, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, R. W.</span><span> </span><span class="NLM_article-title">Anticancer activities of histone deacetylase inhibitors</span> <span class="citation_source-journal">Nat. Rev. Drug. Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">769</span><span class="NLM_x">–</span> <span class="NLM_lpage">784</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1038%2Fnrd2133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=16955068" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD28XptVCltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=769-784&author=J.+E.+Boldenauthor=M.+J.+Peartauthor=R.+W.+Johnstone&title=Anticancer+activities+of+histone+deacetylase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer activities of histone deacetylase inhibitors</span></div><div class="casAuthors">Bolden, Jessica E.; Peart, Melissa J.; Johnstone, Ricky W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">769-784</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Histone deacetylases (HDACs) are enzymes involved in the remodelling of chromatin, and have a key role in the epigenetic regulation of gene expression.  In addn., the activity of non-histone proteins can be regulated through HDAC-mediated hypo-acetylation.  In recent years, inhibition of HDACs has emerged as a potential strategy to reverse aberrant epigenetic changes assocd. with cancer, and several classes of HDAC inhibitors have been found to have potent and specific anticancer activities in preclin. studies.  However, such studies have also indicated that the effects of HDAC inhibitors could be considerably broader and more complicated than originally understood.  Here we summarize recent advances in the understanding of the mol. events that underlie the anticancer effects of HDAC inhibitors, and discuss how such information could be used in optimizing the development and application of these agents in the clinic, either as monotherapies or in combination with other anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhfqS1awkOHbVg90H21EOLACvtfcHk0lifz73moQqSLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptVCltrY%253D&md5=91e55ee942fda3e4e2055ddf299fc866</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1038%2Fnrd2133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2133%26sid%3Dliteratum%253Aachs%26aulast%3DBolden%26aufirst%3DJ.%2BE.%26aulast%3DPeart%26aufirst%3DM.%2BJ.%26aulast%3DJohnstone%26aufirst%3DR.%2BW.%26atitle%3DAnticancer%2520activities%2520of%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DNat.%2520Rev.%2520Drug.%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D769%26epage%3D784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Marks, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rifkind, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richon, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breslow, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, W. K.</span><span> </span><span class="NLM_article-title">Histone deacetylases and cancer: causes and therapies</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">194</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1038%2F35106079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=11902574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD38XlvF2qtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=194-202&author=P.+Marksauthor=R.+A.+Rifkindauthor=V.+M.+Richonauthor=R.+Breslowauthor=T.+Millerauthor=W.+K.+Kelly&title=Histone+deacetylases+and+cancer%3A+causes+and+therapies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylases and cancer: causes and therapies</span></div><div class="casAuthors">Marks, Paul A.; Rifkind, Richard A.; Richon, Victoria M.; Breslow, Ronald; Miller, Thomas; Kelly, William K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">194-202</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Together, histone acetyltransferases and histone deacetylases (HDACs) det. the acetylation status of histones.  This acetylation affects the regulation of gene expression, and inhibitors of HDACs have been found to cause growth arrest, differentiation and/or apoptosis of many tumors cells by altering the transcription of a small no. of genes.  HDAC inhibitors are proving to be an exciting therapeutic approach to cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNXyL8yvd0OrVg90H21EOLACvtfcHk0lifz73moQqSLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlvF2qtr0%253D&md5=ea50a1a72a6df9ea3a0e1a6a0d5cda5e</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1038%2F35106079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35106079%26sid%3Dliteratum%253Aachs%26aulast%3DMarks%26aufirst%3DP.%26aulast%3DRifkind%26aufirst%3DR.%2BA.%26aulast%3DRichon%26aufirst%3DV.%2BM.%26aulast%3DBreslow%26aufirst%3DR.%26aulast%3DMiller%26aufirst%3DT.%26aulast%3DKelly%26aufirst%3DW.%2BK.%26atitle%3DHistone%2520deacetylases%2520and%2520cancer%253A%2520causes%2520and%2520therapies%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2001%26volume%3D1%26spage%3D194%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Minucci, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelicci, P. G.</span><span> </span><span class="NLM_article-title">Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">38</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1038%2Fnrc1779" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=16397526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1GgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=38-51&author=S.+Minucciauthor=P.+G.+Pelicci&title=Histone+deacetylase+inhibitors+and+the+promise+of+epigenetic+%28and+more%29+treatments+for+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer</span></div><div class="casAuthors">Minucci, Saverio; Pelicci, Pier Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-51</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Histone deacetylases (HDACs) are considered to be among the most promising targets in drug development for cancer therapy, and first-generation histone deacetylase inhibitors (HDACi) are currently being tested in phase I/II clin. trials.  A wide-ranging knowledge of the role of HDACs in tumorigenesis, and of the action of HDACi, has been achieved.  However, several basic aspects are not yet fully understood.  Investigating these aspects in the context of what we now understand about HDACi action both in vitro and in vivo will further improve the design of optimized clin. protocols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxXiACZV1sK7Vg90H21EOLACvtfcHk0lhhuFx7QKB38g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1GgsA%253D%253D&md5=384e1f8d676d61531e46843c060a9380</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1038%2Fnrc1779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1779%26sid%3Dliteratum%253Aachs%26aulast%3DMinucci%26aufirst%3DS.%26aulast%3DPelicci%26aufirst%3DP.%2BG.%26atitle%3DHistone%2520deacetylase%2520inhibitors%2520and%2520the%2520promise%2520of%2520epigenetic%2520%2528and%2520more%2529%2520treatments%2520for%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2006%26volume%3D6%26spage%3D38%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Glozak, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seto, E.</span><span> </span><span class="NLM_article-title">Histone deacetylases and cancer</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">5420</span><span class="NLM_x">–</span> <span class="NLM_lpage">5432</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=5420-5432&author=M.+A.+Glozakauthor=E.+Seto&title=Histone+deacetylases+and+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGlozak%26aufirst%3DM.%2BA.%26aulast%3DSeto%26aufirst%3DE.%26atitle%3DHistone%2520deacetylases%2520and%2520cancer%26jtitle%3DOncogene%26date%3D2007%26volume%3D26%26spage%3D5420%26epage%3D5432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Murata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurokawa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krones, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatsumi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagisawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenfeld, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glass, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, Y.</span><span> </span><span class="NLM_article-title">Defect of histone acetyltransferase activity of the nuclear transcriptional coactivator CBP in Rubinstein−Taybi syndrome</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1071</span><span class="NLM_x">–</span> <span class="NLM_lpage">1076</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1093%2Fhmg%2F10.10.1071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=11331617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjslyqtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2001&pages=1071-1076&author=T.+Murataauthor=R.+Kurokawaauthor=A.+Kronesauthor=K.+Tatsumiauthor=M.+Ishiiauthor=T.+Takiauthor=M.+Masunoauthor=H.+Ohashiauthor=M.+Yanagisawaauthor=M.+G.+Rosenfeldauthor=C.+K.+Glassauthor=Y.+Hayashi&title=Defect+of+histone+acetyltransferase+activity+of+the+nuclear+transcriptional+coactivator+CBP+in+Rubinstein%E2%88%92Taybi+syndrome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Defect of histone acetyltransferase activity of the nuclear transcriptional coactivator CBP in Rubinstein-Taybi syndrome</span></div><div class="casAuthors">Murata, Takashi; Kurokawa, Riki; Krones, Anna; Tatsumi, Ken; Ishii, Masami; Taki, Tomohiko; Masuno, Mitsuo; Ohashi, Hirofumi; Yanagisawa, Masayoshi; Rosenfeld, Michael G.; Glass, Christopher K.; Hayashi, Yasuhide</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1071-1076</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">CREB-binding protein (CBP) is a transcriptional coactivator that has intrinsic histone acetyltransferase (HAT) activity.  CBP is the causative gene of Rubinstein-Taybi syndrome (RTS).  To investigate the relationships between CBP HAT activity and RTS, we analyzed 16 RTS patients.  A microdeletion was identified in one patient by fluorescent in situ hybridization anal.  Heteroallelic mutations were identified in five patients by reverse transcriptase-polymerase chain reaction-single-strand conformation polymorphism anal. and sequencing.  These included a 2 bp deletion between nucleotides 4319 and 4320, an 11 bp deletion between nucleotides 4898 and 4908, a 14 bp insertion (CCTCGGTCCTGCAC) between nucleotides 5212 and 5213, a 2 bp deletion between nucleotides 5222 and 5223, and a missense mutation from guanine (G) to cytosine (C) at nucleotide 4951 that changed codon 1378 from CGG (arginine) to CCG (proline).  The identical missense mutation was introduced into the recombinant mouse CBP.  It abolished the HAT activity of CBP and the ability of CBP to transactivate cAMP-response element binding protein (CREB), in HAT assays and in microinjection expts., resp.  These results suggest that the loss of the HAT activity of CBP may cause RTS, as the first example of a defect of HAT activity in a human disease.  Our findings raise the possibility that treatment of RTS patients with histone deacetylase inhibitors might have beneficial effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0NXqRzSn_uLVg90H21EOLACvtfcHk0lhhuFx7QKB38g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjslyqtLc%253D&md5=cb2ec6c582fd28159c13fe3390af20b0</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2F10.10.1071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252F10.10.1071%26sid%3Dliteratum%253Aachs%26aulast%3DMurata%26aufirst%3DT.%26aulast%3DKurokawa%26aufirst%3DR.%26aulast%3DKrones%26aufirst%3DA.%26aulast%3DTatsumi%26aufirst%3DK.%26aulast%3DIshii%26aufirst%3DM.%26aulast%3DTaki%26aufirst%3DT.%26aulast%3DMasuno%26aufirst%3DM.%26aulast%3DOhashi%26aufirst%3DH.%26aulast%3DYanagisawa%26aufirst%3DM.%26aulast%3DRosenfeld%26aufirst%3DM.%2BG.%26aulast%3DGlass%26aufirst%3DC.%2BK.%26aulast%3DHayashi%26aufirst%3DY.%26atitle%3DDefect%2520of%2520histone%2520acetyltransferase%2520activity%2520of%2520the%2520nuclear%2520transcriptional%2520coactivator%2520CBP%2520in%2520Rubinstein%25E2%2588%2592Taybi%2520syndrome%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2001%26volume%3D10%26spage%3D1071%26epage%3D1076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoshino, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redner, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kajigaya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. M.</span><span> </span><span class="NLM_article-title">ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">10860</span><span class="NLM_x">–</span> <span class="NLM_lpage">10865</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=10860-10865&author=J.+Wangauthor=T.+Hoshinoauthor=R.+L.+Rednerauthor=S.+Kajigayaauthor=J.+M.+Liu&title=ETO%2C+fusion+partner+in+t%288%3B21%29+acute+myeloid+leukemia%2C+represses+transcription+by+interaction+with+the+human+N-CoR%2FmSin3%2FHDAC1+complex"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DHoshino%26aufirst%3DT.%26aulast%3DRedner%26aufirst%3DR.%2BL.%26aulast%3DKajigaya%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DJ.%2BM.%26atitle%3DETO%252C%2520fusion%2520partner%2520in%2520t%25288%253B21%2529%2520acute%2520myeloid%2520leukemia%252C%2520represses%2520transcription%2520by%2520interaction%2520with%2520the%2520human%2520N-CoR%252FmSin3%252FHDAC1%2520complex%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1998%26volume%3D95%26spage%3D10860%26epage%3D10865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Zhu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mengwasser, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlag, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Göttlicher, M.</span><span> </span><span class="NLM_article-title">Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">463</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1016%2FS1535-6108%2804%2900114-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=15144953" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksFCmt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=455-463&author=P.+Zhuauthor=E.+Martinauthor=J.+Mengwasserauthor=P.+Schlagauthor=K.+P.+Janssenauthor=M.+G%C3%B6ttlicher&title=Induction+of+HDAC2+expression+upon+loss+of+APC+in+colorectal+tumorigenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis</span></div><div class="casAuthors">Zhu, Ping; Martin, Elke; Mengwasser, Joerg; Schlag, Peter; Janssen, Klaus-Peter; Goettlicher, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">455-463</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Inappropriate transcriptional repression involving histone deacetylases (HDACs) is a prominent cause for the development of leukemia.  We now identify faulty expression of a specific mediator of transcriptional repression in a solid tumor.  Loss of the adenomatosis polyposis coli (APC) tumor suppressor induces HDAC2 expression depending on the Wnt pathway and c-Myc.  Increased HDAC2 expression is found in the majority of human colon cancer explants, as well as in intestinal mucosa and polyps of APC-deficient mice.  HDAC2 is required for, and sufficient on its own to prevent, apoptosis of colonic cancer cells.  Interference with HDAC2 by valproic acid largely diminishes adenoma formation in APCmin mice.  These findings point toward HDAC2 as a particularly relevant potential target in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP4i9iItBfArVg90H21EOLACvtfcHk0lg4oXxgSiqwnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksFCmt7c%253D&md5=bfd948db793310e303ad8d71d8cbf8b0</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS1535-6108%2804%2900114-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1535-6108%252804%252900114-X%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DP.%26aulast%3DMartin%26aufirst%3DE.%26aulast%3DMengwasser%26aufirst%3DJ.%26aulast%3DSchlag%26aufirst%3DP.%26aulast%3DJanssen%26aufirst%3DK.%2BP.%26aulast%3DG%25C3%25B6ttlicher%26aufirst%3DM.%26atitle%3DInduction%2520of%2520HDAC2%2520expression%2520upon%2520loss%2520of%2520APC%2520in%2520colorectal%2520tumorigenesis%26jtitle%3DCancer%2520Cell%26date%3D2004%26volume%3D5%26spage%3D455%26epage%3D463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Weichert, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Röske, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gekeler, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pross, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denkert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Röcken, C.</span><span> </span><span class="NLM_article-title">Class I HDAC expression patterns are highly prognostic in human gastric cancer</span> <span class="citation_source-journal">Lancet Oncology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">148</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1016%2FS1470-2045%2808%2970004-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=18207460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVOnu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=139-148&author=W.+Weichertauthor=A.+R%C3%B6skeauthor=V.+Gekelerauthor=T.+Beckersauthor=M.+Ebertauthor=M.+Prossauthor=M.+Dietelauthor=C.+Denkertauthor=C.+R%C3%B6cken&title=Class+I+HDAC+expression+patterns+are+highly+prognostic+in+human+gastric+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis</span></div><div class="casAuthors">Weichert, Wilko; Roeske, Annika; Gekeler, Volker; Beckers, Thomas; Ebert, Matthias PA; Pross, Matthias; Dietel, Manfred; Denkert, Carsten; Roecken, Christoph</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">139-148</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Although histone deacetylases (HDACs) are known to have an important regulatory role in cancer cells, and HDAC inhibitors (HDIs) have entered late-phase clin. trials for the treatment of several cancers, little is known about the expression patterns of HDAC isoforms in tumors.  We aimed to clarify these expression patterns and identify potential diagnostic and prognostic uses of selected class I HDAC isoforms in gastric cancer.  Tissue samples from a training cohort and a validation cohort of patients with gastric cancer from two German institutions were used for analyses.  Tissue microarrays were generated from tumor tissue collected from patients in the training group, whereas tissue slides were used in the validation group.  The tissues were scored for expression of class I HDAC isoforms 1, 2, and 3.  Overall expression patterns (gHDAC) were grouped as being neg. (all three isoforms neg.), partially pos. (one or two isoforms pos.), or completely pos. (all isoforms pos.), and correlated with clinicopathol. parameters and patient survival.  The main endpoints were amt. of expression of each of the three HDAC isoforms, patterns of expression of gHDAC, effect of metastasis on expression of HDAC and gHDAC, and overall survival according to HDAC expression patterns.  With 2617 tissue microarray spots from 143 patients in the training cohort and 606 tissue slides from 150 patients in the validation cohort were studied. 52 of the 143 (36%) gastric tumors in the training cohort and 32 of the 150 (21%) gastric tumors in the validation cohort showed nuclear expression of all three HDAC isoforms. 60 (42%) of tumors in the training cohort and 65 (43%) in the validation cohort expressed one or two isoforms in the nuclei, whereas 31 (22%) of tumors in the training cohort and 53 (35%) in the validation cohort were scored neg. for all three proteins. gHDAC expression in both cohorts was higher when lymph-node metastases were present (p=0.0175 for the training group and p=0.0242 for the validation group).  Survival data were available for 49 patients in the training group and 123 patients in the validation group.  In the validation cohort, 3-yr survival was 44% (95% CI 34-57) in the HDAC1-neg. group, 50% (39-64) in the HDAC2-neg. group, and 48% (34-67) in the gHDAC-neg. group. 3-yr survival decreased to 21% (11-37) when HDAC1 was pos., 16% (9-31) when HDAC2 was pos., and 5% (1-31) when gHDAC (all isoforms) were pos.  Those patients highly expressing one or two isoforms (the gHDAC-intermediate group) had an estd. 3-yr survival of 40% (29-56).  In multivariate analyses, high gHDAC and HDAC2 expression were assocd. with shorter survival in the training cohort (gHDAC: hazard ratio [HR] 4.15 [1.23-13.99], p=0.0250; HDAC2: HR 3.58 [1.36-9.44], p=0.0100) and in the validation cohort (gHDAC: HR 2.18 [1.19-4.01], p=0.0433; HDAC2: HR 1.72 [1.08-2.73], p=0.0225), independent of std. clin. predictors.  High HDAC expression is significantly assocd. with nodal spread and is an independent prognostic marker for gastric cancer.  Addnl., we postulate that immunohistochem. detection of HDAC as a companion diagnostic method might predict treatment response to HDIs, thereby enabling selection of patients for this specific targeted treatment in gastric cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrS-sW_bc85KLVg90H21EOLACvtfcHk0lg4oXxgSiqwnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVOnu7c%253D&md5=8be9de726d97c67924e3cd3543b94c73</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2808%2970004-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252808%252970004-4%26sid%3Dliteratum%253Aachs%26aulast%3DWeichert%26aufirst%3DW.%26aulast%3DR%25C3%25B6ske%26aufirst%3DA.%26aulast%3DGekeler%26aufirst%3DV.%26aulast%3DBeckers%26aufirst%3DT.%26aulast%3DEbert%26aufirst%3DM.%26aulast%3DPross%26aufirst%3DM.%26aulast%3DDietel%26aufirst%3DM.%26aulast%3DDenkert%26aufirst%3DC.%26aulast%3DR%25C3%25B6cken%26aufirst%3DC.%26atitle%3DClass%2520I%2520HDAC%2520expression%2520patterns%2520are%2520highly%2520prognostic%2520in%2520human%2520gastric%2520cancer%26jtitle%3DLancet%2520Oncology%26date%3D2008%26volume%3D9%26spage%3D139%26epage%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Weichert, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Röske, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niesporek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noske, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckendahl, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gekeler, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denkert, C.</span><span> </span><span class="NLM_article-title">Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I HDACs in vitro and in vivo</span> <span class="citation_source-journal">Clin. Cancer. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1669</span><span class="NLM_x">–</span> <span class="NLM_lpage">1677</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1158%2F1078-0432.CCR-07-0990" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=18347167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtlejt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=1669-1677&author=W.+Weichertauthor=A.+R%C3%B6skeauthor=S.+Niesporekauthor=A.+Noskeauthor=A.+C.+Buckendahlauthor=M.+Dietelauthor=V.+Gekelerauthor=M.+Boehmauthor=T.+Beckersauthor=C.+Denkert&title=Class+I+histone+deacetylase+expression+has+independent+prognostic+impact+in+human+colorectal+cancer%3A+specific+role+of+class+I+HDACs+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Class I Histone Deacetylase Expression Has Independent Prognostic Impact in Human Colorectal Cancer: Specific Role of Class I Histone Deacetylases In vitro and In vivo</span></div><div class="casAuthors">Weichert, Wilko; Roeske, Annika; Niesporek, Silvia; Noske, Aurelia; Buckendahl, Ann-Christin; Dietel, Manfred; Gekeler, Volker; Boehm, Markus; Beckers, Thomas; Denkert, Carsten</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1669-1677</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: Recently, several studies reported a strong functional link between histone deacetylases (HDAC) and the development of tumors of the large intestine.  However, despite the importance of these mols., comparably little is known on expression patterns and functions of specific HDAC isoforms in colorectal cancer.  Exptl. Design: We characterized class I HDAC isoform expression patterns in a cohort of 140 colorectal carcinomas by immunohistochem.  In addn., effects of HDAC inhibition by valproic acid and suberoylanilide hydroxamic acid, and specific HDAC isoform knockdown by short interfering RNA, were investigated in a cell culture model.  RESULTS: We found class I HDACs highly expressed in a subset of colorectal carcinomas with positivity for HDAC1 in 36.4%, HDAC2 in 57.9%, and HDAC3 in 72.9% of cases.  Expression was significantly enhanced in strongly proliferating (P = 0.002), dedifferentiated (P = 0.022) tumors.  High HDAC expression levels implicated significantly reduced patient survival (P = 0.001), with HDAC2 expression being an independent survival prognosticator (hazard ratio, 2.6; P = 0.03).  Short interfering RNA-based inhibition of HDAC1 and HDAC2 but not HDAC3 suppressed growth of colon cancer cells in vitro, although to a lesser extent than chem. HDAC inhibitors did.  CONCLUSIONS: The strong prognostic impact of HDAC isoforms in colorectal cancer, the interactions of HDACs with tumor cell proliferation and differentiation in vivo, and our finding that HDACs are differentially expressed in colorectal tumors suggest that the evaluation of HDAC expression in clin. trials for HDAC inhibitors might help to identify a patient subgroup who will exceptionally profit from such a treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQAUfNzjDakrVg90H21EOLACvtfcHk0liSgF9Z33tKLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtlejt7o%253D&md5=f54611c0b65fe4cd8a0cfea3ea143126</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-0990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-0990%26sid%3Dliteratum%253Aachs%26aulast%3DWeichert%26aufirst%3DW.%26aulast%3DR%25C3%25B6ske%26aufirst%3DA.%26aulast%3DNiesporek%26aufirst%3DS.%26aulast%3DNoske%26aufirst%3DA.%26aulast%3DBuckendahl%26aufirst%3DA.%2BC.%26aulast%3DDietel%26aufirst%3DM.%26aulast%3DGekeler%26aufirst%3DV.%26aulast%3DBoehm%26aufirst%3DM.%26aulast%3DBeckers%26aufirst%3DT.%26aulast%3DDenkert%26aufirst%3DC.%26atitle%3DClass%2520I%2520histone%2520deacetylase%2520expression%2520has%2520independent%2520prognostic%2520impact%2520in%2520human%2520colorectal%2520cancer%253A%2520specific%2520role%2520of%2520class%2520I%2520HDACs%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DClin.%2520Cancer.%2520Res.%26date%3D2008%26volume%3D14%26spage%3D1669%26epage%3D1677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Weichert, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Röske, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gekeler, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niesporek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denkert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kristiansen, G.</span><span> </span><span class="NLM_article-title">Expression, function and prognostic role of class I histone deacetylase isoforms in prostate cancer in vitro and in vivo</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">604</span><span class="NLM_x">–</span> <span class="NLM_lpage">610</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1038%2Fsj.bjc.6604199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=18212746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhs1Krsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2008&pages=604-610&author=W.+Weichertauthor=A.+R%C3%B6skeauthor=G.+Gekelerauthor=T.+Beckersauthor=C.+Stephanauthor=K.+Jungauthor=S.+Niesporekauthor=C.+Denkertauthor=M.+Dietelauthor=G.+Kristiansen&title=Expression%2C+function+and+prognostic+role+of+class+I+histone+deacetylase+isoforms+in+prostate+cancer+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9cR"><div class="casContent"><span class="casTitleNuber">9c</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy</span></div><div class="casAuthors">Weichert, W.; Roeske, A.; Gekeler, V.; Beckers, T.; Stephan, C.; Jung, K.; Fritzsche, F. R.; Niesporek, S.; Denkert, C.; Dietel, M.; Kristiansen, G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">604-610</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">High activity of histone deacetylases (HDACs) causes epigenetic alterations assocd. with malignant cell behavior.  Consequently, HDAC inhibitors have entered late-phase clin. trials as new antineoplastic drugs.  However, little is known about expression and function of specific HDAC isoforms in human tumors including prostate cancer.  We investigated the expression of class I HDACs in 192 prostate carcinomas by immunohistochem. and correlated our findings to clinicopathol. parameters including follow-up data.  Class I HDAC isoforms were strongly expressed in the majority of the cases (HDAC1: 69.8%, HDAC2: 74%, HDAC3: 94.8%).  High rates of HDAC1 and HDAC2 expression were significantly assocd. with tumor dedifferentiation.  Strong expression of all HDACs was accompanied by enhanced tumor cell proliferation.  In addn., HDAC2 was an independent prognostic marker in our prostate cancer cohort.  In conclusion, we showed that the known effects of HDACs on differentiation and proliferation of cancer cells obsd. in vitro can also be confirmed in vivo.  The class I HDAC isoforms 1, 2 and 3 are differentially expressed in prostate cancer, which might be important for upcoming studies on HDAC inhibitors in this tumor entity.  Also, the highly significant prognostic value of HDAC2 clearly deserves further study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbq9wIwyKVYLVg90H21EOLACvtfcHk0liSgF9Z33tKLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhs1Krsbo%253D&md5=deebe5cf3cb1c08909282a807000827a</span></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6604199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6604199%26sid%3Dliteratum%253Aachs%26aulast%3DWeichert%26aufirst%3DW.%26aulast%3DR%25C3%25B6ske%26aufirst%3DA.%26aulast%3DGekeler%26aufirst%3DG.%26aulast%3DBeckers%26aufirst%3DT.%26aulast%3DStephan%26aufirst%3DC.%26aulast%3DJung%26aufirst%3DK.%26aulast%3DNiesporek%26aufirst%3DS.%26aulast%3DDenkert%26aufirst%3DC.%26aulast%3DDietel%26aufirst%3DM.%26aulast%3DKristiansen%26aufirst%3DG.%26atitle%3DExpression%252C%2520function%2520and%2520prognostic%2520role%2520of%2520class%2520I%2520histone%2520deacetylase%2520isoforms%2520in%2520prostate%2520cancer%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2008%26volume%3D98%26spage%3D604%26epage%3D610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yoo, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, P. A.</span><span> </span><span class="NLM_article-title">Epigenetic therapy of cancer: past, present and future</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1038%2Fnrd1930" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=16485345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD28Xmt1yqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=37-50&author=C.+B.+Yooauthor=P.+A.+Jones&title=Epigenetic+therapy+of+cancer%3A+past%2C+present+and+future"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Epigenetic therapy of cancer: past, present and future</span></div><div class="casAuthors">Yoo, Christine B.; Jones, Peter A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-50</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The initiation and progression of cancer is controlled by both genetic and epigenetic events.  Unlike genetic alterations, which are almost impossible to reverse, epigenetic aberrations are potentially reversible, allowing the malignant cell population to revert to a more normal state.  With the advent of numerous drugs that target specific enzymes involved in the epigenetic regulation of gene expression, the utilization of epigenetic targets is emerging as an effective and valuable approach to chemotherapy as well as chemoprevention of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOQv6jMPAK1LVg90H21EOLACvtfcHk0lhb2XjOeMp9Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xmt1yqsA%253D%253D&md5=5c552ef929369b8466d2ab2c324cf092</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1038%2Fnrd1930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1930%26sid%3Dliteratum%253Aachs%26aulast%3DYoo%26aufirst%3DC.%2BB.%26aulast%3DJones%26aufirst%3DP.%2BA.%26atitle%3DEpigenetic%2520therapy%2520of%2520cancer%253A%2520past%252C%2520present%2520and%2520future%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D37%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Riester, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hildmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwienhorst, A.</span><span> </span><span class="NLM_article-title">Histone deacetylase inhibitors-turning epigenic mechanisms of gene regulation into tools of therapeutic intervention in malignant and other diseases</span> <span class="citation_source-journal">Appl. Microbiol. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">499</span><span class="NLM_x">–</span> <span class="NLM_lpage">514</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2007&pages=499-514&author=D.+Riesterauthor=C.+Hildmannauthor=A.+Schwienhorst&title=Histone+deacetylase+inhibitors-turning+epigenic+mechanisms+of+gene+regulation+into+tools+of+therapeutic+intervention+in+malignant+and+other+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRiester%26aufirst%3DD.%26aulast%3DHildmann%26aufirst%3DC.%26aulast%3DSchwienhorst%26aufirst%3DA.%26atitle%3DHistone%2520deacetylase%2520inhibitors-turning%2520epigenic%2520mechanisms%2520of%2520gene%2520regulation%2520into%2520tools%2520of%2520therapeutic%2520intervention%2520in%2520malignant%2520and%2520other%2520diseases%26jtitle%3DAppl.%2520Microbiol.%2520Biotechnol.%26date%3D2007%26volume%3D75%26spage%3D499%26epage%3D514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Sorbera, L. A.</span><span> </span><span class="NLM_article-title">Epigenetic targets as an approach to cancer therapy and chemoprevention</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">335</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1358%2Fdof.2006.031.04.985053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD28XntVylsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2006&pages=335-344&author=L.+A.+Sorbera&title=Epigenetic+targets+as+an+approach+to+cancer+therapy+and+chemoprevention"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Epigenetic target as an approach to cancer therapy and chemoprevention</span></div><div class="casAuthors">Sorbera, Lisa A.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">335-344</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Carcinogenesis and tumor progression are controlled by both genetic and epigenetic events.  Unlike genetic aberrations, epigenetic aberrations such as DNA methylation and histone deacetylation evident in cancer cells can usually be reversed to reactivate epigenetically silenced tumor suppressor genes and possibly normalize a malignant cell population.  Thus, researchers have focused on epigenetic events as targets for effective cancer therapy and chemoprevention.  At the 97th American Assocn. for Cancer Research Annual Meeting in Washington, D.C., the preclin. and clin. activity of several histone deacetylase (HDAC) and DNA methyltransferase (DNMT) inhibitors was described, indicating promising anticancer effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCi1AxorTZnrVg90H21EOLACvtfcHk0lhb2XjOeMp9Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntVylsbc%253D&md5=32b4c23f6b9735485eb3fe411e919a96</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1358%2Fdof.2006.031.04.985053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2006.031.04.985053%26sid%3Dliteratum%253Aachs%26aulast%3DSorbera%26aufirst%3DL.%2BA.%26atitle%3DEpigenetic%2520targets%2520as%2520an%2520approach%2520to%2520cancer%2520therapy%2520and%2520chemoprevention%26jtitle%3DDrugs%2520Future%26date%3D2006%26volume%3D31%26spage%3D335%26epage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Miller, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witter, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belvedere, S.</span><span> </span><span class="NLM_article-title">Histone Deacetylase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">5097</span><span class="NLM_x">–</span> <span class="NLM_lpage">5116</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0303094" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD3sXosVCktbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=5097-5116&author=T.+A.+Millerauthor=D.+J.+Witterauthor=S.+Belvedere&title=Histone+Deacetylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase inhibitors</span></div><div class="casAuthors">Miller, Thomas A.; Witter, David J.; Belvedere, Sandro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">5097-5116</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on the medicinal chem. and structure-activity relationships underlying advances in histone deacetylase (HDAC) class I/II inhibitor discovery, design, and optimization.  HDAC structural studies and HDAC inhibitory activity of small-mol. hydroxamic acids, carboxylates, benzamides, electrophilic ketones, and cyclic peptides are described.  Miscellaneousness and selectivity of the class I/II HDACs are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoU5UlOsBUF7rVg90H21EOLACvtfcHk0lg-YVRMIv3DHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXosVCktbg%253D&md5=d2d0a95d87d699334c1630df5deda38a</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1021%2Fjm0303094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0303094%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DT.%2BA.%26aulast%3DWitter%26aufirst%3DD.%2BJ.%26aulast%3DBelvedere%26aufirst%3DS.%26atitle%3DHistone%2520Deacetylase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D5097%26epage%3D5116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hildmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wegener, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riester, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hempel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schober, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merena, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guirato, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guccione, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ficner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwienhorst, A.</span><span> </span><span class="NLM_article-title">Substrate and inhibitor specificity of class 1 and class 2 histone deacetylases</span> <span class="citation_source-journal">J. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">258</span><span class="NLM_x">–</span> <span class="NLM_lpage">270</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1016%2Fj.jbiotec.2006.01.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=16567013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD28Xltl2isb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2006&pages=258-270&author=C.+Hildmannauthor=D.+Wegenerauthor=D.+Riesterauthor=R.+Hempelauthor=A.+Schoberauthor=J.+Merenaauthor=L.+Guiratoauthor=S.+Guccioneauthor=T.+K.+Nielsenauthor=R.+Ficnerauthor=A.+Schwienhorst&title=Substrate+and+inhibitor+specificity+of+class+1+and+class+2+histone+deacetylases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate and inhibitor specificity of class 1 and class 2 histone deacetylases</span></div><div class="casAuthors">Hildmann, Christian; Wegener, Dennis; Riester, Daniel; Hempel, Rene; Schober, Andreas; Merana, Joachim; Giurato, Laura; Guccione, Salvatore; Nielsen, Tine Kragh; Ficner, Ralf; Schwienhorst, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biotechnology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">258-270</span>CODEN:
                <span class="NLM_cas:coden">JBITD4</span>;
        ISSN:<span class="NLM_cas:issn">0168-1656</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Histone deacetylases (HDACs) are key enzymes in the transcriptional regulation of gene expression in eukaryotic cells.  In recent years HDACs have attracted considerable attention as promising new targets in anticancer therapy.  Currently, different histone deacetylase subtypes are divided into four groups denoted as classes 1-4.  Here, we compare in more detail representatives of class 1 HDACs and FB188 HDAH as a close bacterial homolog of class 2 HDAC6, in regard to substrate and inhibitor specificity.  Structure comparison is used to identify candidate regions responsible for obsd. specificity differences.  Knowledge of these structural elements expedite studies on the biochem. role of different HDAC subtypes as well as the development of highly selective HDAC inhibitors as antitumor agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV3e94dR7LFbVg90H21EOLACvtfcHk0lg-YVRMIv3DHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xltl2isb0%253D&md5=4a47e29f8453b7b218b6641a5fd89f26</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1016%2Fj.jbiotec.2006.01.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jbiotec.2006.01.030%26sid%3Dliteratum%253Aachs%26aulast%3DHildmann%26aufirst%3DC.%26aulast%3DWegener%26aufirst%3DD.%26aulast%3DRiester%26aufirst%3DD.%26aulast%3DHempel%26aufirst%3DR.%26aulast%3DSchober%26aufirst%3DA.%26aulast%3DMerena%26aufirst%3DJ.%26aulast%3DGuirato%26aufirst%3DL.%26aulast%3DGuccione%26aufirst%3DS.%26aulast%3DNielsen%26aufirst%3DT.%2BK.%26aulast%3DFicner%26aufirst%3DR.%26aulast%3DSchwienhorst%26aufirst%3DA.%26atitle%3DSubstrate%2520and%2520inhibitor%2520specificity%2520of%2520class%25201%2520and%2520class%25202%2520histone%2520deacetylases%26jtitle%3DJ.%2520Biotechnol.%26date%3D2006%26volume%3D124%26spage%3D258%26epage%3D270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Finnin, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donigian, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richon, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rifkind, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breslow, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavletich, N. P.</span><span> </span><span class="NLM_article-title">Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">401</span><span class="NLM_x">, </span> <span class="NLM_fpage">188</span><span class="NLM_x">–</span> <span class="NLM_lpage">193</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1038%2F43710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=10490031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADyaK1MXlvFKgtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=401&publication_year=1999&pages=188-193&author=M.+S.+Finninauthor=J.+R.+Donigianauthor=A.+Cohenauthor=V.+M.+Richonauthor=R.+A.+Rifkindauthor=P.+A.+Marksauthor=R.+Breslowauthor=N.+P.+Pavletich&title=Structures+of+a+histone+deacetylase+homologue+bound+to+the+TSA+and+SAHA+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors</span></div><div class="casAuthors">Finnin, Michael S.; Donigian, Jill R.; Cohen, Alona; Richon, Victoria M.; Rifkind, Richard A.; Marks, Paul A.; Breslow, Ronald; Pavletich, Nikola P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">401</span>
        (<span class="NLM_cas:issue">6749</span>),
    <span class="NLM_cas:pages">188-193</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Histone deacetylases (HDACs) mediate changes in nucleosome conformation and are important in the regulation of gene expression.  HDACs are involved in cell-cycle progression and differentiation, and their deregulation is assocd. with several cancers.  HDAC inhibitors, such as trichostatin A (TSA) and suberoylanilide hydroxamic acid (SAHA), have anti-tumor effects, as they can inhibit cell growth, induce terminal differentiation and prevent the formation of tumors in mice models, and they are effective in the treatment of promyelocytic leukemia.  Here we describe the structure of the histone deacetylase catalytic core, as revealed by the crystal structure of a homolog from the hyperthermophilic bacterium Aquifex aeolicus, that shares 35.2% identity with human HDAC1 over 375 residues, deacetylates histones in vitro and is inhibited by TSA and SAHA.  The deacetylase, deacetylase-TSA and deacetylase-SAHA structures reveal an active site consisting of a tubular pocket, a zinc-binding site and two Asp-His charge-relay systems, and establish the mechanism of HDAC inhibition.  The residues that make up the active site and contact the inhibitors are conserved across the HDAC family.  These structures also suggest a mechanism for the deacetylation reaction and provide a framework for the further development of HDAC inhibitors as antitumor agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrG0lsZMMo37Vg90H21EOLACvtfcHk0lgO0W0bkBSjbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvFKgtrc%253D&md5=29bbc6d3ba9a9d2a8c330349ae8199a8</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1038%2F43710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F43710%26sid%3Dliteratum%253Aachs%26aulast%3DFinnin%26aufirst%3DM.%2BS.%26aulast%3DDonigian%26aufirst%3DJ.%2BR.%26aulast%3DCohen%26aufirst%3DA.%26aulast%3DRichon%26aufirst%3DV.%2BM.%26aulast%3DRifkind%26aufirst%3DR.%2BA.%26aulast%3DMarks%26aufirst%3DP.%2BA.%26aulast%3DBreslow%26aufirst%3DR.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26atitle%3DStructures%2520of%2520a%2520histone%2520deacetylase%2520homologue%2520bound%2520to%2520the%2520TSA%2520and%2520SAHA%2520inhibitors%26jtitle%3DNature%26date%3D1999%26volume%3D401%26spage%3D188%26epage%3D193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Somoza, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skene, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mol, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luong, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arvai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buggy, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chi, El.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sang, B.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wynands, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leahy, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougan, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snell, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navre, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knuth, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swanson, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McRee, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tari, L. W.</span><span> </span><span class="NLM_article-title">Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1325</span><span class="NLM_x">–</span> <span class="NLM_lpage">1334</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1016%2Fj.str.2004.04.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=15242608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsFyrsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=1325-1334&author=J.+R.+Somozaauthor=R.+J.+Skeneauthor=B.+A.+Katzauthor=C.+Molauthor=J.+D.+Hoauthor=A.+J.+Jenningsauthor=C.+Luongauthor=A.+Arvaiauthor=J.+J.+Buggyauthor=El.+Chiauthor=J.+Tangauthor=B.-C.+Sangauthor=E.+Vernerauthor=R.+Wynandsauthor=E.+M.+Leahyauthor=D.+R.+Douganauthor=G.+Snellauthor=M.+Navreauthor=M.+W.+Knuthauthor=R.+V.+Swansonauthor=D.+E.+McReeauthor=L.+W.+Tari&title=Structural+Snapshots+of+Human+HDAC8+Provide+Insights+into+the+Class+I+Histone+Deacetylases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases</span></div><div class="casAuthors">Somoza, John R.; Skene, Robert J.; Katz, Bradley A.; Mol, Clifford; Ho, Joseph D.; Jennings, Andy J.; Luong, Christine; Arvai, Andrew; Buggy, Joseph J.; Chi, Ellen; Tang, Jie; Sang, Bi-Ching; Verner, Erik; Wynands, Robert; Leahy, Ellen M.; Dougan, Douglas R.; Snell, Gyorgy; Navre, Marc; Knuth, Mark W.; Swanson, Ronald V.; McRee, Duncan E.; Tari, Leslie W.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1325-1334</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Modulation of the acetylation state of histones plays a pivotal role in the regulation of gene expression.  Histone deacetylases (HDACs) catalyze the removal of acetyl groups from lysines near the N termini of histones.  This reaction promotes the condensation of chromatin, leading to repression of transcription.  HDAC deregulation has been linked to several types of cancer, suggesting a potential use for HDAC inhibitors in oncol.  Here we describe the first crystal structures of a human HDAC: the structures of human HDAC8 complexed with four structurally diverse hydroxamate inhibitors.  This work sheds light on the catalytic mechanism of the HDACs, and on differences in substrate specificity across the HDAC family.  The structure also suggests how phosphorylation of Ser39 affects HDAC8 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPLrZup76hGLVg90H21EOLACvtfcHk0lgO0W0bkBSjbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsFyrsLc%253D&md5=3f1842802bac2543509a25f5ddbea5f6</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2004.04.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2004.04.012%26sid%3Dliteratum%253Aachs%26aulast%3DSomoza%26aufirst%3DJ.%2BR.%26aulast%3DSkene%26aufirst%3DR.%2BJ.%26aulast%3DKatz%26aufirst%3DB.%2BA.%26aulast%3DMol%26aufirst%3DC.%26aulast%3DHo%26aufirst%3DJ.%2BD.%26aulast%3DJennings%26aufirst%3DA.%2BJ.%26aulast%3DLuong%26aufirst%3DC.%26aulast%3DArvai%26aufirst%3DA.%26aulast%3DBuggy%26aufirst%3DJ.%2BJ.%26aulast%3DChi%26aufirst%3DEl.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DSang%26aufirst%3DB.-C.%26aulast%3DVerner%26aufirst%3DE.%26aulast%3DWynands%26aufirst%3DR.%26aulast%3DLeahy%26aufirst%3DE.%2BM.%26aulast%3DDougan%26aufirst%3DD.%2BR.%26aulast%3DSnell%26aufirst%3DG.%26aulast%3DNavre%26aufirst%3DM.%26aulast%3DKnuth%26aufirst%3DM.%2BW.%26aulast%3DSwanson%26aufirst%3DR.%2BV.%26aulast%3DMcRee%26aufirst%3DD.%2BE.%26aulast%3DTari%26aufirst%3DL.%2BW.%26atitle%3DStructural%2520Snapshots%2520of%2520Human%2520HDAC8%2520Provide%2520Insights%2520into%2520the%2520Class%2520I%2520Histone%2520Deacetylases%26jtitle%3DStructure%26date%3D2004%26volume%3D12%26spage%3D1325%26epage%3D1334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Beckers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkhardt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wieland, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gimmnich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciossek, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, K.</span><span> </span><span class="NLM_article-title">Distinct pharmacological properties of 2nd generation HDAC inhibitors with the benzamide or hydroxamate head group</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">1138</span><span class="NLM_x">–</span> <span class="NLM_lpage">1148</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1002%2Fijc.22751" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=17455259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFGhu7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2007&pages=1138-1148&author=T.+Beckersauthor=C.+Burkhardtauthor=H.+Wielandauthor=P.+Gimmnichauthor=T.+Ciossekauthor=T.+Maierauthor=K.+Sanders&title=Distinct+pharmacological+properties+of+2nd+generation+HDAC+inhibitors+with+the+benzamide+or+hydroxamate+head+group"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct pharmacological properties of second generation HDAC inhibitors with the benzamide or hydroxamate head group</span></div><div class="casAuthors">Beckers, Thomas; Burkhardt, Carmen; Wieland, Heike; Gimmnich, Petra; Ciossek, Thomas; Maier, Thomas; Sanders, Karl</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1138-1148</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Advanced second generation inhibitors of histone deacetylases (HDAC) are currently used in clin. development.  This study aimed at comparing the pharmacol. properties of selected second generation HDAC inhibitors with the hydroxamate and benzamide head group, namely SAHA, LAQ824/LBH589, CI994, MS275 and MGCD0103.  In biochem. assays using recombinant HDAC1, 3, 6 and 8 isoenzymes, SAHA and LAQ824/LBH589 behave as quite unselective HDAC inhibitors.  In contrast, the benzamides CI994, MS275 and MGCD0103 are more selective, potent inhibitors of at least HDAC1 and HDAC3.  All HDAC inhibitors induce histone H3 hyperacetylation, correlating with inhibition of proliferation, induction of cell differentiation and apoptosis.  A broad cytotoxicity is seen across cell lines from different tumor entities with LAQ824/LBH589 being the most potent agents.  The apoptosis inducing activity is evident in arrested and proliferating RKO colon cancer cells with inducible, heterologous p21waf1 expression, indicative for a cell-cycle independent mode-of-action.  Differentiation of MDA-MB468 breast cancer cells is induced by benzamide and hydroxamate analogs.  The reversibility of drug action was evaluated by pulse treatment of A549 lung cancer cells.  Whereas paclitaxel induced irreversible cell cycle alterations already after 6 h treatment, HDAC inhibitor action was retarded and irreversible after >16 h treatment.  Interestingly, pulse treatment was equally effective as continous treatment.  Finally, the efficacy of LAQ824, SAHA and MS275 in A549 nude mice xenografts was comparable to that of paclitaxel at well tolerated doses.  We conclude that despite a different HDAC isoenzyme inhibition profile, hydroxamate and benzamide analogs as studied display similar cellular profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiDHz24Jk1RLVg90H21EOLACvtfcHk0lgO0W0bkBSjbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFGhu7nN&md5=b022385076ee75290c2b6f8d3cdf4bbe</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Fijc.22751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.22751%26sid%3Dliteratum%253Aachs%26aulast%3DBeckers%26aufirst%3DT.%26aulast%3DBurkhardt%26aufirst%3DC.%26aulast%3DWieland%26aufirst%3DH.%26aulast%3DGimmnich%26aufirst%3DP.%26aulast%3DCiossek%26aufirst%3DT.%26aulast%3DMaier%26aufirst%3DT.%26aulast%3DSanders%26aufirst%3DK.%26atitle%3DDistinct%2520pharmacological%2520properties%2520of%25202nd%2520generation%2520HDAC%2520inhibitors%2520with%2520the%2520benzamide%2520or%2520hydroxamate%2520head%2520group%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2007%26volume%3D121%26spage%3D1138%26epage%3D1148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Haggarty, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeller, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grozinger, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S. L.</span><span> </span><span class="NLM_article-title">Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">4389</span><span class="NLM_x">–</span> <span class="NLM_lpage">4394</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1073%2Fpnas.0430973100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=12677000" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjt12gtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=4389-4394&author=S.+J.+Haggartyauthor=K.+M.+Koellerauthor=J.+C.+Wongauthor=C.+M.+Grozingerauthor=S.+L.+Schreiber&title=Domain-selective+small-molecule+inhibitor+of+histone+deacetylase+6+%28HDAC6%29-mediated+tubulin+deacetylation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation</span></div><div class="casAuthors">Haggarty, Stephen J.; Koeller, Kathryn M.; Wong, Jason C.; Grozinger, Christina M.; Schreiber, Stuart L.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4389-4394</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Protein acetylation, esp. histone acetylation, is the subject of both research and clin. investigation.  At least four small-mol. histone deacetylase inhibitors are currently in clin. trials for the treatment of cancer.  These and other inhibitors also affect microtubule acetylation.  A multidimensional, chem. genetic screen of 7392 small mols. was used to discover "tubacin," which inhibits α-tubulin deacetylation in mammalian cells.  Tubacin does not affect the level of histone acetylation, gene-expression patterns, or cell-cycle progression.  We provide evidence that class II histone deacetylase 6 (HDAC6) is the intracellular target of tubacin.  Only one of the two catalytic domains of HDAC6 possesses tubulin deacetylase activity, and only this domain is bound by tubacin.  Tubacin treatment did not affect the stability of microtubules but did decrease cell motility.  HDAC6 overexpression disrupted the localization of p58, a protein that mediates binding of Golgi elements to microtubules.  Our results highlight the role of α-tubulin acetylation in mediating the localization of microtubule-assocd. proteins.  They also suggest that small mols. that selectively inhibit HDAC6-mediated α-tubulin deacetylation, a first example of which is tubacin, might have therapeutic applications as antimetastatic and antiangiogenic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbQBWjEZr47rVg90H21EOLACvtfcHk0lhrTeaxoDAf2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjt12gtL0%253D&md5=260da1ede64782ddbddda31b740b9782</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0430973100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0430973100%26sid%3Dliteratum%253Aachs%26aulast%3DHaggarty%26aufirst%3DS.%2BJ.%26aulast%3DKoeller%26aufirst%3DK.%2BM.%26aulast%3DWong%26aufirst%3DJ.%2BC.%26aulast%3DGrozinger%26aufirst%3DC.%2BM.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26atitle%3DDomain-selective%2520small-molecule%2520inhibitor%2520of%2520histone%2520deacetylase%25206%2520%2528HDAC6%2529-mediated%2520tubulin%2520deacetylation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2003%26volume%3D100%26spage%3D4389%26epage%3D4394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Hodawadekar, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marmorstein, R.</span><span> </span><span class="NLM_article-title">Chemistry of acetyl transfer by histone modifying enzymes: structure, mechanismand implications for effector design</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">5528</span><span class="NLM_x">–</span> <span class="NLM_lpage">5540</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=5528-5540&author=S.+C.+Hodawadekarauthor=R.+Marmorstein&title=Chemistry+of+acetyl+transfer+by+histone+modifying+enzymes%3A+structure%2C+mechanismand+implications+for+effector+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHodawadekar%26aufirst%3DS.%2BC.%26aulast%3DMarmorstein%26aufirst%3DR.%26atitle%3DChemistry%2520of%2520acetyl%2520transfer%2520by%2520histone%2520modifying%2520enzymes%253A%2520structure%252C%2520mechanismand%2520implications%2520for%2520effector%2520design%26jtitle%3DOncogene%26date%3D2007%26volume%3D26%26spage%3D5528%26epage%3D5540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Rational Design of Non-Hydroxamate Histone Deacetylase Inhibitors</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">515</span><span class="NLM_x">–</span> <span class="NLM_lpage">526</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=515-526&author=T.+Suzukiauthor=N.+Miyata&title=Rational+Design+of+Non-Hydroxamate+Histone+Deacetylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DRational%2520Design%2520of%2520Non-Hydroxamate%2520Histone%2520Deacetylase%2520Inhibitors%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D515%26epage%3D526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Non-hydroxamate Histone Deacetylase Inhibitors</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2867</span><span class="NLM_x">–</span> <span class="NLM_lpage">2880</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.2174%2F092986705774454706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=16305476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1ShsrvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=2867-2880&author=T.+Suzukiauthor=N.+Miyata&title=Non-hydroxamate+Histone+Deacetylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">Non-hydroxamate histone deacetylase inhibitors</span></div><div class="casAuthors">Suzuki, Takayoshi; Miyata, Naoki</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2867-2880</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  A no. of histone deacetylase (HDAC) inhibitors have been developed as anticancer agents and most of them are hydroxamic acid derivs., typified by suberoylanilide hydroxamic acid (SAHA), Trichostatin A (TSA) and NVP-LAQ824.  However, hydroxamic acids have been assocd. with poor pharmacokinetics and severe toxicity.  In addn., although isoenzyme-selective HDAC inhibitors are considered useful not only as tools for probing the biol. of an enzyme but as drugs with low toxicity, many of the hydroxamate HDAC inhibitors do not distinguish well among the HDAC isoenzymes.  Thus, there has been considerable interest in developing non-hydroxamate HDAC inhibitors.  To date, small fatty acids, o-aminoanilides, electrophilic ketones, N-formyl hydroxylamines, thiols and mercaptoamides have been reported as non-hydroxamate HDAC inhibitors, and some of them show antiproliferative activity comparable to hydroxamates.  Interestingly, hydroxamate HDAC inhibitors such as SAHA and TSA do not discriminate well among the HDAC isoenzymes whereas many non-hydroxamate HDAC inhibitors have shown selectivity.  These non-hydroxamate HDAC inhibitors should pave the way for the development of tools for biol. research and new medicines with few side effects.  In this review, we introduce non-hydroxamate HDAC inhibitors describing their design, enzyme inhibition, cancer cell growth inhibition and isoenzyme selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWm6vIRhSCELVg90H21EOLACvtfcHk0lhrTeaxoDAf2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1ShsrvK&md5=e36fdb1fdccf41ce542b10687b890218</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.2174%2F092986705774454706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986705774454706%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DNon-hydroxamate%2520Histone%2520Deacetylase%2520Inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2005%26volume%3D12%26spage%3D2867%26epage%3D2880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18a"><span><span class="NLM_label">(a) </span><div class="note"><p class="first last">For recent studies on hydroxamtes and benzamides, see for instance</p></div><span class="NLM_contrib-group">Anandan, S.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brokx, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bray, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, X.-Y.</span><span> </span><span class="NLM_article-title">Design and synthesis of thiazole-5-hydroxamic acids as novel histone deacetylase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">5995</span><span class="NLM_x">–</span> <span class="NLM_lpage">5999</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=5995-5999&author=S.-K.+Anandanauthor=J.+S.+Wardauthor=R.+D.+Brokxauthor=T.+Dennyauthor=M.+R.+Brayauthor=D.+V.+Patelauthor=X.-Y.+Xiao&title=Design+and+synthesis+of+thiazole-5-hydroxamic+acids+as+novel+histone+deacetylase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnandan%26aufirst%3DS.-K.%26aulast%3DWard%26aufirst%3DJ.%2BS.%26aulast%3DBrokx%26aufirst%3DR.%2BD.%26aulast%3DDenny%26aufirst%3DT.%26aulast%3DBray%26aufirst%3DM.%2BR.%26aulast%3DPatel%26aufirst%3DD.%2BV.%26aulast%3DXiao%26aufirst%3DX.-Y.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520thiazole-5-hydroxamic%2520acids%2520as%2520novel%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D5995%26epage%3D5999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Moradei, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallais, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frechette, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tessier, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leit, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fournel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonfils, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trachy-Bourget, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahil, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wand, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaisburg, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bestermann, J. M.</span><span> </span><span class="NLM_article-title">Novel Aminophenyl Benzamide-Type Histone Deacetylase Inhibitors with Enhanced Potency and Selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5543</span><span class="NLM_x">–</span> <span class="NLM_lpage">5546</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701079h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFKksLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5543-5546&author=O.+M.+Moradeiauthor=T.+C.+Mallaisauthor=S.+Frechetteauthor=I.+Paquinauthor=P.+E.+Tessierauthor=S.+M.+Leitauthor=M.+Fournelauthor=C.+Bonfilsauthor=M.-C.+Trachy-Bourgetauthor=J.+Liuauthor=T.+P.+Yanauthor=A.+H.+Luauthor=J.+Rahilauthor=J.+Wandauthor=S.+Lefebvreauthor=Z.+Liauthor=A.+F.+Vaisburgauthor=J.+M.+Bestermann&title=Novel+Aminophenyl+Benzamide-Type+Histone+Deacetylase+Inhibitors+with+Enhanced+Potency+and+Selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Aminophenyl Benzamide-Type Histone Deacetylase Inhibitors with Enhanced Potency and Selectivity</span></div><div class="casAuthors">Moradei, Oscar M.; Mallais, Tammy C.; Frechette, Sylvie; Paquin, Isabelle; Tessier, Pierre E.; Leit, Silvana M.; Fournel, Marielle; Bonfils, Claire; Trachy-Bourget, Marie-Claude; Liu, Jianhong; Yan, Theresa P.; Lu, Ai-Hua; Rahil, Jubrail; Wang, James; Lefebvre, Sylvain; Li, Zuomei; Vaisburg, Arkadii F.; Besterman, Jeffrey M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5543-5546</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Significant effort is being made to understand the role of HDAC isotypes in human cancer and to develop antitumor agents with better therapeutic windows.  A part of this endeavor was the exploration of the 14 Å internal cavity adjacent to the enzyme catalytic site, which led to the design and synthesis of compd. 4 (I) with the unusual bis(aryl)-type pharmacophore.  SAR studies around this lead resulted in optimization to potent, selective, nonhydroxamic acid HDAC inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlM848KF3mo7Vg90H21EOLACvtfcHk0ljmQanTIpwzbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFKksLrL&md5=17012416f4be84479762acac0cff5e6f</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1021%2Fjm701079h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701079h%26sid%3Dliteratum%253Aachs%26aulast%3DMoradei%26aufirst%3DO.%2BM.%26aulast%3DMallais%26aufirst%3DT.%2BC.%26aulast%3DFrechette%26aufirst%3DS.%26aulast%3DPaquin%26aufirst%3DI.%26aulast%3DTessier%26aufirst%3DP.%2BE.%26aulast%3DLeit%26aufirst%3DS.%2BM.%26aulast%3DFournel%26aufirst%3DM.%26aulast%3DBonfils%26aufirst%3DC.%26aulast%3DTrachy-Bourget%26aufirst%3DM.-C.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DT.%2BP.%26aulast%3DLu%26aufirst%3DA.%2BH.%26aulast%3DRahil%26aufirst%3DJ.%26aulast%3DWand%26aufirst%3DJ.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DVaisburg%26aufirst%3DA.%2BF.%26aulast%3DBestermann%26aufirst%3DJ.%2BM.%26atitle%3DNovel%2520Aminophenyl%2520Benzamide-Type%2520Histone%2520Deacetylase%2520Inhibitors%2520with%2520Enhanced%2520Potency%2520and%2520Selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5543%26epage%3D5546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hamblett, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Methot, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mampreian, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloman, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kral, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruz, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chenard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozerova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitz, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nazef, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harsch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlberg, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szewczak, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Secrist, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, T. A.</span><span> </span><span class="NLM_article-title">The discovery of 6-amino nicotinamides as potent and selective histone deacetylase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">5300</span><span class="NLM_x">–</span> <span class="NLM_lpage">5309</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=5300-5309&author=C.+L.+Hamblettauthor=J.+L.+Methotauthor=D.+M.+Mampreianauthor=D.+L.+Slomanauthor=M.+G.+Stantonauthor=A.+M.+Kralauthor=J.+C.+Flemingauthor=J.+C.+Cruzauthor=M.+Chenardauthor=N.+Ozerovaauthor=A.+M.+Hitzauthor=H.+Wangauthor=S.+V.+Deshmukhauthor=N.+Nazefauthor=A.+Harschauthor=B.+Hughesauthor=W.+K.+Dahlbergauthor=A.+A.+Szewczakauthor=R.+E.+Middletonauthor=R.+T.+Mosleyauthor=J.+P.+Secristauthor=T.+A.+Miller&title=The+discovery+of+6-amino+nicotinamides+as+potent+and+selective+histone+deacetylase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHamblett%26aufirst%3DC.%2BL.%26aulast%3DMethot%26aufirst%3DJ.%2BL.%26aulast%3DMampreian%26aufirst%3DD.%2BM.%26aulast%3DSloman%26aufirst%3DD.%2BL.%26aulast%3DStanton%26aufirst%3DM.%2BG.%26aulast%3DKral%26aufirst%3DA.%2BM.%26aulast%3DFleming%26aufirst%3DJ.%2BC.%26aulast%3DCruz%26aufirst%3DJ.%2BC.%26aulast%3DChenard%26aufirst%3DM.%26aulast%3DOzerova%26aufirst%3DN.%26aulast%3DHitz%26aufirst%3DA.%2BM.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DDeshmukh%26aufirst%3DS.%2BV.%26aulast%3DNazef%26aufirst%3DN.%26aulast%3DHarsch%26aufirst%3DA.%26aulast%3DHughes%26aufirst%3DB.%26aulast%3DDahlberg%26aufirst%3DW.%2BK.%26aulast%3DSzewczak%26aufirst%3DA.%2BA.%26aulast%3DMiddleton%26aufirst%3DR.%2BE.%26aulast%3DMosley%26aufirst%3DR.%2BT.%26aulast%3DSecrist%26aufirst%3DJ.%2BP.%26aulast%3DMiller%26aufirst%3DT.%2BA.%26atitle%3DThe%2520discovery%2520of%25206-amino%2520nicotinamides%2520as%2520potent%2520and%2520selective%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D5300%26epage%3D5309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouketsu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ninomiya, S.-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Thiol-based SAHA analogues as potent histone deacetylase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3313</span><span class="NLM_x">–</span> <span class="NLM_lpage">3317</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3313-3317&author=T.+Suzukiauthor=A.+Kouketsuauthor=A.+Matsuuraauthor=A.+Koharaauthor=S.-i.+Ninomiyaauthor=K.+Kohdaauthor=N.+Miyata&title=Thiol-based+SAHA+analogues+as+potent+histone+deacetylase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DKouketsu%26aufirst%3DA.%26aulast%3DMatsuura%26aufirst%3DA.%26aulast%3DKohara%26aufirst%3DA.%26aulast%3DNinomiya%26aufirst%3DS.-i.%26aulast%3DKohda%26aufirst%3DK.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DThiol-based%2520SAHA%2520analogues%2520as%2520potent%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3313%26epage%3D3317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Nishino, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jose, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebisusaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sumida, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, M.</span><span> </span><span class="NLM_article-title">Cyclic Tetrapeptides Bearing a Sulfhydryl Group Potently Inhibit Histone Deacetylases</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">5079</span><span class="NLM_x">–</span> <span class="NLM_lpage">5082</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol036098e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=5079-5082&author=N.+Nishinoauthor=B.+Joseauthor=S.+Okamuraauthor=S.+Ebisusakiauthor=T.+Katoauthor=Y.+Sumidaauthor=M.+Yoshida&title=Cyclic+Tetrapeptides+Bearing+a+Sulfhydryl+Group+Potently+Inhibit+Histone+Deacetylases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1021%2Fol036098e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol036098e%26sid%3Dliteratum%253Aachs%26aulast%3DNishino%26aufirst%3DN.%26aulast%3DJose%26aufirst%3DB.%26aulast%3DOkamura%26aufirst%3DS.%26aulast%3DEbisusaki%26aufirst%3DS.%26aulast%3DKato%26aufirst%3DT.%26aulast%3DSumida%26aufirst%3DY.%26aulast%3DYoshida%26aufirst%3DM.%26atitle%3DCyclic%2520Tetrapeptides%2520Bearing%2520a%2520Sulfhydryl%2520Group%2520Potently%2520Inhibit%2520Histone%2520Deacetylases%26jtitle%3DOrg.%2520Lett.%26date%3D2003%26volume%3D5%26spage%3D5079%26epage%3D5082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouketsu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Design, Synthesis, Structure−Selectivity Relationship, and Effect on Human Cancer Cells of a Novel Series of Histone Deacetylase 6-Selective Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5425</span><span class="NLM_x">–</span> <span class="NLM_lpage">5438</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm7009217" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5425-5438&author=Y.+Itohauthor=T.+Suzukiauthor=A.+Kouketsuauthor=N.+Suzukiauthor=S.+Maedaauthor=M.+Yoshidaauthor=H.+Nakagawaauthor=N.+Miyata&title=Design%2C+Synthesis%2C+Structure%E2%88%92Selectivity+Relationship%2C+and+Effect+on+Human+Cancer+Cells+of+a+Novel+Series+of+Histone+Deacetylase+6-Selective+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=10.1021%2Fjm7009217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7009217%26sid%3Dliteratum%253Aachs%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DKouketsu%26aufirst%3DA.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DMaeda%26aufirst%3DS.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DDesign%252C%2520Synthesis%252C%2520Structure%25E2%2588%2592Selectivity%2520Relationship%252C%2520and%2520Effect%2520on%2520Human%2520Cancer%2520Cells%2520of%2520a%2520Novel%2520Series%2520of%2520Histone%2520Deacetylase%25206-Selective%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5425%26epage%3D5438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouketsu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurotaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Novel Inhibitors of Human Histone Deacetylases: Design, Synthesis, Enzyme Inhibition, and Cancer Cell Growth Inhibition of SAHA-Based Non-hydroxamates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1019</span><span class="NLM_x">–</span> <span class="NLM_lpage">1032</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049207j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1019-1032&author=T.+Suzukiauthor=Y.+Naganoauthor=A.+Kouketsuauthor=A.+Matsuuraauthor=S.+Maruyamaauthor=M.+Kurotakiauthor=H.+Nakagawaauthor=N.+Miyata&title=Novel+Inhibitors+of+Human+Histone+Deacetylases%3A+Design%2C+Synthesis%2C+Enzyme+Inhibition%2C+and+Cancer+Cell+Growth+Inhibition+of+SAHA-Based+Non-hydroxamates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm049207j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049207j%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DNagano%26aufirst%3DY.%26aulast%3DKouketsu%26aufirst%3DA.%26aulast%3DMatsuura%26aufirst%3DA.%26aulast%3DMaruyama%26aufirst%3DS.%26aulast%3DKurotaki%26aufirst%3DM.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DNovel%2520Inhibitors%2520of%2520Human%2520Histone%2520Deacetylases%253A%2520Design%252C%2520Synthesis%252C%2520Enzyme%2520Inhibition%252C%2520and%2520Cancer%2520Cell%2520Growth%2520Inhibition%2520of%2520SAHA-Based%2520Non-hydroxamates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1019%26epage%3D1032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Furumai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuyama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishiyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komatsu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishino, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horinouchi, S.</span><span> </span><span class="NLM_article-title">FK228 (Depsipeptide) as a Natural Prodrug That Inhibits Class I Histone Deacetylases</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">4916</span><span class="NLM_x">–</span> <span class="NLM_lpage">4921</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=12208741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD38Xmslylu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=4916-4921&author=R.+Furumaiauthor=A.+Matsuyamaauthor=N.+Kobashiauthor=K-H.+Leeauthor=M.+Nishiyamaauthor=H.+Nakajimaauthor=A.+Tanakaauthor=Y.+Komatsuauthor=N.+Nishinoauthor=M.+Yoshidaauthor=S.+Horinouchi&title=FK228+%28Depsipeptide%29+as+a+Natural+Prodrug+That+Inhibits+Class+I+Histone+Deacetylases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases</span></div><div class="casAuthors">Furumai, Ryohei; Matsuyama, Akihisa; Kobashi, Nobuyuki; Lee, Kun-Hyung; Nishiyama, Makoto; Nakajima, Hidenori; Tanaka, Akito; Komatsu, Yasuhiko; Nishino, Norikazu; Yoshida, Minoru; Horinouchi, Sueharu</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4916-4921</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">FK228 is a histone deacetylase (HDAC) inhibitor, the mol. mechanism of inhibition of which has been unknown.  Here we show that redn. of an intramol. disulfide bond of FK228 greatly enhanced its inhibitory activity and that the disulfide bond was rapidly reduced in cells by cellular reducing activity involving glutathione.  Computer modeling suggests that one of the sulfhydryl groups of the reduced form of FK228 (redFK) interacts with the active-site zinc, preventing the access of the substrate.  HDAC1 and HDAC2 were more strongly inhibited by redFK than HDAC4 and HDAC6.  RedFK was less active than FK228 in inhibiting in vivo HDAC activity, due to rapid inactivation in medium and serum.  Thus, FK228 serves as a stable prodrug to inhibit class I enzymes and is activated by redn. after uptake into the cells.  The glutathione-mediated activation also implicates its clin. usefulness for counteracting glutathione-mediated drug resistance in chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohcl-TJJMBcbVg90H21EOLACvtfcHk0lipvG12xn8HPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xmslylu78%253D&md5=691ed84f8a35b1664b4bab770d69a194</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFurumai%26aufirst%3DR.%26aulast%3DMatsuyama%26aufirst%3DA.%26aulast%3DKobashi%26aufirst%3DN.%26aulast%3DLee%26aufirst%3DK-H.%26aulast%3DNishiyama%26aufirst%3DM.%26aulast%3DNakajima%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DA.%26aulast%3DKomatsu%26aufirst%3DY.%26aulast%3DNishino%26aufirst%3DN.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DHorinouchi%26aufirst%3DS.%26atitle%3DFK228%2520%2528Depsipeptide%2529%2520as%2520a%2520Natural%2520Prodrug%2520That%2520Inhibits%2520Class%2520I%2520Histone%2520Deacetylases%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D62%26spage%3D4916%26epage%3D4921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yurek-George, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cecil, A. R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mo, A. H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shijun, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habens, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packham, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganesan, A.</span><span> </span><span class="NLM_article-title">The First Biologically Active Synthetic Analogues of FK228, the Depsipeptide Histone Deacetylase Inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5720</span><span class="NLM_x">–</span> <span class="NLM_lpage">5726</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0703800" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1WmtL7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5720-5726&author=A.+Yurek-Georgeauthor=A.+R.+L.+Cecilauthor=A.+H.+K.+Moauthor=W.+Shijunauthor=H.+Rogersauthor=F.+Habensauthor=S.+Maedaauthor=M.+Yoshidaauthor=G.+Packhamauthor=A.+Ganesan&title=The+First+Biologically+Active+Synthetic+Analogues+of+FK228%2C+the+Depsipeptide+Histone+Deacetylase+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">The First Biologically Active Synthetic Analogues of FK228, the Depsipeptide Histone Deacetylase Inhibitor</span></div><div class="casAuthors">Yurek-George, Alexander; Cecil, Alexander Richard Liam; Mo, Alex Hon Kit; Wen, Shijun; Rogers, Helen; Habens, Fay; Maeda, Satoko; Yoshida, Minoru; Packham, Graham; Ganesan, A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5720-5726</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Macrocyclic peptide lactone analogs of the histone deacetylase (HDAC) inhibitor FK228 such as I (R = Me, Me2CH) are prepd.; their inhibition of human breast cancer cell line and of HDAC 1 and 6 is detd.  The dehydrobutyrine residue in FK228 is not essential and can be replaced by other residues such as D-valine without loss of HDAC inhibition.  Conformational restriction by the macrocyclic scaffold is important for HDAC inhibition; a linear peptide analog inhibits neither HDAC1 or HDAC6 and does not inhibit breast cancer cells.  The bridging disulfide of FK228 can be removed and one of its component cysteines replaced with an alanine residue with little or no loss in HDAC inhibition if the resultant thiol is protected (for example with an acetyl group).  The FK228 analogs are less effective at inhibiting HDAC6 (a class II HDAC) than HDAC1 (a class I HDAC).  The structure of I (R = Me) is detd. by X-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLSbpJiC7igbVg90H21EOLACvtfcHk0lipvG12xn8HPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1WmtL7M&md5=7c44919259524c0d825e373c8466e536</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1021%2Fjm0703800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0703800%26sid%3Dliteratum%253Aachs%26aulast%3DYurek-George%26aufirst%3DA.%26aulast%3DCecil%26aufirst%3DA.%2BR.%2BL.%26aulast%3DMo%26aufirst%3DA.%2BH.%2BK.%26aulast%3DShijun%26aufirst%3DW.%26aulast%3DRogers%26aufirst%3DH.%26aulast%3DHabens%26aufirst%3DF.%26aulast%3DMaeda%26aufirst%3DS.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DPackham%26aufirst%3DG.%26aulast%3DGanesan%26aufirst%3DA.%26atitle%3DThe%2520First%2520Biologically%2520Active%2520Synthetic%2520Analogues%2520of%2520FK228%252C%2520the%2520Depsipeptide%2520Histone%2520Deacetylase%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5720%26epage%3D5726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Shivashimpi, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amagai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishino, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishino, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, M.</span><span> </span><span class="NLM_article-title">Molecular design of histone deacetylase inhibitors by aromatic ring shifting in chlamydocin framework</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">7830</span><span class="NLM_x">–</span> <span class="NLM_lpage">7839</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=7830-7839&author=G.+M.+Shivashimpiauthor=S.+Amagaiauthor=T.+Katoauthor=N.+Nishinoauthor=S.+Maedaauthor=T.+G.+Nishinoauthor=M.+Yoshida&title=Molecular+design+of+histone+deacetylase+inhibitors+by+aromatic+ring+shifting+in+chlamydocin+framework"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShivashimpi%26aufirst%3DG.%2BM.%26aulast%3DAmagai%26aufirst%3DS.%26aulast%3DKato%26aufirst%3DT.%26aulast%3DNishino%26aufirst%3DN.%26aulast%3DMaeda%26aufirst%3DS.%26aulast%3DNishino%26aufirst%3DT.%2BG.%26aulast%3DYoshida%26aufirst%3DM.%26atitle%3DMolecular%2520design%2520of%2520histone%2520deacetylase%2520inhibitors%2520by%2520aromatic%2520ring%2520shifting%2520in%2520chlamydocin%2520framework%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D7830%26epage%3D7839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hisakawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurotaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Identification of a potent and stable antiproliferative agent by the prodrug formation of a thiolate histone deacetylase inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1558</span><span class="NLM_x">–</span> <span class="NLM_lpage">1561</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1558-1561&author=T.+Suzukiauthor=S.+Hisakawaauthor=Y.+Itohauthor=S.+Maruyamaauthor=M.+Kurotakiauthor=H.+Nakagawaauthor=N.+Miyata&title=Identification+of+a+potent+and+stable+antiproliferative+agent+by+the+prodrug+formation+of+a+thiolate+histone+deacetylase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DHisakawa%26aufirst%3DS.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DMaruyama%26aufirst%3DS.%26aulast%3DKurotaki%26aufirst%3DM.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DIdentification%2520of%2520a%2520potent%2520and%2520stable%2520antiproliferative%2520agent%2520by%2520the%2520prodrug%2520formation%2520of%2520a%2520thiolate%2520histone%2520deacetylase%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1558%26epage%3D1561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouketsu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hisakawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Highly Potent and Selective Histone Deacetylase 6 Inhibitors Designed Based on a Small-Molecular Substrate</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4809</span><span class="NLM_x">–</span> <span class="NLM_lpage">4812</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060554y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4809-4812&author=T.+Suzukiauthor=A.+Kouketsuauthor=Y.+Itohauthor=S.+Hisakawaauthor=S.+Maedaauthor=M.+Yoshidaauthor=H.+Nakagawaauthor=N.+Miyata&title=Highly+Potent+and+Selective+Histone+Deacetylase+6+Inhibitors+Designed+Based+on+a+Small-Molecular+Substrate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=10.1021%2Fjm060554y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060554y%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DKouketsu%26aufirst%3DA.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DHisakawa%26aufirst%3DS.%26aulast%3DMaeda%26aufirst%3DS.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DHighly%2520Potent%2520and%2520Selective%2520Histone%2520Deacetylase%25206%2520Inhibitors%2520Designed%2520Based%2520on%2520a%2520Small-Molecular%2520Substrate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4809%26epage%3D4812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Anandan, S.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brokx, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bray, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, X.-X.</span><span> </span><span class="NLM_article-title">Mercaptoamide-based non-hydroxamic acid type histone deacetylase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1969</span><span class="NLM_x">–</span> <span class="NLM_lpage">1972</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1969-1972&author=S.-K.+Anandanauthor=J.+S.+Wardauthor=R.+D.+Brokxauthor=M.+R.+Brayauthor=D.+V.+Patelauthor=X.-X.+Xiao&title=Mercaptoamide-based+non-hydroxamic+acid+type+histone+deacetylase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnandan%26aufirst%3DS.-K.%26aulast%3DWard%26aufirst%3DJ.%2BS.%26aulast%3DBrokx%26aufirst%3DR.%2BD.%26aulast%3DBray%26aufirst%3DM.%2BR.%26aulast%3DPatel%26aufirst%3DD.%2BV.%26aulast%3DXiao%26aufirst%3DX.-X.%26atitle%3DMercaptoamide-based%2520non-hydroxamic%2520acid%2520type%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1969%26epage%3D1972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petukhov, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velena, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eliseeva, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dritschilo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span> </span><span class="NLM_article-title">Chemistry and biology of mercaptoacetamides as novel histone deacetylase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1389</span><span class="NLM_x">–</span> <span class="NLM_lpage">1392</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1389-1392&author=B.+Chenauthor=P.+A.+Petukhovauthor=M.+Jungauthor=A.+Velenaauthor=E.+Eliseevaauthor=A.+Dritschiloauthor=A.+P.+Kozikowski&title=Chemistry+and+biology+of+mercaptoacetamides+as+novel+histone+deacetylase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DB.%26aulast%3DPetukhov%26aufirst%3DP.%2BA.%26aulast%3DJung%26aufirst%3DM.%26aulast%3DVelena%26aufirst%3DA.%26aulast%3DEliseeva%26aufirst%3DE.%26aulast%3DDritschilo%26aufirst%3DA.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DChemistry%2520and%2520biology%2520of%2520mercaptoacetamides%2520as%2520novel%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1389%26epage%3D1392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouketsu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Identification of a potent non-hydroxamate histone deacetylase inhibitor by mechanism-based drug design</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">335</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=331-335&author=T.+Suzukiauthor=A.+Matsuuraauthor=A.+Kouketsuauthor=H.+Nakagawaauthor=N.+Miyata&title=Identification+of+a+potent+non-hydroxamate+histone+deacetylase+inhibitor+by+mechanism-based+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DMatsuura%26aufirst%3DA.%26aulast%3DKouketsu%26aufirst%3DA.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DIdentification%2520of%2520a%2520potent%2520non-hydroxamate%2520histone%2520deacetylase%2520inhibitor%2520by%2520mechanism-based%2520drug%2520design%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D331%26epage%3D335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Gu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nusinzon, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. D.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horvarth, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">Carbonyl- and sulfur-containing analogs of suberoylanilide hydroxamic acid: Potent inhibition of histone deacetylases</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3320</span><span class="NLM_x">–</span> <span class="NLM_lpage">3329</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=3320-3329&author=W.+Guauthor=I.+Nusinzonauthor=R.+D.+Smithauthor=C.+M.+Horvarthauthor=R.+B.+Silverman&title=Carbonyl-+and+sulfur-containing+analogs+of+suberoylanilide+hydroxamic+acid%3A+Potent+inhibition+of+histone+deacetylases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DW.%26aulast%3DNusinzon%26aufirst%3DI.%26aulast%3DSmith%26aufirst%3DR.%2BD.%26aulast%3DHorvarth%26aufirst%3DC.%2BM.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DCarbonyl-%2520and%2520sulfur-containing%2520analogs%2520of%2520suberoylanilide%2520hydroxamic%2520acid%253A%2520Potent%2520inhibition%2520of%2520histone%2520deacetylases%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D3320%26epage%3D3329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Dehmel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciossek, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinbrenner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoche, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckers, T.</span><span> </span><span class="NLM_article-title">Trithiocarbonates—Exploration of a new head group for HDAC inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4746</span><span class="NLM_x">–</span> <span class="NLM_lpage">4752</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=4746-4752&author=F.+Dehmelauthor=T.+Ciossekauthor=T.+Maierauthor=S.+Weinbrennerauthor=B.+Schmidtauthor=M.+Zocheauthor=T.+Beckers&title=Trithiocarbonates%E2%80%94Exploration+of+a+new+head+group+for+HDAC+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDehmel%26aufirst%3DF.%26aulast%3DCiossek%26aufirst%3DT.%26aulast%3DMaier%26aufirst%3DT.%26aulast%3DWeinbrenner%26aufirst%3DS.%26aulast%3DSchmidt%26aufirst%3DB.%26aulast%3DZoche%26aufirst%3DM.%26aulast%3DBeckers%26aufirst%3DT.%26atitle%3DTrithiocarbonates%25E2%2580%2594Exploration%2520of%2520a%2520new%2520head%2520group%2520for%2520HDAC%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D4746%26epage%3D4752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Ciossek, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Julius, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wieland, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckers, T.</span><span> </span><span class="NLM_article-title">A homogeneous cellular histone deacetylase assay suitable for compound profiling and robotic screening</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">372</span><span class="NLM_x">, </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">81</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1016%2Fj.ab.2007.07.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=17868634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlajsbbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=2008&pages=72-81&author=T.+Ciossekauthor=H.+Juliusauthor=H.+Wielandauthor=T.+Maierauthor=T.+Beckers&title=A+homogeneous+cellular+histone+deacetylase+assay+suitable+for+compound+profiling+and+robotic+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A homogeneous cellular histone deacetylase assay suitable for compound profiling and robotic screening</span></div><div class="casAuthors">Ciossek, Thomas; Julius, Heiko; Wieland, Heike; Maier, Thomas; Beckers, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">372</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">72-81</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Most cellular assays that quantify the efficacy of histone deacetylase (HDAC) inhibitors measure hyperacetylation of core histone proteins H3 and H4.  Here we describe a new approach, directly measuring cellular HDAC enzymic activity using the substrate Boc-K(Ac)-7-amino-4-methylcoumarin (AMC).  After penetration into HeLa cervical carcinoma or K562 chronic myeloid leukemia cells, the deacetylated product Boc-K-AMC is formed which, after cell lysis, is cleaved by trypsin, finally releasing the fluorophor AMC.  The cellular potency of suberoylanilide hydroxamic acid, LBH589, trichostatin A, and MS275 as well-known HDAC inhibitors was detd. using this assay.  IC50 values derived from concn.-effect curves correlated well with EC50 values derived from a cellomics array scan histone H3 hyperacetylation assay.  The cellular HDAC activity assay was adapted to a homogeneous format, fully compatible with robotic screening.  Concn.-effect curves generated on a Tecan Genesis Freedom workstation were highly reproducible with a signal-to-noise ratio of 5.7 and a Z' factor of 0.88, indicating a very robust assay.  Finally, a HDAC-inhibitor focused library was profiled in a medium-throughput screening campaign.  Inhibition of cellular HDAC activity correlated well with cytotoxicity and histone H3 hyperacetylation in HeLa cells and with inhibition of human recombinant HDAC1 in a biochem. assay.  Thus, by using Boc-K(Ac)-AMC as a cell-permeable HDAC substrate, the activity of various protein lysine-specific deacetylases including HDAC1-contg. complexes is measurable in intact cells in a simple and homogeneous manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwqcthSklVtbVg90H21EOLACvtfcHk0lgenMhk8d-h9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlajsbbE&md5=8ee83fa7270002c84108a915b9ba719e</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2007.07.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2007.07.024%26sid%3Dliteratum%253Aachs%26aulast%3DCiossek%26aufirst%3DT.%26aulast%3DJulius%26aufirst%3DH.%26aulast%3DWieland%26aufirst%3DH.%26aulast%3DMaier%26aufirst%3DT.%26aulast%3DBeckers%26aufirst%3DT.%26atitle%3DA%2520homogeneous%2520cellular%2520histone%2520deacetylase%2520assay%2520suitable%2520for%2520compound%2520profiling%2520and%2520robotic%2520screening%26jtitle%3DAnal.%2520Biochem.%26date%3D2008%26volume%3D372%26spage%3D72%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">O’Brien, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orton, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pognan, F.</span><span> </span><span class="NLM_article-title">Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">5421</span><span class="NLM_x">–</span> <span class="NLM_lpage">5426</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1046%2Fj.1432-1327.2000.01606.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=10951200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsVensbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=2000&pages=5421-5426&author=J.+O%E2%80%99Brienauthor=I.+Wilsonauthor=T.+Ortonauthor=F.+Pognan&title=Investigation+of+the+Alamar+Blue+%28resazurin%29+fluorescent+dye+for+the+assessment+of+mammalian+cell+cytotoxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity</span></div><div class="casAuthors">O'Brien, John; Wilson, Ian; Orton, Terry; Pognan, Francois</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5421-5426</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">The authors show here the identity of Alamar Blue as resazurin.  The "resazurin redn. test" has been used for about 50 yr to monitor bacterial and yeast contamination of milk, and also for assessing semen quality.  Resazurin (blue and nonfluorescent) is reduced to resorufin (pink and highly fluorescent) which is further reduced to hydroresorufin (uncolored and nonfluorescent).  It is still not known how this redn. occurs, intracellularly via enzyme activity or in the medium as a chem. reaction, although the reduced fluorescent form of Alamar Blue was found in the cytoplasm and of living cells nucleus of dead cells.  Recently, the dye has gained popularity as a very simple and versatile way of measuring cell proliferation and cytotoxicity.  This dye presents numerous advantages over other cytotoxicity or proliferation tests but the authors obsd. several drawbacks to the routine use of Alamar Blue.  Tests with several toxicants in different cell lines and rat primary hepatocytes have shown accumulation of the fluorescent product of Alamar Blue in the medium which could lead to an overestimation of cell population.  Also, the extensive redn. of Alamar Blue by metabolically active cells led to a final nonfluorescent product, and hence an underestimation of cellular activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3trjtqePmK7Vg90H21EOLACvtfcHk0lhJQg0F9-xJjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsVensbY%253D&md5=7109c114d8d7d6e16f964d69f08f97fd</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1327.2000.01606.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1327.2000.01606.x%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DI.%26aulast%3DOrton%26aufirst%3DT.%26aulast%3DPognan%26aufirst%3DF.%26atitle%3DInvestigation%2520of%2520the%2520Alamar%2520Blue%2520%2528resazurin%2529%2520fluorescent%2520dye%2520for%2520the%2520assessment%2520of%2520mammalian%2520cell%2520cytotoxicity%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D2000%26volume%3D267%26spage%3D5421%26epage%3D5426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Mahboobi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellmer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocher, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garhammer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pongratz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciossek, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckers, T.</span><span> </span><span class="NLM_article-title">2-Aroylindoles and 2-aroylbenzofurans with <i>N</i>-hydroxyacrylamide substructures as a novel series of rationally designed histone deacetylase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4405</span><span class="NLM_x">–</span> <span class="NLM_lpage">4418</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0703136" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4405-4418&author=S.+Mahboobiauthor=A.+Sellmerauthor=H.+Hocherauthor=C.+Garhammerauthor=H.+Pongratzauthor=T.+Maierauthor=T.+Ciossekauthor=T.+Beckers&title=2-Aroylindoles+and+2-aroylbenzofurans+with+N-hydroxyacrylamide+substructures+as+a+novel+series+of+rationally+designed+histone+deacetylase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm0703136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0703136%26sid%3Dliteratum%253Aachs%26aulast%3DMahboobi%26aufirst%3DS.%26aulast%3DSellmer%26aufirst%3DA.%26aulast%3DHocher%26aufirst%3DH.%26aulast%3DGarhammer%26aufirst%3DC.%26aulast%3DPongratz%26aufirst%3DH.%26aulast%3DMaier%26aufirst%3DT.%26aulast%3DCiossek%26aufirst%3DT.%26aulast%3DBeckers%26aufirst%3DT.%26atitle%3D2-Aroylindoles%2520and%25202-aroylbenzofurans%2520with%2520N-hydroxyacrylamide%2520substructures%2520as%2520a%2520novel%2520series%2520of%2520rationally%2520designed%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4405%26epage%3D4418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kao, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shabanowitz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phelan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazar, M. A.</span><span> </span><span class="NLM_article-title">A novel histone deacetylase pathway regulates mitosis by modulating Aurora B kinase activity</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2566</span><span class="NLM_x">–</span> <span class="NLM_lpage">2579</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1101%2Fgad.1455006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=16980585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVamsr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=2566-2579&author=Y.+Liauthor=G.+D.+Kaoauthor=B.+A.+Garciaauthor=J.+Shabanowitzauthor=D.+F.+Huntauthor=J.+Qinauthor=C.+Phelanauthor=M.+A.+Lazar&title=A+novel+histone+deacetylase+pathway+regulates+mitosis+by+modulating+Aurora+B+kinase+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A novel histone deacetylase pathway regulates mitosis by modulating Aurora B kinase activity</span></div><div class="casAuthors">Li, Yun; Kao, Gary D.; Garcia, Benjamin A.; Shabanowitz, Jeffrey; Hunt, Donald F.; Qin, Jun; Phelan, Caroline; Lazar, Mitchell A.</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2566-2579</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Histone deacetylase (HDAC) inhibitors perturb the cell cycle and have great potential as anti-cancer agents, but their mechanism of action is not well established.  HDACs classically function as repressors of gene expression, tethered to sequence-specific transcription factors.  Here we report that HDAC3 is a crit., transcription-independent regulator of mitosis.  HDAC3 forms a complex with A-Kinase-Anchoring Proteins AKAP95 and HA95, which are targeted to mitotic chromosomes.  Deacetylation of H3 in mitosis requires AKAP95/HA95 and HDAC3 and provides a hypoacetylated H3 tail that is the preferred substrate for Aurora B kinase.  Phosphorylation of H3S10 by Aurora B leads to dissocn. of HP1 proteins from methylated H3K9 residues on mitotic heterochromatin.  This transcription-independent pathway, involving interdependent changes in histone modification and protein assocn., is required for normal progression through mitosis and is an unexpected target of HDAC inhibitors, a class of drugs currently in clin. trials for treating cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkA181czLeGrVg90H21EOLACvtfcHk0lhJQg0F9-xJjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVamsr3J&md5=9abb518bd5f86ee9778ba9e0a724c8a9</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1101%2Fgad.1455006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.1455006%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DKao%26aufirst%3DG.%2BD.%26aulast%3DGarcia%26aufirst%3DB.%2BA.%26aulast%3DShabanowitz%26aufirst%3DJ.%26aulast%3DHunt%26aufirst%3DD.%2BF.%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DPhelan%26aufirst%3DC.%26aulast%3DLazar%26aufirst%3DM.%2BA.%26atitle%3DA%2520novel%2520histone%2520deacetylase%2520pathway%2520regulates%2520mitosis%2520by%2520modulating%2520Aurora%2520B%2520kinase%2520activity%26jtitle%3DGenes%2520Dev.%26date%3D2006%26volume%3D20%26spage%3D2566%26epage%3D2579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Dignam, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebovitz, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roeder, R. G.</span><span> </span><span class="NLM_article-title">Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1475</span><span class="NLM_x">–</span> <span class="NLM_lpage">1489</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1093%2Fnar%2F11.5.1475" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=6828386" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADyaL3sXhslCit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1983&pages=1475-1489&author=J.+D.+Dignamauthor=R.+M.+Lebovitzauthor=R.+G.+Roeder&title=Accurate+transcription+initiation+by+RNA+polymerase+II+in+a+soluble+extract+from+isolated+mammalian+nuclei"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei</span></div><div class="casAuthors">Dignam, John David; Lebovitz, Russell M.; Roeder, Robert G.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1475-89</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    </div><div class="casAbstract">A new procedure was developed for prepg. exts. from nuclei of human tissue culture cells (HeLa cells) that directs accurate transcription initiation in vitro from promoters of class II by RNA polymerase II  [9014-24-8].  Conditions of extn. and assay were optimized for max. activity by using the major late promoter of adenovirus 2.  The ext. also directs accurate transcription initiation from other adenovirus promoters and cellular promoters.  The ext. also directs accurate transcription initiation from class III promoters (tRNA and adenovirus 2 VA).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpacSBbgqUIyrVg90H21EOLACvtfcHk0lhQKck_Ey7WoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXhslCit74%253D&md5=9a1031cfc1503d0179d166d9efe68ac5</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1093%2Fnar%2F11.5.1475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252F11.5.1475%26sid%3Dliteratum%253Aachs%26aulast%3DDignam%26aufirst%3DJ.%2BD.%26aulast%3DLebovitz%26aufirst%3DR.%2BM.%26aulast%3DRoeder%26aufirst%3DR.%2BG.%26atitle%3DAccurate%2520transcription%2520initiation%2520by%2520RNA%2520polymerase%2520II%2520in%2520a%2520soluble%2520extract%2520from%2520isolated%2520mammalian%2520nuclei%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D1983%26volume%3D11%26spage%3D1475%26epage%3D1489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Wegener, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wirsching, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riester, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwienhorst, A.</span><span> </span><span class="NLM_article-title">A fluorogenic histone deacetylase assay well suited for high-throughput activity screening</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1016%2FS1074-5521%2802%2900305-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=12573699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD3sXps1Skuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=61-68&author=D.+Wegenerauthor=F.+Wirschingauthor=D.+Riesterauthor=A.+Schwienhorst&title=A+fluorogenic+histone+deacetylase+assay+well+suited+for+high-throughput+activity+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">A Fluorogenic Histone Deacetylase Assay Well Suited for High-Throughput Activity Screening</span></div><div class="casAuthors">Wegener, Dennis; Wirsching, Frank; Riester, Daniel; Schwienhorst, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-68</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Histone deacetylases (HDACs) are important enzymes for the transcriptional regulation of gene expression in eukaryotic cells.  Recent findings suggest that HDACs could be key targets for chemotherapeutic intervention in malignant diseases.  A convenient and sensitive fluorogenic assay for HDAC activity would therefore expedite studies of HDAC in transcriptional regulation and in vitro screening for drug discovery.  In this study, novel fluorogenic substrates of HDACs were synthesized with an ε-acetylated lysyl moiety and an adjacent MCA moiety at the C terminus of the peptide chain.  Upon deacetylation of the acetylated lysyl moiety, mols. became substrates for trypsin, which released highly fluorescent AMC mols. in a subsequent step of the assay.  The fluorescence increased in direct proportion to the amt. of deacetylated substrate mols., i.e., HDAC activity.  The nonisotopic, homogeneous assay is well suited for high-throughput HDAC inhibitor screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5ogyqEBSC3bVg90H21EOLACvtfcHk0lhQKck_Ey7WoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXps1Skuw%253D%253D&md5=eea350d8066f6ebd773ba50cc0211fdc</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2802%2900305-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252802%252900305-8%26sid%3Dliteratum%253Aachs%26aulast%3DWegener%26aufirst%3DD.%26aulast%3DWirsching%26aufirst%3DF.%26aulast%3DRiester%26aufirst%3DD.%26aulast%3DSchwienhorst%26aufirst%3DA.%26atitle%3DA%2520fluorogenic%2520histone%2520deacetylase%2520assay%2520well%2520suited%2520for%2520high-throughput%2520activity%2520screening%26jtitle%3DChem.%2520Biol.%26date%3D2003%26volume%3D10%26spage%3D61%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Ise, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heuser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, K.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">P-Glycoprotein-associated resistance to taxol and taxotere and its reversal by dexniguldipine-HCl, dexverapamil-HCl, or cyclosporin A</span> <span class="citation_source-journal">Int. J. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">951</span><span class="NLM_x">–</span> <span class="NLM_lpage">956</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADyaK28XjtVGkur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1996&pages=951-956&author=W.+Iseauthor=M.+Heuserauthor=K.+Sanders&title=P-Glycoprotein-associated+resistance+to+taxol+and+taxotere+and+its+reversal+by+dexniguldipine-HCl%2C+dexverapamil-HCl%2C+or+cyclosporin+A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">P-glycoprotein-associated resistance to taxol and taxotere and its reversal by dexniguldipine-HCl, dexverapamil-HCl, or cyclosporin A</span></div><div class="casAuthors">Ise, Wolfgang; Heuser, Margrit; Sanders, Karl Heinrich; Beck, James; Gekeler, Volker</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">951-956</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">A series of different human MDR (multidrug-resistant) cell lines including a HeLa-MDR1 transfectant which exhibit high overexpression of the MDR1/P-glycoprotein gene, but no enhanced expression of the MRP (multidrug resistance assocd. protein) gene, showed different ratios of relative resistances to the taxanes taxol and taxotere.  Using these cell lines the chemosensitizing efficacies of several structurally different chemosensitizers, i.e. the dihydropyridine dexniguldipine-HCl (B8509-035), its main pyridine metabolite M1 (B8909-008), the cyclic peptide cyclosporin A, or the phenylalkylamine dexverapamil-HCl, were examd. applying a 72 h tetrazolium based colorimetric MTT-assay, or a 96 h sulforhodamine B assay.  Remarkably, we obsd. in some instances that the modulating efficacy of a particular chemosensitizer was strongly dependent on the cell line used for experimentation.  Thus, dexniguldipine-HCl efficiently modulated taxane resistances of the ovarian carcinoma MDR cell line 2780AD in the submicromolar concn. range, whereas cyclosporin A and the other chemosensitizers were rather ineffective.  Dexniguldipine-HCl or cyclosporin A, however, both showed a similarly strong modulating activity on the HeLa-MDR1 transfectant in clear contrast to the effects obsd. using the pyridine B8909-008, or dexverapamil-HCl, resp., at the same final concns.  Our results point to addnl., as yet unidentified factors beyond the expression levels of P-glycoprotein which could contribute to the susceptibility of MDR cells to a combined treatment using taxanes and different chemosensitizing compds.  This result appears to be important considering the clin. application of chemosensitizers for combination therapy of tumors of different origin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpds9KBEh9B1rVg90H21EOLACvtfcHk0lhQKck_Ey7WoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjtVGkur0%253D&md5=12bcb43223e88dd7295fd4309374a762</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIse%26aufirst%3DW.%26aulast%3DHeuser%26aufirst%3DM.%26aulast%3DSanders%26aufirst%3DK.%26atitle%3DP-Glycoprotein-associated%2520resistance%2520to%2520taxol%2520and%2520taxotere%2520and%2520its%2520reversal%2520by%2520dexniguldipine-HCl%252C%2520dexverapamil-HCl%252C%2520or%2520cyclosporin%2520A%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D1996%26volume%3D8%26spage%3D951%26epage%3D956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Schmidt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendelsohn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Z.</span><span> </span><span class="NLM_article-title">Differential modulation of paclitaxel-mediated apoptosis by p21waf1 and p27kip1</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2423</span><span class="NLM_x">–</span> <span class="NLM_lpage">2429</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=2423-2429&author=M.+Schmidtauthor=Y.+Luauthor=B.+Liuauthor=M.+Fangauthor=J.+Mendelsohnauthor=Z.+Fan&title=Differential+modulation+of+paclitaxel-mediated+apoptosis+by+p21waf1+and+p27kip1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DM.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DFang%26aufirst%3DM.%26aulast%3DMendelsohn%26aufirst%3DJ.%26aulast%3DFan%26aufirst%3DZ.%26atitle%3DDifferential%2520modulation%2520of%2520paclitaxel-mediated%2520apoptosis%2520by%2520p21waf1%2520and%2520p27kip1%26jtitle%3DOncogene%26date%3D2000%26volume%3D19%26spage%3D2423%26epage%3D2429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2'],'ref3':['cit3a','cit3b'],'ref4':['cit4a','cit4b'],'ref5':['cit5a','cit5b','cit5c'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9a','cit9b','cit9c'],'ref10':['cit10a','cit10b'],'ref11':['cit11'],'ref12':['cit12a','cit12b'],'ref13':['cit13a','cit13b'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17a','cit17b'],'ref18':['cit18a','cit18b','cit18c'],'ref19':['cit19a','cit19b','cit19c'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22a','cit22b'],'ref23':['cit23a','cit23b'],'ref24':['cit24a','cit24b','cit24c'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 28 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Torben  Schlüter</span>, <span class="hlFld-ContribAuthor ">Azim  Ziyaei Halimehjani</span>, <span class="hlFld-ContribAuthor ">Daniel  Wachtendorf</span>, <span class="hlFld-ContribAuthor ">Marc  Schmidtmann</span>, and <span class="hlFld-ContribAuthor ">Jürgen  Martens</span>  . </span><span class="cited-content_cbyCitation_article-title">Four-Component Reaction for the Synthesis of Dithiocarbamates Starting from Cyclic Imines. </span><span class="cited-content_cbyCitation_journal-name">ACS Combinatorial Science</span><span> <strong>2016,</strong> <em>18 </em>
                                    (8)
                                     , 456-460. <a href="https://doi.org/10.1021/acscombsci.6b00029" title="DOI URL">https://doi.org/10.1021/acscombsci.6b00029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscombsci.6b00029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscombsci.6b00029%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Combinatorial%2520Science%26atitle%3DFour-Component%252BReaction%252Bfor%252Bthe%252BSynthesis%252Bof%252BDithiocarbamates%252BStarting%252Bfrom%252BCyclic%252BImines%26aulast%3DSchl%25C3%25BCter%26aufirst%3DTorben%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D07032016%26date%3D15062016%26date%3D12072016%26date%3D08082016%26date%3D30062016%26volume%3D18%26issue%3D8%26spage%3D456%26epage%3D460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raquel  Pereira</span>, <span class="hlFld-ContribAuthor ">Rosaria  Benedetti</span>, <span class="hlFld-ContribAuthor ">Santiago  Pérez-Rodríguez</span>, <span class="hlFld-ContribAuthor ">Angela  Nebbioso</span>, <span class="hlFld-ContribAuthor ">José  García-Rodríguez</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Carafa</span>, <span class="hlFld-ContribAuthor ">Mayra  Stuhldreier</span>, <span class="hlFld-ContribAuthor ">Mariarosaria  Conte</span>, <span class="hlFld-ContribAuthor ">Fátima  Rodríguez-Barrios</span>, <span class="hlFld-ContribAuthor ">Hendrik G.  Stunnenberg</span>, <span class="hlFld-ContribAuthor ">Hinrich  Gronemeyer</span>, <span class="hlFld-ContribAuthor ">Lucia  Altucci</span>, and <span class="hlFld-ContribAuthor ">Ángel R.  de Lera</span>  . </span><span class="cited-content_cbyCitation_article-title">Indole-Derived Psammaplin A Analogues as Epigenetic Modulators with Multiple Inhibitory Activities. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (22)
                                     , 9467-9491. <a href="https://doi.org/10.1021/jm300618u" title="DOI URL">https://doi.org/10.1021/jm300618u</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm300618u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm300618u%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIndole-Derived%252BPsammaplin%252BA%252BAnalogues%252Bas%252BEpigenetic%252BModulators%252Bwith%252BMultiple%252BInhibitory%252BActivities%26aulast%3DPereira%26aufirst%3DRaquel%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D03052012%26date%3D17102012%26date%3D26112012%26date%3D03102012%26volume%3D55%26issue%3D22%26spage%3D9467%26epage%3D9491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Siavosh  Mahboobi</span>, <span class="hlFld-ContribAuthor ">Stefan  Dove</span>, <span class="hlFld-ContribAuthor ">Andreas  Sellmer</span>, <span class="hlFld-ContribAuthor ">Matthias  Winkler</span>, <span class="hlFld-ContribAuthor ">Emerich  Eichhorn</span>, <span class="hlFld-ContribAuthor ">Herwig  Pongratz</span>, <span class="hlFld-ContribAuthor ">Thomas  Ciossek</span>, <span class="hlFld-ContribAuthor ">Thomas  Baer</span>, <span class="hlFld-ContribAuthor ">Thomas  Maier</span> and <span class="hlFld-ContribAuthor ">Thomas  Beckers</span>  . </span><span class="cited-content_cbyCitation_article-title">Design of Chimeric Histone Deacetylase- and Tyrosine Kinase-Inhibitors: A Series of Imatinib Hybrides as Potent Inhibitors of Wild-Type and Mutant BCR-ABL, PDGF-Rβ, and Histone Deacetylases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2009,</strong> <em>52 </em>
                                    (8)
                                     , 2265-2279. <a href="https://doi.org/10.1021/jm800988r" title="DOI URL">https://doi.org/10.1021/jm800988r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm800988r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm800988r%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Bof%252BChimeric%252BHistone%252BDeacetylase-%252Band%252BTyrosine%252BKinase-Inhibitors%25253A%252BA%252BSeries%252Bof%252BImatinib%252BHybrides%252Bas%252BPotent%252BInhibitors%252Bof%252BWild-Type%252Band%252BMutant%252BBCR-ABL%25252C%252BPDGF-R%2525CE%2525B2%25252C%252Band%252BHistone%252BDeacetylases%26aulast%3DMahboobi%26aufirst%3DSiavosh%26date%3D2009%26date%3D2009%26date%3D2008%26date%3D5%252008%25202008%26date%3D20032009%26date%3D23042009%26volume%3D52%26issue%3D8%26spage%3D2265%26epage%3D2279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying-Chao  Duan</span>, <span class="hlFld-ContribAuthor ">Shao-Jie  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiao-Jing  Shi</span>, <span class="hlFld-ContribAuthor ">Lin-Feng  Jin</span>, <span class="hlFld-ContribAuthor ">Tong  Yu</span>, <span class="hlFld-ContribAuthor ">Yu  Song</span>, <span class="hlFld-ContribAuthor ">Yuan-Yuan  Guan</span>. </span><span class="cited-content_cbyCitation_article-title">Research progress of dual inhibitors targeting crosstalk between histone epigenetic modulators for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>222 </em>, 113588. <a href="https://doi.org/10.1016/j.ejmech.2021.113588" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113588</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113588&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113588%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DResearch%252Bprogress%252Bof%252Bdual%252Binhibitors%252Btargeting%252Bcrosstalk%252Bbetween%252Bhistone%252Bepigenetic%252Bmodulators%252Bfor%252Bcancer%252Btherapy%26aulast%3DDuan%26aufirst%3DYing-Chao%26date%3D2021%26volume%3D222%26spage%3D113588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maurício T.  Tavares</span>, <span class="hlFld-ContribAuthor ">Alan P.  Kozikowski</span>, <span class="hlFld-ContribAuthor ">Sida  Shen</span>. </span><span class="cited-content_cbyCitation_article-title">Mercaptoacetamide: A promising zinc-binding group for the discovery of selective histone deacetylase 6 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>209 </em>, 112887. <a href="https://doi.org/10.1016/j.ejmech.2020.112887" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112887</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112887%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMercaptoacetamide%25253A%252BA%252Bpromising%252Bzinc-binding%252Bgroup%252Bfor%252Bthe%252Bdiscovery%252Bof%252Bselective%252Bhistone%252Bdeacetylase%252B6%252Binhibitors%26aulast%3DTavares%26aufirst%3DMaur%25C3%25ADcio%2BT.%26date%3D2021%26volume%3D209%26spage%3D112887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yang  Zhang</span>, <span class="hlFld-ContribAuthor ">Tingting  Fu</span>, <span class="hlFld-ContribAuthor ">Yuxiang  Ren</span>, <span class="hlFld-ContribAuthor ">Fengcheng  Li</span>, <span class="hlFld-ContribAuthor ">Guoxun  Zheng</span>, <span class="hlFld-ContribAuthor ">Jiajun  Hong</span>, <span class="hlFld-ContribAuthor ">Xiaojun  Yao</span>, <span class="hlFld-ContribAuthor ">Weiwei  Xue</span>, <span class="hlFld-ContribAuthor ">Feng  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Selective Inhibition of HDAC1 by Macrocyclic Polypeptide for the Treatment of Glioblastoma: A Binding Mechanistic Analysis Based on Molecular Dynamics. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Molecular Biosciences</span><span> <strong>2020,</strong> <em>7 </em><a href="https://doi.org/10.3389/fmolb.2020.00041" title="DOI URL">https://doi.org/10.3389/fmolb.2020.00041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fmolb.2020.00041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffmolb.2020.00041%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Molecular%2520Biosciences%26atitle%3DSelective%252BInhibition%252Bof%252BHDAC1%252Bby%252BMacrocyclic%252BPolypeptide%252Bfor%252Bthe%252BTreatment%252Bof%252BGlioblastoma%25253A%252BA%252BBinding%252BMechanistic%252BAnalysis%252BBased%252Bon%252BMolecular%252BDynamics%26aulast%3DZhang%26aufirst%3DYang%26date%3D2020%26date%3D2020%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hélène  Losson</span>, <span class="hlFld-ContribAuthor ">Michael  Schnekenburger</span>, <span class="hlFld-ContribAuthor ">Mario  Dicato</span>, <span class="hlFld-ContribAuthor ">Marc  Diederich</span>. </span><span class="cited-content_cbyCitation_article-title">HDAC6—An Emerging Target Against Chronic Myeloid Leukemia?. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (2)
                                     , 318. <a href="https://doi.org/10.3390/cancers12020318" title="DOI URL">https://doi.org/10.3390/cancers12020318</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12020318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12020318%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DHDAC6%2525E2%252580%252594An%252BEmerging%252BTarget%252BAgainst%252BChronic%252BMyeloid%252BLeukemia%25253F%26aulast%3DLosson%26aufirst%3DH%25C3%25A9l%25C3%25A8ne%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D2%26spage%3D318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dongyuan  Wang</span>, <span class="hlFld-ContribAuthor ">Wenjun  Li</span>, <span class="hlFld-ContribAuthor ">Rongtong  Zhao</span>, <span class="hlFld-ContribAuthor ">Longjian  Chen</span>, <span class="hlFld-ContribAuthor ">Na  Liu</span>, <span class="hlFld-ContribAuthor ">Yuan  Tian</span>, <span class="hlFld-ContribAuthor ">Hui  Zhao</span>, <span class="hlFld-ContribAuthor ">Mingsheng  Xie</span>, <span class="hlFld-ContribAuthor ">Fei  Lu</span>, <span class="hlFld-ContribAuthor ">Qi  Fang</span>, <span class="hlFld-ContribAuthor ">Wei  Liang</span>, <span class="hlFld-ContribAuthor ">Feng  Yin</span>, <span class="hlFld-ContribAuthor ">Zigang  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Stabilized Peptide HDAC Inhibitors Derived from HDAC1 Substrate H3K56 for the Treatment of Cancer Stem–Like Cells
              In Vivo. </span><span class="cited-content_cbyCitation_journal-name">Cancer Research</span><span> <strong>2019,</strong> <em>79 </em>
                                    (8)
                                     , 1769-1783. <a href="https://doi.org/10.1158/0008-5472.CAN-18-1421" title="DOI URL">https://doi.org/10.1158/0008-5472.CAN-18-1421</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/0008-5472.CAN-18-1421&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F0008-5472.CAN-18-1421%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Research%26atitle%3DStabilized%252BPeptide%252BHDAC%252BInhibitors%252BDerived%252Bfrom%252BHDAC1%252BSubstrate%252BH3K56%252Bfor%252Bthe%252BTreatment%252Bof%252BCancer%252BStem%2525E2%252580%252593Like%252BCells%252BIn%252BVivo%26aulast%3DWang%26aufirst%3DDongyuan%26date%3D2019%26date%3D2019%26volume%3D79%26issue%3D8%26spage%3D1769%26epage%3D1783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mehdi  Fallah-Mehrjardi</span>. </span><span class="cited-content_cbyCitation_article-title">Review of the organic trithiocarbonates synthesis. </span><span class="cited-content_cbyCitation_journal-name">Monatshefte für Chemie - Chemical Monthly</span><span> <strong>2018,</strong> <em>149 </em>
                                    (11)
                                     , 1931-1944. <a href="https://doi.org/10.1007/s00706-018-2256-1" title="DOI URL">https://doi.org/10.1007/s00706-018-2256-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00706-018-2256-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00706-018-2256-1%26sid%3Dliteratum%253Aachs%26jtitle%3DMonatshefte%2520f%25C3%25BCr%2520Chemie%2520-%2520Chemical%2520Monthly%26atitle%3DReview%252Bof%252Bthe%252Borganic%252Btrithiocarbonates%252Bsynthesis%26aulast%3DFallah-Mehrjardi%26aufirst%3DMehdi%26date%3D2018%26date%3D2018%26volume%3D149%26issue%3D11%26spage%3D1931%26epage%3D1944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiu-Xiu  Wang</span>, <span class="hlFld-ContribAuthor ">Ren-Zhong  Wan</span>, <span class="hlFld-ContribAuthor ">Zhao-Peng  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in the discovery of potent and selective HDAC6 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>143 </em>, 1406-1418. <a href="https://doi.org/10.1016/j.ejmech.2017.10.040" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.10.040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.10.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.10.040%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvances%252Bin%252Bthe%252Bdiscovery%252Bof%252Bpotent%252Band%252Bselective%252BHDAC6%252Binhibitors%26aulast%3DWang%26aufirst%3DXiu-Xiu%26date%3D2018%26volume%3D143%26spage%3D1406%26epage%3D1418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yahui  Ding</span>, <span class="hlFld-ContribAuthor ">Zhongjin  Yang</span>, <span class="hlFld-ContribAuthor ">Weizhi  Ge</span>, <span class="hlFld-ContribAuthor ">Beijia  Kuang</span>, <span class="hlFld-ContribAuthor ">Junqing  Xu</span>, <span class="hlFld-ContribAuthor ">Juan  Yang</span>, <span class="hlFld-ContribAuthor ">Yue  Chen</span>, <span class="hlFld-ContribAuthor ">Quan  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of dithiocarbamate esters of parthenolide as potential anti-acute myelogenous leukaemia agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2018,</strong> <em>33 </em>
                                    (1)
                                     , 1376-1391. <a href="https://doi.org/10.1080/14756366.2018.1490734" title="DOI URL">https://doi.org/10.1080/14756366.2018.1490734</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2018.1490734&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2018.1490734%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bdithiocarbamate%252Besters%252Bof%252Bparthenolide%252Bas%252Bpotential%252Banti-acute%252Bmyelogenous%252Bleukaemia%252Bagents%26aulast%3DDing%26aufirst%3DYahui%26date%3D2018%26date%3D2018%26volume%3D33%26issue%3D1%26spage%3D1376%26epage%3D1391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">T.  Kobkeatthawin</span>, <span class="hlFld-ContribAuthor ">S.  Chantrapromma</span>, <span class="hlFld-ContribAuthor ">C. S.  Chidan Kumar</span>, <span class="hlFld-ContribAuthor ">H.-K.  Fun</span>. </span><span class="cited-content_cbyCitation_article-title">Highly Efficient and Simple Route to Synthesize N-(4-Acetylphenyl)-4-chlorobenzenesulfonamide and Its Crystal Structure. </span><span class="cited-content_cbyCitation_journal-name">Crystallography Reports</span><span> <strong>2017,</strong> <em>62 </em>
                                    (7)
                                     , 1165-1170. <a href="https://doi.org/10.1134/S1063774517070136" title="DOI URL">https://doi.org/10.1134/S1063774517070136</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1063774517070136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1063774517070136%26sid%3Dliteratum%253Aachs%26jtitle%3DCrystallography%2520Reports%26atitle%3DHighly%252BEfficient%252Band%252BSimple%252BRoute%252Bto%252BSynthesize%252BN-%2525284-Acetylphenyl%252529-4-chlorobenzenesulfonamide%252Band%252BIts%252BCrystal%252BStructure%26aulast%3DKobkeatthawin%26aufirst%3DT.%26date%3D2017%26date%3D2018%26volume%3D62%26issue%3D7%26spage%3D1165%26epage%3D1170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Efrain  Polo</span>, <span class="hlFld-ContribAuthor ">Jorge  Trilleras</span>, <span class="hlFld-ContribAuthor ">Margarita  Gutiérrez Cabrera</span>. </span><span class="cited-content_cbyCitation_article-title">N-{4-[(2E)-3-(2H-1,3-Benzodioxol-5-yl)prop-2-enoyl]phenyl}quinoline-3-carboxamide. </span><span class="cited-content_cbyCitation_journal-name">Molbank</span><span> <strong>2017,</strong> <em>2017 </em>
                                    (4)
                                     , M960. <a href="https://doi.org/10.3390/M960" title="DOI URL">https://doi.org/10.3390/M960</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/M960&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2FM960%26sid%3Dliteratum%253Aachs%26jtitle%3DMolbank%26atitle%3DN-%25257B4-%25255B%2525282E%252529-3-%2525282H-1%25252C3-Benzodioxol-5-yl%252529prop-2-enoyl%25255Dphenyl%25257Dquinoline-3-carboxamide%26aulast%3DPolo%26aufirst%3DEfrain%26date%3D2017%26date%3D2017%26volume%3D2017%26issue%3D4%26spage%3DM960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhi-gang  YIN</span>, <span class="hlFld-ContribAuthor ">Wei  SUN</span>, <span class="hlFld-ContribAuthor ">Yue-hua  HU</span>, <span class="hlFld-ContribAuthor ">Qing-jun  GUAN</span>, <span class="hlFld-ContribAuthor ">Chen-hu  ZHANG</span>, <span class="hlFld-ContribAuthor ">Yue-sheng  GAO</span>, <span class="hlFld-ContribAuthor ">Ji-hua  ZHAI</span>. </span><span class="cited-content_cbyCitation_article-title">Depressing behaviors and mechanism of disodium bis (carboxymethyl) trithiocarbonate on separation of chalcopyrite and molybdenite. </span><span class="cited-content_cbyCitation_journal-name">Transactions of Nonferrous Metals Society of China</span><span> <strong>2017,</strong> <em>27 </em>
                                    (4)
                                     , 883-890. <a href="https://doi.org/10.1016/S1003-6326(17)60100-6" title="DOI URL">https://doi.org/10.1016/S1003-6326(17)60100-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/S1003-6326(17)60100-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FS1003-6326%2817%2960100-6%26sid%3Dliteratum%253Aachs%26jtitle%3DTransactions%2520of%2520Nonferrous%2520Metals%2520Society%2520of%2520China%26atitle%3DDepressing%252Bbehaviors%252Band%252Bmechanism%252Bof%252Bdisodium%252Bbis%252B%252528carboxymethyl%252529%252Btrithiocarbonate%252Bon%252Bseparation%252Bof%252Bchalcopyrite%252Band%252Bmolybdenite%26aulast%3DYIN%26aufirst%3DZhi-gang%26date%3D2017%26volume%3D27%26issue%3D4%26spage%3D883%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sri N.  Batchu</span>, <span class="hlFld-ContribAuthor ">Angela S.  Brijmohan</span>, <span class="hlFld-ContribAuthor ">Andrew  Advani</span>. </span><span class="cited-content_cbyCitation_article-title">The therapeutic hope for HDAC6 inhibitors in malignancy and chronic disease. </span><span class="cited-content_cbyCitation_journal-name">Clinical Science</span><span> <strong>2016,</strong> <em>130 </em>
                                    (12)
                                     , 987-1003. <a href="https://doi.org/10.1042/CS20160084" title="DOI URL">https://doi.org/10.1042/CS20160084</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/CS20160084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FCS20160084%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Science%26atitle%3DThe%252Btherapeutic%252Bhope%252Bfor%252BHDAC6%252Binhibitors%252Bin%252Bmalignancy%252Band%252Bchronic%252Bdisease%26aulast%3DBatchu%26aufirst%3DSri%25C2%25A0N.%26date%3D2016%26date%3D2016%26volume%3D130%26issue%3D12%26spage%3D987%26epage%3D1003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying-Bo  Li</span>, <span class="hlFld-ContribAuthor ">Xu  Yan</span>, <span class="hlFld-ContribAuthor ">Ri-Dong  Li</span>, <span class="hlFld-ContribAuthor ">Peng  Liu</span>, <span class="hlFld-ContribAuthor ">Shao-Qian  Sun</span>, <span class="hlFld-ContribAuthor ">Xin  Wang</span>, <span class="hlFld-ContribAuthor ">Jing-Rong  Cui</span>, <span class="hlFld-ContribAuthor ">De-Min  Zhou</span>, <span class="hlFld-ContribAuthor ">Ze-Mei  Ge</span>, <span class="hlFld-ContribAuthor ">Run-Tao  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel heteroarylmethylcarbamodithioates as potent anticancer agents: Synthesis, structure-activity relationship analysis and biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>112 </em>, 217-230. <a href="https://doi.org/10.1016/j.ejmech.2016.02.015" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.02.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.02.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.02.015%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252Bheteroarylmethylcarbamodithioates%252Bas%252Bpotent%252Banticancer%252Bagents%25253A%252BSynthesis%25252C%252Bstructure-activity%252Brelationship%252Banalysis%252Band%252Bbiological%252Bevaluation%26aulast%3DLi%26aufirst%3DYing-Bo%26date%3D2016%26volume%3D112%26spage%3D217%26epage%3D230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muniyappa  Krishnamurthy</span>, <span class="hlFld-ContribAuthor ">Basavaprabhu</span>, <span class="hlFld-ContribAuthor ">Vommina V.  Sureshbabu</span>. </span><span class="cited-content_cbyCitation_article-title">One-Pot Synthesis of New Class of Dithiocarbonate-Tethered Peptidomimetics. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Peptide Research and Therapeutics</span><span> <strong>2015,</strong> <em>21 </em>
                                    (2)
                                     , 195-203. <a href="https://doi.org/10.1007/s10989-014-9448-2" title="DOI URL">https://doi.org/10.1007/s10989-014-9448-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10989-014-9448-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10989-014-9448-2%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Peptide%2520Research%2520and%2520Therapeutics%26atitle%3DOne-Pot%252BSynthesis%252Bof%252BNew%252BClass%252Bof%252BDithiocarbonate-Tethered%252BPeptidomimetics%26aulast%3DKrishnamurthy%26aufirst%3DMuniyappa%26date%3D2015%26date%3D2014%26volume%3D21%26issue%3D2%26spage%3D195%26epage%3D203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hayet  Medini</span>, <span class="hlFld-ContribAuthor ">Faten  Medini</span>, <span class="hlFld-ContribAuthor ">Nejib Hussein  Mekni</span>, <span class="hlFld-ContribAuthor ">Riadh  Ksouri</span>, <span class="hlFld-ContribAuthor ">Jean  Legault</span>, <span class="hlFld-ContribAuthor ">Khaled  Boujlel</span>. </span><span class="cited-content_cbyCitation_article-title">Electrochemically generated base-promoted synthesis and biological activities of 2,4-disubstituted carbonotrithioates. </span><span class="cited-content_cbyCitation_journal-name">Journal of Sulfur Chemistry</span><span> <strong>2015,</strong> <em>36 </em>
                                    (3)
                                     , 308-316. <a href="https://doi.org/10.1080/17415993.2015.1024121" title="DOI URL">https://doi.org/10.1080/17415993.2015.1024121</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17415993.2015.1024121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17415993.2015.1024121%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Sulfur%2520Chemistry%26atitle%3DElectrochemically%252Bgenerated%252Bbase-promoted%252Bsynthesis%252Band%252Bbiological%252Bactivities%252Bof%252B2%25252C4-disubstituted%252Bcarbonotrithioates%26aulast%3DMedini%26aufirst%3DHayet%26date%3D2015%26date%3D2015%26volume%3D36%26issue%3D3%26spage%3D308%26epage%3D316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Soheil  Sayyahi</span>, <span class="hlFld-ContribAuthor ">Saeid  Moonesi</span>, <span class="hlFld-ContribAuthor ">Mehdi  Fallah-Mehrjardi</span>. </span><span class="cited-content_cbyCitation_article-title">An Efficient and Straightforward Access to Symmetrical Dialkyl Trithiocarbonates Using a Basic Task-Specific Ionic Liquid and Carbon Disulfide. </span><span class="cited-content_cbyCitation_journal-name">Phosphorus, Sulfur, and Silicon and the Related Elements</span><span> <strong>2014,</strong> <em>189 </em>
                                    (11)
                                     , 1718-1722. <a href="https://doi.org/10.1080/10426507.2014.887078" title="DOI URL">https://doi.org/10.1080/10426507.2014.887078</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10426507.2014.887078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10426507.2014.887078%26sid%3Dliteratum%253Aachs%26jtitle%3DPhosphorus%252C%2520Sulfur%252C%2520and%2520Silicon%2520and%2520the%2520Related%2520Elements%26atitle%3DAn%252BEfficient%252Band%252BStraightforward%252BAccess%252Bto%252BSymmetrical%252BDialkyl%252BTrithiocarbonates%252BUsing%252Ba%252BBasic%252BTask-Specific%252BIonic%252BLiquid%252Band%252BCarbon%252BDisulfide%26aulast%3DSayyahi%26aufirst%3DSoheil%26date%3D2014%26date%3D2014%26volume%3D189%26issue%3D11%26spage%3D1718%26epage%3D1722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michel  Weïwer</span>, <span class="hlFld-ContribAuthor ">Michael C  Lewis</span>, <span class="hlFld-ContribAuthor ">Florence F  Wagner</span>, <span class="hlFld-ContribAuthor ">Edward B  Holson</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic potential of isoform selective HDAC inhibitors for the treatment of schizophrenia. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2013,</strong> <em>5 </em>
                                    (13)
                                     , 1491-1508. <a href="https://doi.org/10.4155/fmc.13.141" title="DOI URL">https://doi.org/10.4155/fmc.13.141</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.13.141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.13.141%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DTherapeutic%252Bpotential%252Bof%252Bisoform%252Bselective%252BHDAC%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Bschizophrenia%26aulast%3DWe%25C3%25AFwer%26aufirst%3DMichel%26date%3D2013%26volume%3D5%26issue%3D13%26spage%3D1491%26epage%3D1508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jose  Parada-Aliste</span>, <span class="hlFld-ContribAuthor ">Alicia  Megia-Fernandez</span>, <span class="hlFld-ContribAuthor ">Diego  De la Torre-Gonzalez</span>, <span class="hlFld-ContribAuthor ">Fernando  Hernandez-Mateo</span>, <span class="hlFld-ContribAuthor ">Francisco  Santoyo-Gonzalez</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of
              S
              - and
              N
              -Functionalized Dithiocarbamates from Cyclic Sulfates. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2013,</strong> <em>2013 </em>
                                    (18)
                                     , 3758-3763. <a href="https://doi.org/10.1002/ejoc.201201522" title="DOI URL">https://doi.org/10.1002/ejoc.201201522</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201201522&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201201522%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BS%252B-%252Band%252BN%252B-Functionalized%252BDithiocarbamates%252Bfrom%252BCyclic%252BSulfates%26aulast%3DParada-Aliste%26aufirst%3DJose%26date%3D2013%26date%3D2013%26volume%3D2013%26issue%3D18%26spage%3D3758%26epage%3D3763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammad  Soleiman-Beigi</span>, <span class="hlFld-ContribAuthor ">Azadeh  Izadi</span>. </span><span class="cited-content_cbyCitation_article-title">CuI-Catalyzed: One-Pot Synthesis of Diaryl Disulfides from Aryl Halides and Carbon Disulfide. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemistry</span><span> <strong>2013,</strong> <em>2013 </em>, 1-5. <a href="https://doi.org/10.1155/2013/725265" title="DOI URL">https://doi.org/10.1155/2013/725265</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2013/725265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2013%2F725265%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemistry%26atitle%3DCuI-Catalyzed%25253A%252BOne-Pot%252BSynthesis%252Bof%252BDiaryl%252BDisulfides%252Bfrom%252BAryl%252BHalides%252Band%252BCarbon%252BDisulfide%26aulast%3DSoleiman-Beigi%26aufirst%3DMohammad%26date%3D2013%26volume%3D2013%26spage%3D1%26epage%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eleni  Pontiki</span>, <span class="hlFld-ContribAuthor ">Dimitra  Hadjipavlou-Litina</span>. </span><span class="cited-content_cbyCitation_article-title">Histone deacetylase inhibitors (HDACIs). Structure-activity relationships: history and new QSAR perspectives. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2012,</strong> <em>32 </em>
                                    (1)
                                     , 1-165. <a href="https://doi.org/10.1002/med.20200" title="DOI URL">https://doi.org/10.1002/med.20200</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.20200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.20200%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DHistone%252Bdeacetylase%252Binhibitors%252B%252528HDACIs%252529.%252BStructure-activity%252Brelationships%25253A%252Bhistory%252Band%252Bnew%252BQSAR%252Bperspectives%26aulast%3DPontiki%26aufirst%3DEleni%26date%3D2012%26date%3D2010%26volume%3D32%26issue%3D1%26spage%3D1%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">N.  Narendra</span>, <span class="hlFld-ContribAuthor ">H.S.  Lalithamba</span>, <span class="hlFld-ContribAuthor ">Vommina V.  Sureshbabu</span>. </span><span class="cited-content_cbyCitation_article-title">An efficient one-pot access to trithiocarbonate-tethered peptidomimetics. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2010,</strong> <em>51 </em>
                                    (47)
                                     , 6169-6173. <a href="https://doi.org/10.1016/j.tetlet.2010.09.075" title="DOI URL">https://doi.org/10.1016/j.tetlet.2010.09.075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2010.09.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2010.09.075%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DAn%252Befficient%252Bone-pot%252Baccess%252Bto%252Btrithiocarbonate-tethered%252Bpeptidomimetics%26aulast%3DNarendra%26aufirst%3DN.%26date%3D2010%26volume%3D51%26issue%3D47%26spage%3D6169%26epage%3D6173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">P.  Angibaud</span>, <span class="hlFld-ContribAuthor ">K.  Van Emelen</span>, <span class="hlFld-ContribAuthor ">J.  Arts</span>. </span><span class="cited-content_cbyCitation_article-title">Histone Deacetylase Inhibitors: A Brief Overview Of Their Role And Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2010,</strong>,, 49-82. <a href="https://doi.org/10.1002/0471266949.bmc213" title="DOI URL">https://doi.org/10.1002/0471266949.bmc213</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc213%26sid%3Dliteratum%253Aachs%26atitle%3DHistone%252BDeacetylase%252BInhibitors%25253A%252BA%252BBrief%252BOverview%252BOf%252BTheir%252BRole%252BAnd%252BMedicinal%252BChemistry%26aulast%3DAngibaud%26aufirst%3DP.%26date%3D2010%26date%3D2010%26spage%3D49%26epage%3D82%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul M.  Howell</span>, <span class="hlFld-ContribAuthor ">Suhu  Liu</span>, <span class="hlFld-ContribAuthor ">Suping  Ren</span>, <span class="hlFld-ContribAuthor ">Campbell  Behlen</span>, <span class="hlFld-ContribAuthor ">Oystein  Fodstad</span>, <span class="hlFld-ContribAuthor ">Adam I.  Riker</span>. </span><span class="cited-content_cbyCitation_article-title">Epigenetics in Human Melanoma. </span><span class="cited-content_cbyCitation_journal-name">Cancer Control</span><span> <strong>2009,</strong> <em>16 </em>
                                    (3)
                                     , 200-218. <a href="https://doi.org/10.1177/107327480901600302" title="DOI URL">https://doi.org/10.1177/107327480901600302</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/107327480901600302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F107327480901600302%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Control%26atitle%3DEpigenetics%252Bin%252BHuman%252BMelanoma%26aulast%3DHowell%26aufirst%3DPaul%2BM.%26date%3D2009%26date%3D2009%26volume%3D16%26issue%3D3%26spage%3D200%26epage%3D218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessio  Innocenti</span>, <span class="hlFld-ContribAuthor ">Andrea  Scozzafava</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">Carbonic anhydrase inhibitors. Inhibition of cytosolic isoforms I, II, III, VII and XIII with less investigated inorganic anions. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2009,</strong> <em>19 </em>
                                    (7)
                                     , 1855-1857. <a href="https://doi.org/10.1016/j.bmcl.2009.02.088" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.02.088</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.02.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.02.088%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DCarbonic%252Banhydrase%252Binhibitors.%252BInhibition%252Bof%252Bcytosolic%252Bisoforms%252BI%25252C%252BII%25252C%252BIII%25252C%252BVII%252Band%252BXIII%252Bwith%252Bless%252Binvestigated%252Binorganic%252Banions%26aulast%3DInnocenti%26aufirst%3DAlessio%26date%3D2009%26volume%3D19%26issue%3D7%26spage%3D1855%26epage%3D1857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shailendra  Kapoor</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of HDAC6-dependent carcinogenesis: Emerging, new therapeutic options besides belinostat. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Cancer</span><span> <strong>2009,</strong> <em>124 </em>
                                    (2)
                                     , 509-509. <a href="https://doi.org/10.1002/ijc.23975" title="DOI URL">https://doi.org/10.1002/ijc.23975</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ijc.23975&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fijc.23975%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Cancer%26atitle%3DInhibition%252Bof%252BHDAC6-dependent%252Bcarcinogenesis%25253A%252BEmerging%25252C%252Bnew%252Btherapeutic%252Boptions%252Bbesides%252Bbelinostat%26aulast%3DKapoor%26aufirst%3DShailendra%26date%3D2009%26volume%3D124%26issue%3D2%26spage%3D509%26epage%3D509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_null" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0026.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800093c&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0001.jpeg" id="rightTab-gs1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800093c&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) EtSNa, CS<sub>2</sub>, THF, rt.</p></p></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0002.jpeg" id="rightTab-gs2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800093c&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>n</i>PrMgCl, CS<sub>2</sub>, CuI, THF, −20 °C; (b) EtOH, KOH, CS<sub>2</sub>, H<sub>2</sub>O, rt; (c) KSAc, THF, 50 °C, then NaOH, MeOH, rt; (d) EtNCS, THF, rt; (e) EtO(C═O)Cl, DIPEA, THF, rt; (f) EtNCO, THF, rt; (g) RC<sub>2</sub>H<sub>4</sub>SH, NaH, THF, 0 °C, CS<sub>2</sub>; (h) morpholine, NaOAc, CS<sub>2</sub>, THF, rt; (i) CS<sub>2</sub>, NaOH, THF, then EtOC<sub>2</sub>H<sub>4</sub>Br, rt.</p></p></figure><figure data-id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0003.jpeg" id="rightTab-gs3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800093c&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) EtNCS, NEt<sub>3</sub>, THF, rt; (b) EtBr, CS<sub>2</sub>, 1 M NaOH, ethyl acetate/EtOH, rt.</p></p></figure><figure data-id="sch4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0004.jpeg" id="rightTab-gs4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800093c&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HOC<sub>2</sub>H<sub>4</sub>OH, amberlyst 15, PhH, 80 °C; (b) NaH, imidazole, THF, 0 °C, then CS<sub>2</sub>, then EtI; (c) cat. HCl, THF/H<sub>2</sub>O, 60 °C.</p></p></figure><figure data-id="sch5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0005.jpeg" id="rightTab-gs5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800093c&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) PTT, THF, rt; then EtS(C═S)SNa.</p></p></figure><figure data-id="sch6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0006.jpeg" id="rightTab-gs6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800093c&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) i. <i>n</i>-PrMgCl, CS<sub>2</sub>, CuI, THF, −20 °C, then HCl, H<sub>2</sub>O, ii. <b>9</b>, NEt<sub>3</sub>, DMF, rt; (b) EtOH, KOH, CS<sub>2</sub>, H<sub>2</sub>O, rt; (c) EtNH<sub>2</sub>, aq NaOH, CS<sub>2</sub>, DMF, 10 °C to rt.</p></p></figure><figure data-id="sch7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0007.jpeg" id="rightTab-gs7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 7. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800093c&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) EtS(C═S)SNa, THF, rt.</p></p></figure><figure data-id="sch8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0008.jpeg" id="rightTab-gs8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 8. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800093c&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) PTT, THF, rt; then EtS(C═S)SNa (method a); (b) TBDMSOTf, NEt<sub>3</sub>, THF; then NBS, 0 °C, then EtS(C═S)SNa, rt (method b); (c) NaHMDS, THF, −78 °C, then TMSCl, then Br<sub>2</sub>, then EtS(C═S)SNa, warm to rt (method c).</p></p></figure><figure data-id="sch9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0009.jpeg" id="rightTab-gs9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 9. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800093c&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) PTT, THF, rt; then EtS(C═S)SNa.</p></p></figure><figure data-id="sch10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0010.jpeg" id="rightTab-gs10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 10. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800093c&amp;id=sch10"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) RR’NH, DIPEA, THF, rt; then EtS(C═S)SNa (method d).</p></p></figure><figure data-id="sch11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0011.jpeg" id="rightTab-gs11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 11. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800093c&amp;id=sch11"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NMM, IBCF, THF, 0 °C, then RR’NH, rt, then PTT, then EtS(C═S)SNa. NMM: <i>N</i>-methyl-morpholine; IBCF: <i>i</i>-butylchloroformiate.</p></p></figure><figure data-id="sch12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0012.jpeg" id="rightTab-gs12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 12. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800093c&amp;id=sch12"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NMM, IBCF, THF, 0 °C, then RR’NH, rt, then EtS(C═S)SNa. NMM: <i>N</i>-methyl-morpholine; IBCF: <i>i</i>-butylchloroformiate.</p></p></figure><figure data-id="sch13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0013.jpeg" id="rightTab-gs13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 13. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800093c&amp;id=sch13"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Pd(dppf)Cl<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O, rt; (b) NaHMDS, THF, −78 °C, then TMSCl, then Br<sub>2</sub>, then EtS(C═S)SNa, warm to rt; NaHMDS: sodium hexamethyldisilazide.</p></p></figure><figure data-id="fig1" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0015.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Inhibition of HDAC enzymatic activity. Trithiocarbonate analogues, namely <b>2</b> as initial HTS hit, <b>3b</b> (dithiobutyrate analogue), <b>12ac</b> (phenylamide analogue), <b>18a</b> and <b>22</b> (thiophene analogues) were tested for inhibition of HeLa nuclear extract HDAC activity (A), rHDAC1 (B), and rHDAC6 (C) as class I and IIb representatives, respectively. SAHA was included as a reference HDAC inhibitor with the hydroxamate head group. IC<sub>50</sub> values calculated from the concentration−effect curves using Graphpad prism nonlinear curve fitting are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800093c&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0016.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Enzyme kinetic analysis of rHDAC1 and rHDAC6 inhibition. The initial hit <b>2</b> and the thiophene analogue <b>18d</b> were tested for inhibition of rHDAC1 enzymatic activity at various substrate concentrations up to 100 µM. Respective Lineweaver−Burk plots with calculated <i>K</i><sub>i</sub> values are shown in (A). A similar analysis was done for isoenzyme selective analogues <b>12ac</b> and <b>13</b> regarding inhibition of rHDAC6 at various substrate concentrations up to 100 µM. Respective Lineweaver−Burk plots with calculated <i>K</i><sub>i</sub> values are shown in (B). Ac-GGK(Ac)-AMC was used as the substrate for both, rHDAC1 and rHDAC6 assays.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800093c&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0018.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Inhibition of HDAC activity in HeLa cells. The inhibition of cellular HDAC activity by selected analogues <b>2</b>, <b>8c</b>, <b>18a</b>, <b>18c</b>, <b>22</b>, and SAHA as reference was measured in two independent assays in HeLa cells. The induction of histone H3 hyperacetylation was quantified by single-cell image analysis using the Cellomics Array Scan (A). The inhibition of HDAC enzymatic activity was quantified with the cell permeable HDAC substrate Boc-K(Ac)-AMC. After cell lysis, only the deacetylated substrate Boc-K-AMC is cleaved by trypsin with subsequent release of the fluorophore AMC.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800093c&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0019.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Induction of p21<sup>waf</sup> expression, histone H3, and α-tubulin hyperacetylation. The induction of histone H3 K<sup>1−20</sup> hyperacetylation and p21<sup>waf1</sup> as a HDAC inhibitor marker gene was analyzed in HeLa cells, treated with analogues <b>8b</b>, <b>8c</b>, <b>12az</b>, <b>18a</b>, <b>18c</b>, <b>22</b>, and <b>23</b> at concentrations of 5 and 50 µM for 24 h (A). As a control, rehybridization was done with a β-actin specific antibody. The induction of histone H3 K<sup>1−20</sup> and α-tubulin hyperacetylation was studied in A549 NSCLC cells treated for 24 h with the HDAC6 selective analogues <b>12ac</b> and <b>13</b> (B). The natural product HC-toxin was included as HDAC inhibitor with weak, µM inhibition of HDAC6. As a control, rehybridization was done with antibodies specific for histone H3 or α-tubulin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800093c&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0024.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Cytotoxicity profile for selected trithiocarbonate analogues. The overall cytotoxicity profile was studied for <b>2</b> as the initial HTS hit and the potent thiophene analogues <b>18a</b> and <b>22</b>. A selection of 21 different solid and hematological tumor cell lines representing 15 different histotypes was treated for 72 h with the HDAC inhibitors before quantification of metabolic activity, correlating with cell viability/cell number. Mean graph blots with the deviation from the mean IC<sub>50</sub> expressed in log IC<sub>50</sub> [M] are shown in (A). In this graphic representation, the mean IC<sub>50</sub> value for a given compound is defined as “0” and deviations of individual IC<sub>50</sub> values (log IC<sub>50</sub> [M]) to higher and lower potency are expressed as negative and positive values, respectively. Mean IC<sub>50</sub> values were determined as 8.31 µM (−5.08) for <b>2</b>, 1.41 µM (−5.85) for <b>18a</b>, and 2.37 µM (−5.57) for <b>22</b>. Individual concentration−effect curves are shown for proliferating and arrested, nonproliferating RKO p21<sup>waf1</sup> colon carcinoma cells in (B). RKO p21<sup>waf1</sup> cells were arrested by induction of the cdk inhibitory p21<sup>waf1</sup> protein.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800093c&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/medium/jm-2008-00093c_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0025.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Cell cycle analysis and induction of histone H3S<sup>10</sup> phosphorylation. The effects of selected analogues <b>2</b>, <b>8c</b>, <b>18a</b>, and <b>22</b> on the cell division cycle of RKO colon carcinoma cells was studied by flow cytometry. RKO cells were treated for 24 h with the trithiocarbonate analogues at 1 and 10 µM concentration. The percentage of cells in apoptosis (subG1), G1(2N), S, and G2/M (4N) was determined and is shown in a column diagram in (A). 10 nM taxol as a tubulin interacting, antimitotic agent and 5 μM SAHA were included as control agents. The phosphorylation of histone H3 at residue S<sup>10</sup> in RKO cells treated for 24 h with <b>2</b>, <b>8c</b>, <b>18a</b>, and <b>22</b> at 1, 3, and 10 µM concentration was analyzed by Western blotting (B). Hyperacetylation of histone H3 K<sup>1−20</sup> as well as α-tubulin was analyzed in parallel. As a control, rehybridization was done with a β-actin specific antibody.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-13/jm800093c/production/images/large/jm-2008-00093c_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm800093c&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i54">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04226" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04226" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 34 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cohen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, T. P.</span><span> </span><span class="NLM_article-title">AcK-Knowledge reversible acetylation</span> <span class="citation_source-journal">Sci. STKE 3</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_fpage">pe42</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1126%2Fstke.2452004pe42" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&pages=pe42&author=T.+Cohenauthor=T.+P.+Yao&title=AcK-Knowledge+reversible+acetylation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1126%2Fstke.2452004pe42&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fstke.2452004pe42%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DT.%26aulast%3DYao%26aufirst%3DT.%2BP.%26atitle%3DAcK-Knowledge%2520reversible%2520acetylation%26jtitle%3DSci.%2520STKE%25203%26date%3D2004%26spage%3Dpe42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Yang, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seto, E.</span><span> </span><span class="NLM_article-title">HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">5310</span><span class="NLM_x">–</span> <span class="NLM_lpage">5318</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1038%2Fsj.onc.1210599" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=17694074" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD2sXovFekurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=5310-5318&author=X.+J.+Yangauthor=E.+Seto&title=HATs+and+HDACs%3A+from+structure%2C+function+and+regulation+to+novel+strategies+for+therapy+and+prevention"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention</span></div><div class="casAuthors">Yang, X.-J.; Seto, E.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">5310-5318</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The acetylation of the ε-NH2 group of a Lys residue was 1st discovered with histones in 1968, but the responsible enzymes, histone acetyltransferases (HATs) and histone deacetylases (HDACs), were not identified until the mid-1990s.  In the past decade, knowledge about this modification has exploded, with targets rapidly expanding from histones to transcription factors and other nuclear proteins, and then to the cytoskeleton, metabolic enzymes, and signaling regulators in the cytoplasm.  Thus, protein Lys acetylation has emerged as a major post-translational modification to rival phosphorylation.  Here, various aspects of the enzymes governing Lys acetylation, esp. about their intimate links to cancer are reviewed.  For central themes are highlighted: (1) multisubunit enzymic complexes; (2) non-histone substrates in diverse cellular processes; (3) interplay of Lys acetylation with other regulatory mechanisms, such as noncoding RNA-mediated gene silencing and activation; and (4) novel therapeutic strategies and preventive measures to combat cancer and other human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuGSkc-b3umrVg90H21EOLACvtfcHk0lgUbSbK6YAQjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXovFekurc%253D&md5=de49d71791356a55d90fd797cbecaf4b</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1210599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1210599%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DX.%2BJ.%26aulast%3DSeto%26aufirst%3DE.%26atitle%3DHATs%2520and%2520HDACs%253A%2520from%2520structure%252C%2520function%2520and%2520regulation%2520to%2520novel%2520strategies%2520for%2520therapy%2520and%2520prevention%26jtitle%3DOncogene%26date%3D2007%26volume%3D26%26spage%3D5310%26epage%3D5318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Strahl, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allis, C. D.</span><span> </span><span class="NLM_article-title">The language of covalent histone modifications</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">403</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1038%2F47412" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=10638745" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A280%3ADC%252BD3c7gt1arsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=403&publication_year=2000&pages=41-45&author=B.+D.+Strahlauthor=C.+D.+Allis&title=The+language+of+covalent+histone+modifications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">The language of covalent histone modifications</span></div><div class="casAuthors">Strahl B D; Allis C D</div><div class="citationInfo"><span class="NLM_cas:title">Nature</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">403</span>
        (<span class="NLM_cas:issue">6765</span>),
    <span class="NLM_cas:pages">41-5</span>
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Histone proteins and the nucleosomes they form with DNA are the fundamental building blocks of eukaryotic chromatin.  A diverse array of post-translational modifications that often occur on tail domains of these proteins has been well documented.  Although the function of these highly conserved modifications has remained elusive, converging biochemical and genetic evidence suggests functions in several chromatin-based processes.  We propose that distinct histone modifications, on one or more tails, act sequentially or in combination to form a 'histone code' that is, read by other proteins to bring about distinct downstream events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSyzhdlYh9sX7t7lRqEFUJVfW6udTcc2ebMg0EZTmbUWLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c7gt1arsQ%253D%253D&md5=2eb7d093151c6122ccd70fa2adcfd94b</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2F47412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F47412%26sid%3Dliteratum%253Aachs%26aulast%3DStrahl%26aufirst%3DB.%2BD.%26aulast%3DAllis%26aufirst%3DC.%2BD.%26atitle%3DThe%2520language%2520of%2520covalent%2520histone%2520modifications%26jtitle%3DNature%26date%3D2000%26volume%3D403%26spage%3D41%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zhang, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dent, S. Y. J.</span><span> </span><span class="NLM_article-title">Histone modifying enzymes and cancer: going beyond histones</span> <span class="citation_source-journal">Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">1137</span><span class="NLM_x">–</span> <span class="NLM_lpage">1148</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1002%2Fjcb.20615" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1KgtbbK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2005&pages=1137-1148&author=K.+Zhangauthor=S.+Y.+J.+Dent&title=Histone+modifying+enzymes+and+cancer%3A+going+beyond+histones"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Histone modifying enzymes and cancer: Going beyond histones</span></div><div class="casAuthors">Zhang, Ke; Dent, Sharon Y. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1137-1148</span>CODEN:
                <span class="NLM_cas:coden">JCEBD5</span>;
        ISSN:<span class="NLM_cas:issn">0730-2312</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Mutations in the mol. pathways that regulate cell proliferation, differentiation, and cell death all contribute to cancer formation.  Enzymes that covalently modify histones affect these pathways by controlling the dynamic remodeling of chromatin structure.  Here, the authors review several connections between histone-modifying enzymes and cancer that are likely mediated via both histone and non-histone substrates.  The authors propose that multiple protein modifications, including phosphorylation, methylation, and acetylation, cross-regulate one another to coordinate intermol. signaling, and that miscues in this regulation can lead to oncogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmU2D4BWPAyLVg90H21EOLACvtfcHk0lifiINHNGs4XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1KgtbbK&md5=8b6cccbd9c896ec68cd063914f8996da</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1002%2Fjcb.20615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.20615%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DK.%26aulast%3DDent%26aufirst%3DS.%2BY.%2BJ.%26atitle%3DHistone%2520modifying%2520enzymes%2520and%2520cancer%253A%2520going%2520beyond%2520histones%26jtitle%3DCell.%2520Biochem.%26date%3D2005%26volume%3D96%26spage%3D1137%26epage%3D1148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Johnstone, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Licht, J. D.</span><span> </span><span class="NLM_article-title">Histone deacetylase inhibitors in cancer therapy: is transcription the primary target?</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">18</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2003&pages=13-18&author=R.+W.+Johnstoneauthor=J.+D.+Licht&title=Histone+deacetylase+inhibitors+in+cancer+therapy%3A+is+transcription+the+primary+target%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJohnstone%26aufirst%3DR.%2BW.%26aulast%3DLicht%26aufirst%3DJ.%2BD.%26atitle%3DHistone%2520deacetylase%2520inhibitors%2520in%2520cancer%2520therapy%253A%2520is%2520transcription%2520the%2520primary%2520target%253F%26jtitle%3DCancer%2520Cell%26date%3D2003%26volume%3D4%26spage%3D13%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">de Ruijter, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Gennip, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, H. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Kuilenburg, A. B.</span><span> </span><span class="NLM_article-title">Histone deacetylases (HDACs): characterization of the classical HDAC family</span> <span class="citation_source-journal">J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">370</span><span class="NLM_x">, </span> <span class="NLM_fpage">737</span><span class="NLM_x">–</span> <span class="NLM_lpage">749</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1042%2FBJ20021321" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhvFKiu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=370&publication_year=2003&pages=737-749&author=A.+J.+de+Ruijterauthor=A.+H.+van+Gennipauthor=H.+N.+Caronauthor=S.+Kempauthor=A.+B.+van+Kuilenburg&title=Histone+deacetylases+%28HDACs%29%3A+characterization+of+the+classical+HDAC+family"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylases (HDACs): characterization of the classical HDAC family</span></div><div class="casAuthors">de Ruijter, Annemieke J. M.; van Gennip, Albert H.; Caron, Huib N.; Kemp, Stephan; van Kuilenburg, Andre B. P.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">370</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">737-749</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review, with refs.  Transcriptional regulation in eukaryotes occurs within a chromatin setting, and is strongly influenced by the post-translational modification of histones, the building blocks of chromatin, such as methylation, phosphorylation and acetylation.  Acetylation is probably the best understood of these modifications: hyperacetylation leads to an increase in the expression of particular genes, and hypoacetylation has the opposite effect.  Many studies have identified several large, multisubunit enzyme complexes that are responsible for the targeted deacetylation of histones.  The aim of this review is to give a comprehensive overview of the structure, function and tissue distribution of members of the classical histone deacetylase (HDAC) family, in order to gain insight into the regulation of gene expression through HDAC activity.  SAGE (serial anal. of gene expression) data show that HDACs are generally expressed in almost all tissues investigated.  Surprisingly, no major differences were obsd. between the expression pattern in normal and malignant tissues.  However, significant variation in HDAC expression was obsd. within tissue types.  HDAC inhibitors have been shown to induce specific changes in gene expression and to influence a variety of other processes, including growth arrest, differentiation, cytotoxicity and induction of apoptosis.  This challenging field has generated many fascinating results which will ultimately lead to a better understanding of the mechanism of gene transcription as a whole.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN1-6ct5EQtrVg90H21EOLACvtfcHk0lifiINHNGs4XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhvFKiu7o%253D&md5=8a521cd3ddcf046b4b806ebf9f1476b4</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1042%2FBJ20021321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20021321%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BRuijter%26aufirst%3DA.%2BJ.%26aulast%3Dvan%2BGennip%26aufirst%3DA.%2BH.%26aulast%3DCaron%26aufirst%3DH.%2BN.%26aulast%3DKemp%26aufirst%3DS.%26aulast%3Dvan%2BKuilenburg%26aufirst%3DA.%2BB.%26atitle%3DHistone%2520deacetylases%2520%2528HDACs%2529%253A%2520characterization%2520of%2520the%2520classical%2520HDAC%2520family%26jtitle%3DJ.%2520Biochem.%26date%3D2003%26volume%3D370%26spage%3D737%26epage%3D749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bolden, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peart, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstone, R. W.</span><span> </span><span class="NLM_article-title">Anticancer activities of histone deacetylase inhibitors</span> <span class="citation_source-journal">Nat. Rev. Drug. Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">769</span><span class="NLM_x">–</span> <span class="NLM_lpage">784</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1038%2Fnrd2133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=16955068" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD28XptVCltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=769-784&author=J.+E.+Boldenauthor=M.+J.+Peartauthor=R.+W.+Johnstone&title=Anticancer+activities+of+histone+deacetylase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Anticancer activities of histone deacetylase inhibitors</span></div><div class="casAuthors">Bolden, Jessica E.; Peart, Melissa J.; Johnstone, Ricky W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">769-784</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Histone deacetylases (HDACs) are enzymes involved in the remodelling of chromatin, and have a key role in the epigenetic regulation of gene expression.  In addn., the activity of non-histone proteins can be regulated through HDAC-mediated hypo-acetylation.  In recent years, inhibition of HDACs has emerged as a potential strategy to reverse aberrant epigenetic changes assocd. with cancer, and several classes of HDAC inhibitors have been found to have potent and specific anticancer activities in preclin. studies.  However, such studies have also indicated that the effects of HDAC inhibitors could be considerably broader and more complicated than originally understood.  Here we summarize recent advances in the understanding of the mol. events that underlie the anticancer effects of HDAC inhibitors, and discuss how such information could be used in optimizing the development and application of these agents in the clinic, either as monotherapies or in combination with other anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhfqS1awkOHbVg90H21EOLACvtfcHk0lg4yChj9nmcOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptVCltrY%253D&md5=91e55ee942fda3e4e2055ddf299fc866</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1038%2Fnrd2133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2133%26sid%3Dliteratum%253Aachs%26aulast%3DBolden%26aufirst%3DJ.%2BE.%26aulast%3DPeart%26aufirst%3DM.%2BJ.%26aulast%3DJohnstone%26aufirst%3DR.%2BW.%26atitle%3DAnticancer%2520activities%2520of%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DNat.%2520Rev.%2520Drug.%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D769%26epage%3D784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Marks, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rifkind, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richon, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breslow, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, W. K.</span><span> </span><span class="NLM_article-title">Histone deacetylases and cancer: causes and therapies</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">194</span><span class="NLM_x">–</span> <span class="NLM_lpage">202</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1038%2F35106079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=11902574" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD38XlvF2qtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=194-202&author=P.+Marksauthor=R.+A.+Rifkindauthor=V.+M.+Richonauthor=R.+Breslowauthor=T.+Millerauthor=W.+K.+Kelly&title=Histone+deacetylases+and+cancer%3A+causes+and+therapies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylases and cancer: causes and therapies</span></div><div class="casAuthors">Marks, Paul A.; Rifkind, Richard A.; Richon, Victoria M.; Breslow, Ronald; Miller, Thomas; Kelly, William K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">194-202</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Together, histone acetyltransferases and histone deacetylases (HDACs) det. the acetylation status of histones.  This acetylation affects the regulation of gene expression, and inhibitors of HDACs have been found to cause growth arrest, differentiation and/or apoptosis of many tumors cells by altering the transcription of a small no. of genes.  HDAC inhibitors are proving to be an exciting therapeutic approach to cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNXyL8yvd0OrVg90H21EOLACvtfcHk0lg4yChj9nmcOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlvF2qtr0%253D&md5=ea50a1a72a6df9ea3a0e1a6a0d5cda5e</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1038%2F35106079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35106079%26sid%3Dliteratum%253Aachs%26aulast%3DMarks%26aufirst%3DP.%26aulast%3DRifkind%26aufirst%3DR.%2BA.%26aulast%3DRichon%26aufirst%3DV.%2BM.%26aulast%3DBreslow%26aufirst%3DR.%26aulast%3DMiller%26aufirst%3DT.%26aulast%3DKelly%26aufirst%3DW.%2BK.%26atitle%3DHistone%2520deacetylases%2520and%2520cancer%253A%2520causes%2520and%2520therapies%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2001%26volume%3D1%26spage%3D194%26epage%3D202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Minucci, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelicci, P. G.</span><span> </span><span class="NLM_article-title">Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">38</span><span class="NLM_x">–</span> <span class="NLM_lpage">51</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1038%2Fnrc1779" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=16397526" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1GgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=38-51&author=S.+Minucciauthor=P.+G.+Pelicci&title=Histone+deacetylase+inhibitors+and+the+promise+of+epigenetic+%28and+more%29+treatments+for+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer</span></div><div class="casAuthors">Minucci, Saverio; Pelicci, Pier Giuseppe</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">38-51</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Histone deacetylases (HDACs) are considered to be among the most promising targets in drug development for cancer therapy, and first-generation histone deacetylase inhibitors (HDACi) are currently being tested in phase I/II clin. trials.  A wide-ranging knowledge of the role of HDACs in tumorigenesis, and of the action of HDACi, has been achieved.  However, several basic aspects are not yet fully understood.  Investigating these aspects in the context of what we now understand about HDACi action both in vitro and in vivo will further improve the design of optimized clin. protocols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxXiACZV1sK7Vg90H21EOLACvtfcHk0lhK7o0hVxc-JQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1GgsA%253D%253D&md5=384e1f8d676d61531e46843c060a9380</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1038%2Fnrc1779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc1779%26sid%3Dliteratum%253Aachs%26aulast%3DMinucci%26aufirst%3DS.%26aulast%3DPelicci%26aufirst%3DP.%2BG.%26atitle%3DHistone%2520deacetylase%2520inhibitors%2520and%2520the%2520promise%2520of%2520epigenetic%2520%2528and%2520more%2529%2520treatments%2520for%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2006%26volume%3D6%26spage%3D38%26epage%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Glozak, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seto, E.</span><span> </span><span class="NLM_article-title">Histone deacetylases and cancer</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">5420</span><span class="NLM_x">–</span> <span class="NLM_lpage">5432</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=5420-5432&author=M.+A.+Glozakauthor=E.+Seto&title=Histone+deacetylases+and+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGlozak%26aufirst%3DM.%2BA.%26aulast%3DSeto%26aufirst%3DE.%26atitle%3DHistone%2520deacetylases%2520and%2520cancer%26jtitle%3DOncogene%26date%3D2007%26volume%3D26%26spage%3D5420%26epage%3D5432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Murata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurokawa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krones, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatsumi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masuno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanagisawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenfeld, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glass, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, Y.</span><span> </span><span class="NLM_article-title">Defect of histone acetyltransferase activity of the nuclear transcriptional coactivator CBP in Rubinstein−Taybi syndrome</span> <span class="citation_source-journal">Hum. Mol. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1071</span><span class="NLM_x">–</span> <span class="NLM_lpage">1076</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1093%2Fhmg%2F10.10.1071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=11331617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjslyqtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2001&pages=1071-1076&author=T.+Murataauthor=R.+Kurokawaauthor=A.+Kronesauthor=K.+Tatsumiauthor=M.+Ishiiauthor=T.+Takiauthor=M.+Masunoauthor=H.+Ohashiauthor=M.+Yanagisawaauthor=M.+G.+Rosenfeldauthor=C.+K.+Glassauthor=Y.+Hayashi&title=Defect+of+histone+acetyltransferase+activity+of+the+nuclear+transcriptional+coactivator+CBP+in+Rubinstein%E2%88%92Taybi+syndrome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Defect of histone acetyltransferase activity of the nuclear transcriptional coactivator CBP in Rubinstein-Taybi syndrome</span></div><div class="casAuthors">Murata, Takashi; Kurokawa, Riki; Krones, Anna; Tatsumi, Ken; Ishii, Masami; Taki, Tomohiko; Masuno, Mitsuo; Ohashi, Hirofumi; Yanagisawa, Masayoshi; Rosenfeld, Michael G.; Glass, Christopher K.; Hayashi, Yasuhide</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1071-1076</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">CREB-binding protein (CBP) is a transcriptional coactivator that has intrinsic histone acetyltransferase (HAT) activity.  CBP is the causative gene of Rubinstein-Taybi syndrome (RTS).  To investigate the relationships between CBP HAT activity and RTS, we analyzed 16 RTS patients.  A microdeletion was identified in one patient by fluorescent in situ hybridization anal.  Heteroallelic mutations were identified in five patients by reverse transcriptase-polymerase chain reaction-single-strand conformation polymorphism anal. and sequencing.  These included a 2 bp deletion between nucleotides 4319 and 4320, an 11 bp deletion between nucleotides 4898 and 4908, a 14 bp insertion (CCTCGGTCCTGCAC) between nucleotides 5212 and 5213, a 2 bp deletion between nucleotides 5222 and 5223, and a missense mutation from guanine (G) to cytosine (C) at nucleotide 4951 that changed codon 1378 from CGG (arginine) to CCG (proline).  The identical missense mutation was introduced into the recombinant mouse CBP.  It abolished the HAT activity of CBP and the ability of CBP to transactivate cAMP-response element binding protein (CREB), in HAT assays and in microinjection expts., resp.  These results suggest that the loss of the HAT activity of CBP may cause RTS, as the first example of a defect of HAT activity in a human disease.  Our findings raise the possibility that treatment of RTS patients with histone deacetylase inhibitors might have beneficial effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0NXqRzSn_uLVg90H21EOLACvtfcHk0lhK7o0hVxc-JQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjslyqtLc%253D&md5=cb2ec6c582fd28159c13fe3390af20b0</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2F10.10.1071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252F10.10.1071%26sid%3Dliteratum%253Aachs%26aulast%3DMurata%26aufirst%3DT.%26aulast%3DKurokawa%26aufirst%3DR.%26aulast%3DKrones%26aufirst%3DA.%26aulast%3DTatsumi%26aufirst%3DK.%26aulast%3DIshii%26aufirst%3DM.%26aulast%3DTaki%26aufirst%3DT.%26aulast%3DMasuno%26aufirst%3DM.%26aulast%3DOhashi%26aufirst%3DH.%26aulast%3DYanagisawa%26aufirst%3DM.%26aulast%3DRosenfeld%26aufirst%3DM.%2BG.%26aulast%3DGlass%26aufirst%3DC.%2BK.%26aulast%3DHayashi%26aufirst%3DY.%26atitle%3DDefect%2520of%2520histone%2520acetyltransferase%2520activity%2520of%2520the%2520nuclear%2520transcriptional%2520coactivator%2520CBP%2520in%2520Rubinstein%25E2%2588%2592Taybi%2520syndrome%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2001%26volume%3D10%26spage%3D1071%26epage%3D1076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoshino, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Redner, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kajigaya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J. M.</span><span> </span><span class="NLM_article-title">ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">10860</span><span class="NLM_x">–</span> <span class="NLM_lpage">10865</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=10860-10865&author=J.+Wangauthor=T.+Hoshinoauthor=R.+L.+Rednerauthor=S.+Kajigayaauthor=J.+M.+Liu&title=ETO%2C+fusion+partner+in+t%288%3B21%29+acute+myeloid+leukemia%2C+represses+transcription+by+interaction+with+the+human+N-CoR%2FmSin3%2FHDAC1+complex"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DHoshino%26aufirst%3DT.%26aulast%3DRedner%26aufirst%3DR.%2BL.%26aulast%3DKajigaya%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DJ.%2BM.%26atitle%3DETO%252C%2520fusion%2520partner%2520in%2520t%25288%253B21%2529%2520acute%2520myeloid%2520leukemia%252C%2520represses%2520transcription%2520by%2520interaction%2520with%2520the%2520human%2520N-CoR%252FmSin3%252FHDAC1%2520complex%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1998%26volume%3D95%26spage%3D10860%26epage%3D10865" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Zhu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mengwasser, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlag, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janssen, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Göttlicher, M.</span><span> </span><span class="NLM_article-title">Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">–</span> <span class="NLM_lpage">463</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1016%2FS1535-6108%2804%2900114-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=15144953" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksFCmt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=455-463&author=P.+Zhuauthor=E.+Martinauthor=J.+Mengwasserauthor=P.+Schlagauthor=K.+P.+Janssenauthor=M.+G%C3%B6ttlicher&title=Induction+of+HDAC2+expression+upon+loss+of+APC+in+colorectal+tumorigenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis</span></div><div class="casAuthors">Zhu, Ping; Martin, Elke; Mengwasser, Joerg; Schlag, Peter; Janssen, Klaus-Peter; Goettlicher, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">455-463</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Inappropriate transcriptional repression involving histone deacetylases (HDACs) is a prominent cause for the development of leukemia.  We now identify faulty expression of a specific mediator of transcriptional repression in a solid tumor.  Loss of the adenomatosis polyposis coli (APC) tumor suppressor induces HDAC2 expression depending on the Wnt pathway and c-Myc.  Increased HDAC2 expression is found in the majority of human colon cancer explants, as well as in intestinal mucosa and polyps of APC-deficient mice.  HDAC2 is required for, and sufficient on its own to prevent, apoptosis of colonic cancer cells.  Interference with HDAC2 by valproic acid largely diminishes adenoma formation in APCmin mice.  These findings point toward HDAC2 as a particularly relevant potential target in cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP4i9iItBfArVg90H21EOLACvtfcHk0lgDPV8Vjl7qvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksFCmt7c%253D&md5=bfd948db793310e303ad8d71d8cbf8b0</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS1535-6108%2804%2900114-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1535-6108%252804%252900114-X%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DP.%26aulast%3DMartin%26aufirst%3DE.%26aulast%3DMengwasser%26aufirst%3DJ.%26aulast%3DSchlag%26aufirst%3DP.%26aulast%3DJanssen%26aufirst%3DK.%2BP.%26aulast%3DG%25C3%25B6ttlicher%26aufirst%3DM.%26atitle%3DInduction%2520of%2520HDAC2%2520expression%2520upon%2520loss%2520of%2520APC%2520in%2520colorectal%2520tumorigenesis%26jtitle%3DCancer%2520Cell%26date%3D2004%26volume%3D5%26spage%3D455%26epage%3D463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Weichert, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Röske, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gekeler, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pross, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denkert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Röcken, C.</span><span> </span><span class="NLM_article-title">Class I HDAC expression patterns are highly prognostic in human gastric cancer</span> <span class="citation_source-journal">Lancet Oncology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">139</span><span class="NLM_x">–</span> <span class="NLM_lpage">148</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1016%2FS1470-2045%2808%2970004-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=18207460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVOnu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=139-148&author=W.+Weichertauthor=A.+R%C3%B6skeauthor=V.+Gekelerauthor=T.+Beckersauthor=M.+Ebertauthor=M.+Prossauthor=M.+Dietelauthor=C.+Denkertauthor=C.+R%C3%B6cken&title=Class+I+HDAC+expression+patterns+are+highly+prognostic+in+human+gastric+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis</span></div><div class="casAuthors">Weichert, Wilko; Roeske, Annika; Gekeler, Volker; Beckers, Thomas; Ebert, Matthias PA; Pross, Matthias; Dietel, Manfred; Denkert, Carsten; Roecken, Christoph</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">139-148</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Although histone deacetylases (HDACs) are known to have an important regulatory role in cancer cells, and HDAC inhibitors (HDIs) have entered late-phase clin. trials for the treatment of several cancers, little is known about the expression patterns of HDAC isoforms in tumors.  We aimed to clarify these expression patterns and identify potential diagnostic and prognostic uses of selected class I HDAC isoforms in gastric cancer.  Tissue samples from a training cohort and a validation cohort of patients with gastric cancer from two German institutions were used for analyses.  Tissue microarrays were generated from tumor tissue collected from patients in the training group, whereas tissue slides were used in the validation group.  The tissues were scored for expression of class I HDAC isoforms 1, 2, and 3.  Overall expression patterns (gHDAC) were grouped as being neg. (all three isoforms neg.), partially pos. (one or two isoforms pos.), or completely pos. (all isoforms pos.), and correlated with clinicopathol. parameters and patient survival.  The main endpoints were amt. of expression of each of the three HDAC isoforms, patterns of expression of gHDAC, effect of metastasis on expression of HDAC and gHDAC, and overall survival according to HDAC expression patterns.  With 2617 tissue microarray spots from 143 patients in the training cohort and 606 tissue slides from 150 patients in the validation cohort were studied. 52 of the 143 (36%) gastric tumors in the training cohort and 32 of the 150 (21%) gastric tumors in the validation cohort showed nuclear expression of all three HDAC isoforms. 60 (42%) of tumors in the training cohort and 65 (43%) in the validation cohort expressed one or two isoforms in the nuclei, whereas 31 (22%) of tumors in the training cohort and 53 (35%) in the validation cohort were scored neg. for all three proteins. gHDAC expression in both cohorts was higher when lymph-node metastases were present (p=0.0175 for the training group and p=0.0242 for the validation group).  Survival data were available for 49 patients in the training group and 123 patients in the validation group.  In the validation cohort, 3-yr survival was 44% (95% CI 34-57) in the HDAC1-neg. group, 50% (39-64) in the HDAC2-neg. group, and 48% (34-67) in the gHDAC-neg. group. 3-yr survival decreased to 21% (11-37) when HDAC1 was pos., 16% (9-31) when HDAC2 was pos., and 5% (1-31) when gHDAC (all isoforms) were pos.  Those patients highly expressing one or two isoforms (the gHDAC-intermediate group) had an estd. 3-yr survival of 40% (29-56).  In multivariate analyses, high gHDAC and HDAC2 expression were assocd. with shorter survival in the training cohort (gHDAC: hazard ratio [HR] 4.15 [1.23-13.99], p=0.0250; HDAC2: HR 3.58 [1.36-9.44], p=0.0100) and in the validation cohort (gHDAC: HR 2.18 [1.19-4.01], p=0.0433; HDAC2: HR 1.72 [1.08-2.73], p=0.0225), independent of std. clin. predictors.  High HDAC expression is significantly assocd. with nodal spread and is an independent prognostic marker for gastric cancer.  Addnl., we postulate that immunohistochem. detection of HDAC as a companion diagnostic method might predict treatment response to HDIs, thereby enabling selection of patients for this specific targeted treatment in gastric cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrS-sW_bc85KLVg90H21EOLACvtfcHk0lgDPV8Vjl7qvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVOnu7c%253D&md5=8be9de726d97c67924e3cd3543b94c73</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2808%2970004-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252808%252970004-4%26sid%3Dliteratum%253Aachs%26aulast%3DWeichert%26aufirst%3DW.%26aulast%3DR%25C3%25B6ske%26aufirst%3DA.%26aulast%3DGekeler%26aufirst%3DV.%26aulast%3DBeckers%26aufirst%3DT.%26aulast%3DEbert%26aufirst%3DM.%26aulast%3DPross%26aufirst%3DM.%26aulast%3DDietel%26aufirst%3DM.%26aulast%3DDenkert%26aufirst%3DC.%26aulast%3DR%25C3%25B6cken%26aufirst%3DC.%26atitle%3DClass%2520I%2520HDAC%2520expression%2520patterns%2520are%2520highly%2520prognostic%2520in%2520human%2520gastric%2520cancer%26jtitle%3DLancet%2520Oncology%26date%3D2008%26volume%3D9%26spage%3D139%26epage%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Weichert, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Röske, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niesporek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noske, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckendahl, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gekeler, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denkert, C.</span><span> </span><span class="NLM_article-title">Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I HDACs in vitro and in vivo</span> <span class="citation_source-journal">Clin. Cancer. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1669</span><span class="NLM_x">–</span> <span class="NLM_lpage">1677</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1158%2F1078-0432.CCR-07-0990" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=18347167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD1cXjtlejt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=1669-1677&author=W.+Weichertauthor=A.+R%C3%B6skeauthor=S.+Niesporekauthor=A.+Noskeauthor=A.+C.+Buckendahlauthor=M.+Dietelauthor=V.+Gekelerauthor=M.+Boehmauthor=T.+Beckersauthor=C.+Denkert&title=Class+I+histone+deacetylase+expression+has+independent+prognostic+impact+in+human+colorectal+cancer%3A+specific+role+of+class+I+HDACs+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">Class I Histone Deacetylase Expression Has Independent Prognostic Impact in Human Colorectal Cancer: Specific Role of Class I Histone Deacetylases In vitro and In vivo</span></div><div class="casAuthors">Weichert, Wilko; Roeske, Annika; Niesporek, Silvia; Noske, Aurelia; Buckendahl, Ann-Christin; Dietel, Manfred; Gekeler, Volker; Boehm, Markus; Beckers, Thomas; Denkert, Carsten</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1669-1677</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: Recently, several studies reported a strong functional link between histone deacetylases (HDAC) and the development of tumors of the large intestine.  However, despite the importance of these mols., comparably little is known on expression patterns and functions of specific HDAC isoforms in colorectal cancer.  Exptl. Design: We characterized class I HDAC isoform expression patterns in a cohort of 140 colorectal carcinomas by immunohistochem.  In addn., effects of HDAC inhibition by valproic acid and suberoylanilide hydroxamic acid, and specific HDAC isoform knockdown by short interfering RNA, were investigated in a cell culture model.  RESULTS: We found class I HDACs highly expressed in a subset of colorectal carcinomas with positivity for HDAC1 in 36.4%, HDAC2 in 57.9%, and HDAC3 in 72.9% of cases.  Expression was significantly enhanced in strongly proliferating (P = 0.002), dedifferentiated (P = 0.022) tumors.  High HDAC expression levels implicated significantly reduced patient survival (P = 0.001), with HDAC2 expression being an independent survival prognosticator (hazard ratio, 2.6; P = 0.03).  Short interfering RNA-based inhibition of HDAC1 and HDAC2 but not HDAC3 suppressed growth of colon cancer cells in vitro, although to a lesser extent than chem. HDAC inhibitors did.  CONCLUSIONS: The strong prognostic impact of HDAC isoforms in colorectal cancer, the interactions of HDACs with tumor cell proliferation and differentiation in vivo, and our finding that HDACs are differentially expressed in colorectal tumors suggest that the evaluation of HDAC expression in clin. trials for HDAC inhibitors might help to identify a patient subgroup who will exceptionally profit from such a treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQAUfNzjDakrVg90H21EOLACvtfcHk0lg6ZVLQu-TRSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXjtlejt7o%253D&md5=f54611c0b65fe4cd8a0cfea3ea143126</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-0990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-0990%26sid%3Dliteratum%253Aachs%26aulast%3DWeichert%26aufirst%3DW.%26aulast%3DR%25C3%25B6ske%26aufirst%3DA.%26aulast%3DNiesporek%26aufirst%3DS.%26aulast%3DNoske%26aufirst%3DA.%26aulast%3DBuckendahl%26aufirst%3DA.%2BC.%26aulast%3DDietel%26aufirst%3DM.%26aulast%3DGekeler%26aufirst%3DV.%26aulast%3DBoehm%26aufirst%3DM.%26aulast%3DBeckers%26aufirst%3DT.%26aulast%3DDenkert%26aufirst%3DC.%26atitle%3DClass%2520I%2520histone%2520deacetylase%2520expression%2520has%2520independent%2520prognostic%2520impact%2520in%2520human%2520colorectal%2520cancer%253A%2520specific%2520role%2520of%2520class%2520I%2520HDACs%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DClin.%2520Cancer.%2520Res.%26date%3D2008%26volume%3D14%26spage%3D1669%26epage%3D1677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Weichert, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Röske, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gekeler, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niesporek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denkert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kristiansen, G.</span><span> </span><span class="NLM_article-title">Expression, function and prognostic role of class I histone deacetylase isoforms in prostate cancer in vitro and in vivo</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">604</span><span class="NLM_x">–</span> <span class="NLM_lpage">610</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1038%2Fsj.bjc.6604199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=18212746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhs1Krsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2008&pages=604-610&author=W.+Weichertauthor=A.+R%C3%B6skeauthor=G.+Gekelerauthor=T.+Beckersauthor=C.+Stephanauthor=K.+Jungauthor=S.+Niesporekauthor=C.+Denkertauthor=M.+Dietelauthor=G.+Kristiansen&title=Expression%2C+function+and+prognostic+role+of+class+I+histone+deacetylase+isoforms+in+prostate+cancer+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9cR"><div class="casContent"><span class="casTitleNuber">9c</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy</span></div><div class="casAuthors">Weichert, W.; Roeske, A.; Gekeler, V.; Beckers, T.; Stephan, C.; Jung, K.; Fritzsche, F. R.; Niesporek, S.; Denkert, C.; Dietel, M.; Kristiansen, G.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">604-610</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">High activity of histone deacetylases (HDACs) causes epigenetic alterations assocd. with malignant cell behavior.  Consequently, HDAC inhibitors have entered late-phase clin. trials as new antineoplastic drugs.  However, little is known about expression and function of specific HDAC isoforms in human tumors including prostate cancer.  We investigated the expression of class I HDACs in 192 prostate carcinomas by immunohistochem. and correlated our findings to clinicopathol. parameters including follow-up data.  Class I HDAC isoforms were strongly expressed in the majority of the cases (HDAC1: 69.8%, HDAC2: 74%, HDAC3: 94.8%).  High rates of HDAC1 and HDAC2 expression were significantly assocd. with tumor dedifferentiation.  Strong expression of all HDACs was accompanied by enhanced tumor cell proliferation.  In addn., HDAC2 was an independent prognostic marker in our prostate cancer cohort.  In conclusion, we showed that the known effects of HDACs on differentiation and proliferation of cancer cells obsd. in vitro can also be confirmed in vivo.  The class I HDAC isoforms 1, 2 and 3 are differentially expressed in prostate cancer, which might be important for upcoming studies on HDAC inhibitors in this tumor entity.  Also, the highly significant prognostic value of HDAC2 clearly deserves further study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbq9wIwyKVYLVg90H21EOLACvtfcHk0lg6ZVLQu-TRSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhs1Krsbo%253D&md5=deebe5cf3cb1c08909282a807000827a</span></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6604199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6604199%26sid%3Dliteratum%253Aachs%26aulast%3DWeichert%26aufirst%3DW.%26aulast%3DR%25C3%25B6ske%26aufirst%3DA.%26aulast%3DGekeler%26aufirst%3DG.%26aulast%3DBeckers%26aufirst%3DT.%26aulast%3DStephan%26aufirst%3DC.%26aulast%3DJung%26aufirst%3DK.%26aulast%3DNiesporek%26aufirst%3DS.%26aulast%3DDenkert%26aufirst%3DC.%26aulast%3DDietel%26aufirst%3DM.%26aulast%3DKristiansen%26aufirst%3DG.%26atitle%3DExpression%252C%2520function%2520and%2520prognostic%2520role%2520of%2520class%2520I%2520histone%2520deacetylase%2520isoforms%2520in%2520prostate%2520cancer%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2008%26volume%3D98%26spage%3D604%26epage%3D610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yoo, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, P. A.</span><span> </span><span class="NLM_article-title">Epigenetic therapy of cancer: past, present and future</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1038%2Fnrd1930" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=16485345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD28Xmt1yqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=37-50&author=C.+B.+Yooauthor=P.+A.+Jones&title=Epigenetic+therapy+of+cancer%3A+past%2C+present+and+future"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Epigenetic therapy of cancer: past, present and future</span></div><div class="casAuthors">Yoo, Christine B.; Jones, Peter A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">37-50</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The initiation and progression of cancer is controlled by both genetic and epigenetic events.  Unlike genetic alterations, which are almost impossible to reverse, epigenetic aberrations are potentially reversible, allowing the malignant cell population to revert to a more normal state.  With the advent of numerous drugs that target specific enzymes involved in the epigenetic regulation of gene expression, the utilization of epigenetic targets is emerging as an effective and valuable approach to chemotherapy as well as chemoprevention of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOQv6jMPAK1LVg90H21EOLACvtfcHk0liJf0wEuhJ_Jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xmt1yqsA%253D%253D&md5=5c552ef929369b8466d2ab2c324cf092</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1038%2Fnrd1930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1930%26sid%3Dliteratum%253Aachs%26aulast%3DYoo%26aufirst%3DC.%2BB.%26aulast%3DJones%26aufirst%3DP.%2BA.%26atitle%3DEpigenetic%2520therapy%2520of%2520cancer%253A%2520past%252C%2520present%2520and%2520future%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D37%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Riester, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hildmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwienhorst, A.</span><span> </span><span class="NLM_article-title">Histone deacetylase inhibitors-turning epigenic mechanisms of gene regulation into tools of therapeutic intervention in malignant and other diseases</span> <span class="citation_source-journal">Appl. Microbiol. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">499</span><span class="NLM_x">–</span> <span class="NLM_lpage">514</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2007&pages=499-514&author=D.+Riesterauthor=C.+Hildmannauthor=A.+Schwienhorst&title=Histone+deacetylase+inhibitors-turning+epigenic+mechanisms+of+gene+regulation+into+tools+of+therapeutic+intervention+in+malignant+and+other+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRiester%26aufirst%3DD.%26aulast%3DHildmann%26aufirst%3DC.%26aulast%3DSchwienhorst%26aufirst%3DA.%26atitle%3DHistone%2520deacetylase%2520inhibitors-turning%2520epigenic%2520mechanisms%2520of%2520gene%2520regulation%2520into%2520tools%2520of%2520therapeutic%2520intervention%2520in%2520malignant%2520and%2520other%2520diseases%26jtitle%3DAppl.%2520Microbiol.%2520Biotechnol.%26date%3D2007%26volume%3D75%26spage%3D499%26epage%3D514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Sorbera, L. A.</span><span> </span><span class="NLM_article-title">Epigenetic targets as an approach to cancer therapy and chemoprevention</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">335</span><span class="NLM_x">–</span> <span class="NLM_lpage">344</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1358%2Fdof.2006.031.04.985053" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD28XntVylsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2006&pages=335-344&author=L.+A.+Sorbera&title=Epigenetic+targets+as+an+approach+to+cancer+therapy+and+chemoprevention"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Epigenetic target as an approach to cancer therapy and chemoprevention</span></div><div class="casAuthors">Sorbera, Lisa A.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">335-344</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  Carcinogenesis and tumor progression are controlled by both genetic and epigenetic events.  Unlike genetic aberrations, epigenetic aberrations such as DNA methylation and histone deacetylation evident in cancer cells can usually be reversed to reactivate epigenetically silenced tumor suppressor genes and possibly normalize a malignant cell population.  Thus, researchers have focused on epigenetic events as targets for effective cancer therapy and chemoprevention.  At the 97th American Assocn. for Cancer Research Annual Meeting in Washington, D.C., the preclin. and clin. activity of several histone deacetylase (HDAC) and DNA methyltransferase (DNMT) inhibitors was described, indicating promising anticancer effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCi1AxorTZnrVg90H21EOLACvtfcHk0liJf0wEuhJ_Jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntVylsbc%253D&md5=32b4c23f6b9735485eb3fe411e919a96</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1358%2Fdof.2006.031.04.985053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2006.031.04.985053%26sid%3Dliteratum%253Aachs%26aulast%3DSorbera%26aufirst%3DL.%2BA.%26atitle%3DEpigenetic%2520targets%2520as%2520an%2520approach%2520to%2520cancer%2520therapy%2520and%2520chemoprevention%26jtitle%3DDrugs%2520Future%26date%3D2006%26volume%3D31%26spage%3D335%26epage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Miller, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witter, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belvedere, S.</span><span> </span><span class="NLM_article-title">Histone Deacetylase Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">5097</span><span class="NLM_x">–</span> <span class="NLM_lpage">5116</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0303094" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD3sXosVCktbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=5097-5116&author=T.+A.+Millerauthor=D.+J.+Witterauthor=S.+Belvedere&title=Histone+Deacetylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase inhibitors</span></div><div class="casAuthors">Miller, Thomas A.; Witter, David J.; Belvedere, Sandro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">5097-5116</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review on the medicinal chem. and structure-activity relationships underlying advances in histone deacetylase (HDAC) class I/II inhibitor discovery, design, and optimization.  HDAC structural studies and HDAC inhibitory activity of small-mol. hydroxamic acids, carboxylates, benzamides, electrophilic ketones, and cyclic peptides are described.  Miscellaneousness and selectivity of the class I/II HDACs are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoU5UlOsBUF7rVg90H21EOLACvtfcHk0ljd0JOUv9WC1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXosVCktbg%253D&md5=d2d0a95d87d699334c1630df5deda38a</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1021%2Fjm0303094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0303094%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DT.%2BA.%26aulast%3DWitter%26aufirst%3DD.%2BJ.%26aulast%3DBelvedere%26aufirst%3DS.%26atitle%3DHistone%2520Deacetylase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D5097%26epage%3D5116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hildmann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wegener, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riester, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hempel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schober, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merena, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guirato, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guccione, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nielsen, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ficner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwienhorst, A.</span><span> </span><span class="NLM_article-title">Substrate and inhibitor specificity of class 1 and class 2 histone deacetylases</span> <span class="citation_source-journal">J. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">124</span><span class="NLM_x">, </span> <span class="NLM_fpage">258</span><span class="NLM_x">–</span> <span class="NLM_lpage">270</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1016%2Fj.jbiotec.2006.01.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=16567013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD28Xltl2isb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2006&pages=258-270&author=C.+Hildmannauthor=D.+Wegenerauthor=D.+Riesterauthor=R.+Hempelauthor=A.+Schoberauthor=J.+Merenaauthor=L.+Guiratoauthor=S.+Guccioneauthor=T.+K.+Nielsenauthor=R.+Ficnerauthor=A.+Schwienhorst&title=Substrate+and+inhibitor+specificity+of+class+1+and+class+2+histone+deacetylases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Substrate and inhibitor specificity of class 1 and class 2 histone deacetylases</span></div><div class="casAuthors">Hildmann, Christian; Wegener, Dennis; Riester, Daniel; Hempel, Rene; Schober, Andreas; Merana, Joachim; Giurato, Laura; Guccione, Salvatore; Nielsen, Tine Kragh; Ficner, Ralf; Schwienhorst, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biotechnology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">258-270</span>CODEN:
                <span class="NLM_cas:coden">JBITD4</span>;
        ISSN:<span class="NLM_cas:issn">0168-1656</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Histone deacetylases (HDACs) are key enzymes in the transcriptional regulation of gene expression in eukaryotic cells.  In recent years HDACs have attracted considerable attention as promising new targets in anticancer therapy.  Currently, different histone deacetylase subtypes are divided into four groups denoted as classes 1-4.  Here, we compare in more detail representatives of class 1 HDACs and FB188 HDAH as a close bacterial homolog of class 2 HDAC6, in regard to substrate and inhibitor specificity.  Structure comparison is used to identify candidate regions responsible for obsd. specificity differences.  Knowledge of these structural elements expedite studies on the biochem. role of different HDAC subtypes as well as the development of highly selective HDAC inhibitors as antitumor agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV3e94dR7LFbVg90H21EOLACvtfcHk0ljd0JOUv9WC1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xltl2isb0%253D&md5=4a47e29f8453b7b218b6641a5fd89f26</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1016%2Fj.jbiotec.2006.01.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jbiotec.2006.01.030%26sid%3Dliteratum%253Aachs%26aulast%3DHildmann%26aufirst%3DC.%26aulast%3DWegener%26aufirst%3DD.%26aulast%3DRiester%26aufirst%3DD.%26aulast%3DHempel%26aufirst%3DR.%26aulast%3DSchober%26aufirst%3DA.%26aulast%3DMerena%26aufirst%3DJ.%26aulast%3DGuirato%26aufirst%3DL.%26aulast%3DGuccione%26aufirst%3DS.%26aulast%3DNielsen%26aufirst%3DT.%2BK.%26aulast%3DFicner%26aufirst%3DR.%26aulast%3DSchwienhorst%26aufirst%3DA.%26atitle%3DSubstrate%2520and%2520inhibitor%2520specificity%2520of%2520class%25201%2520and%2520class%25202%2520histone%2520deacetylases%26jtitle%3DJ.%2520Biotechnol.%26date%3D2006%26volume%3D124%26spage%3D258%26epage%3D270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Finnin, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donigian, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richon, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rifkind, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breslow, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavletich, N. P.</span><span> </span><span class="NLM_article-title">Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">401</span><span class="NLM_x">, </span> <span class="NLM_fpage">188</span><span class="NLM_x">–</span> <span class="NLM_lpage">193</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1038%2F43710" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=10490031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADyaK1MXlvFKgtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=401&publication_year=1999&pages=188-193&author=M.+S.+Finninauthor=J.+R.+Donigianauthor=A.+Cohenauthor=V.+M.+Richonauthor=R.+A.+Rifkindauthor=P.+A.+Marksauthor=R.+Breslowauthor=N.+P.+Pavletich&title=Structures+of+a+histone+deacetylase+homologue+bound+to+the+TSA+and+SAHA+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors</span></div><div class="casAuthors">Finnin, Michael S.; Donigian, Jill R.; Cohen, Alona; Richon, Victoria M.; Rifkind, Richard A.; Marks, Paul A.; Breslow, Ronald; Pavletich, Nikola P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">401</span>
        (<span class="NLM_cas:issue">6749</span>),
    <span class="NLM_cas:pages">188-193</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Histone deacetylases (HDACs) mediate changes in nucleosome conformation and are important in the regulation of gene expression.  HDACs are involved in cell-cycle progression and differentiation, and their deregulation is assocd. with several cancers.  HDAC inhibitors, such as trichostatin A (TSA) and suberoylanilide hydroxamic acid (SAHA), have anti-tumor effects, as they can inhibit cell growth, induce terminal differentiation and prevent the formation of tumors in mice models, and they are effective in the treatment of promyelocytic leukemia.  Here we describe the structure of the histone deacetylase catalytic core, as revealed by the crystal structure of a homolog from the hyperthermophilic bacterium Aquifex aeolicus, that shares 35.2% identity with human HDAC1 over 375 residues, deacetylates histones in vitro and is inhibited by TSA and SAHA.  The deacetylase, deacetylase-TSA and deacetylase-SAHA structures reveal an active site consisting of a tubular pocket, a zinc-binding site and two Asp-His charge-relay systems, and establish the mechanism of HDAC inhibition.  The residues that make up the active site and contact the inhibitors are conserved across the HDAC family.  These structures also suggest a mechanism for the deacetylation reaction and provide a framework for the further development of HDAC inhibitors as antitumor agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrG0lsZMMo37Vg90H21EOLACvtfcHk0ljSO_C3sAZPKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvFKgtrc%253D&md5=29bbc6d3ba9a9d2a8c330349ae8199a8</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1038%2F43710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F43710%26sid%3Dliteratum%253Aachs%26aulast%3DFinnin%26aufirst%3DM.%2BS.%26aulast%3DDonigian%26aufirst%3DJ.%2BR.%26aulast%3DCohen%26aufirst%3DA.%26aulast%3DRichon%26aufirst%3DV.%2BM.%26aulast%3DRifkind%26aufirst%3DR.%2BA.%26aulast%3DMarks%26aufirst%3DP.%2BA.%26aulast%3DBreslow%26aufirst%3DR.%26aulast%3DPavletich%26aufirst%3DN.%2BP.%26atitle%3DStructures%2520of%2520a%2520histone%2520deacetylase%2520homologue%2520bound%2520to%2520the%2520TSA%2520and%2520SAHA%2520inhibitors%26jtitle%3DNature%26date%3D1999%26volume%3D401%26spage%3D188%26epage%3D193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Somoza, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skene, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katz, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mol, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luong, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arvai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buggy, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chi, El.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sang, B.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wynands, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leahy, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougan, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snell, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navre, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knuth, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swanson, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McRee, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tari, L. W.</span><span> </span><span class="NLM_article-title">Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1325</span><span class="NLM_x">–</span> <span class="NLM_lpage">1334</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1016%2Fj.str.2004.04.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=15242608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsFyrsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=1325-1334&author=J.+R.+Somozaauthor=R.+J.+Skeneauthor=B.+A.+Katzauthor=C.+Molauthor=J.+D.+Hoauthor=A.+J.+Jenningsauthor=C.+Luongauthor=A.+Arvaiauthor=J.+J.+Buggyauthor=El.+Chiauthor=J.+Tangauthor=B.-C.+Sangauthor=E.+Vernerauthor=R.+Wynandsauthor=E.+M.+Leahyauthor=D.+R.+Douganauthor=G.+Snellauthor=M.+Navreauthor=M.+W.+Knuthauthor=R.+V.+Swansonauthor=D.+E.+McReeauthor=L.+W.+Tari&title=Structural+Snapshots+of+Human+HDAC8+Provide+Insights+into+the+Class+I+Histone+Deacetylases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases</span></div><div class="casAuthors">Somoza, John R.; Skene, Robert J.; Katz, Bradley A.; Mol, Clifford; Ho, Joseph D.; Jennings, Andy J.; Luong, Christine; Arvai, Andrew; Buggy, Joseph J.; Chi, Ellen; Tang, Jie; Sang, Bi-Ching; Verner, Erik; Wynands, Robert; Leahy, Ellen M.; Dougan, Douglas R.; Snell, Gyorgy; Navre, Marc; Knuth, Mark W.; Swanson, Ronald V.; McRee, Duncan E.; Tari, Leslie W.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1325-1334</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Modulation of the acetylation state of histones plays a pivotal role in the regulation of gene expression.  Histone deacetylases (HDACs) catalyze the removal of acetyl groups from lysines near the N termini of histones.  This reaction promotes the condensation of chromatin, leading to repression of transcription.  HDAC deregulation has been linked to several types of cancer, suggesting a potential use for HDAC inhibitors in oncol.  Here we describe the first crystal structures of a human HDAC: the structures of human HDAC8 complexed with four structurally diverse hydroxamate inhibitors.  This work sheds light on the catalytic mechanism of the HDACs, and on differences in substrate specificity across the HDAC family.  The structure also suggests how phosphorylation of Ser39 affects HDAC8 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPLrZup76hGLVg90H21EOLACvtfcHk0ljSO_C3sAZPKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsFyrsLc%253D&md5=3f1842802bac2543509a25f5ddbea5f6</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2004.04.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2004.04.012%26sid%3Dliteratum%253Aachs%26aulast%3DSomoza%26aufirst%3DJ.%2BR.%26aulast%3DSkene%26aufirst%3DR.%2BJ.%26aulast%3DKatz%26aufirst%3DB.%2BA.%26aulast%3DMol%26aufirst%3DC.%26aulast%3DHo%26aufirst%3DJ.%2BD.%26aulast%3DJennings%26aufirst%3DA.%2BJ.%26aulast%3DLuong%26aufirst%3DC.%26aulast%3DArvai%26aufirst%3DA.%26aulast%3DBuggy%26aufirst%3DJ.%2BJ.%26aulast%3DChi%26aufirst%3DEl.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DSang%26aufirst%3DB.-C.%26aulast%3DVerner%26aufirst%3DE.%26aulast%3DWynands%26aufirst%3DR.%26aulast%3DLeahy%26aufirst%3DE.%2BM.%26aulast%3DDougan%26aufirst%3DD.%2BR.%26aulast%3DSnell%26aufirst%3DG.%26aulast%3DNavre%26aufirst%3DM.%26aulast%3DKnuth%26aufirst%3DM.%2BW.%26aulast%3DSwanson%26aufirst%3DR.%2BV.%26aulast%3DMcRee%26aufirst%3DD.%2BE.%26aulast%3DTari%26aufirst%3DL.%2BW.%26atitle%3DStructural%2520Snapshots%2520of%2520Human%2520HDAC8%2520Provide%2520Insights%2520into%2520the%2520Class%2520I%2520Histone%2520Deacetylases%26jtitle%3DStructure%26date%3D2004%26volume%3D12%26spage%3D1325%26epage%3D1334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Beckers, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkhardt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wieland, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gimmnich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciossek, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, K.</span><span> </span><span class="NLM_article-title">Distinct pharmacological properties of 2nd generation HDAC inhibitors with the benzamide or hydroxamate head group</span> <span class="citation_source-journal">Int. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">1138</span><span class="NLM_x">–</span> <span class="NLM_lpage">1148</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1002%2Fijc.22751" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=17455259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFGhu7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2007&pages=1138-1148&author=T.+Beckersauthor=C.+Burkhardtauthor=H.+Wielandauthor=P.+Gimmnichauthor=T.+Ciossekauthor=T.+Maierauthor=K.+Sanders&title=Distinct+pharmacological+properties+of+2nd+generation+HDAC+inhibitors+with+the+benzamide+or+hydroxamate+head+group"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Distinct pharmacological properties of second generation HDAC inhibitors with the benzamide or hydroxamate head group</span></div><div class="casAuthors">Beckers, Thomas; Burkhardt, Carmen; Wieland, Heike; Gimmnich, Petra; Ciossek, Thomas; Maier, Thomas; Sanders, Karl</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1138-1148</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Advanced second generation inhibitors of histone deacetylases (HDAC) are currently used in clin. development.  This study aimed at comparing the pharmacol. properties of selected second generation HDAC inhibitors with the hydroxamate and benzamide head group, namely SAHA, LAQ824/LBH589, CI994, MS275 and MGCD0103.  In biochem. assays using recombinant HDAC1, 3, 6 and 8 isoenzymes, SAHA and LAQ824/LBH589 behave as quite unselective HDAC inhibitors.  In contrast, the benzamides CI994, MS275 and MGCD0103 are more selective, potent inhibitors of at least HDAC1 and HDAC3.  All HDAC inhibitors induce histone H3 hyperacetylation, correlating with inhibition of proliferation, induction of cell differentiation and apoptosis.  A broad cytotoxicity is seen across cell lines from different tumor entities with LAQ824/LBH589 being the most potent agents.  The apoptosis inducing activity is evident in arrested and proliferating RKO colon cancer cells with inducible, heterologous p21waf1 expression, indicative for a cell-cycle independent mode-of-action.  Differentiation of MDA-MB468 breast cancer cells is induced by benzamide and hydroxamate analogs.  The reversibility of drug action was evaluated by pulse treatment of A549 lung cancer cells.  Whereas paclitaxel induced irreversible cell cycle alterations already after 6 h treatment, HDAC inhibitor action was retarded and irreversible after >16 h treatment.  Interestingly, pulse treatment was equally effective as continous treatment.  Finally, the efficacy of LAQ824, SAHA and MS275 in A549 nude mice xenografts was comparable to that of paclitaxel at well tolerated doses.  We conclude that despite a different HDAC isoenzyme inhibition profile, hydroxamate and benzamide analogs as studied display similar cellular profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiDHz24Jk1RLVg90H21EOLACvtfcHk0lgwFtyiz-6NgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFGhu7nN&md5=b022385076ee75290c2b6f8d3cdf4bbe</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Fijc.22751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.22751%26sid%3Dliteratum%253Aachs%26aulast%3DBeckers%26aufirst%3DT.%26aulast%3DBurkhardt%26aufirst%3DC.%26aulast%3DWieland%26aufirst%3DH.%26aulast%3DGimmnich%26aufirst%3DP.%26aulast%3DCiossek%26aufirst%3DT.%26aulast%3DMaier%26aufirst%3DT.%26aulast%3DSanders%26aufirst%3DK.%26atitle%3DDistinct%2520pharmacological%2520properties%2520of%25202nd%2520generation%2520HDAC%2520inhibitors%2520with%2520the%2520benzamide%2520or%2520hydroxamate%2520head%2520group%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D2007%26volume%3D121%26spage%3D1138%26epage%3D1148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Haggarty, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeller, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grozinger, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, S. L.</span><span> </span><span class="NLM_article-title">Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">4389</span><span class="NLM_x">–</span> <span class="NLM_lpage">4394</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1073%2Fpnas.0430973100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=12677000" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjt12gtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=4389-4394&author=S.+J.+Haggartyauthor=K.+M.+Koellerauthor=J.+C.+Wongauthor=C.+M.+Grozingerauthor=S.+L.+Schreiber&title=Domain-selective+small-molecule+inhibitor+of+histone+deacetylase+6+%28HDAC6%29-mediated+tubulin+deacetylation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation</span></div><div class="casAuthors">Haggarty, Stephen J.; Koeller, Kathryn M.; Wong, Jason C.; Grozinger, Christina M.; Schreiber, Stuart L.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4389-4394</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Protein acetylation, esp. histone acetylation, is the subject of both research and clin. investigation.  At least four small-mol. histone deacetylase inhibitors are currently in clin. trials for the treatment of cancer.  These and other inhibitors also affect microtubule acetylation.  A multidimensional, chem. genetic screen of 7392 small mols. was used to discover "tubacin," which inhibits α-tubulin deacetylation in mammalian cells.  Tubacin does not affect the level of histone acetylation, gene-expression patterns, or cell-cycle progression.  We provide evidence that class II histone deacetylase 6 (HDAC6) is the intracellular target of tubacin.  Only one of the two catalytic domains of HDAC6 possesses tubulin deacetylase activity, and only this domain is bound by tubacin.  Tubacin treatment did not affect the stability of microtubules but did decrease cell motility.  HDAC6 overexpression disrupted the localization of p58, a protein that mediates binding of Golgi elements to microtubules.  Our results highlight the role of α-tubulin acetylation in mediating the localization of microtubule-assocd. proteins.  They also suggest that small mols. that selectively inhibit HDAC6-mediated α-tubulin deacetylation, a first example of which is tubacin, might have therapeutic applications as antimetastatic and antiangiogenic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbQBWjEZr47rVg90H21EOLACvtfcHk0lgwFtyiz-6NgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjt12gtL0%253D&md5=260da1ede64782ddbddda31b740b9782</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0430973100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0430973100%26sid%3Dliteratum%253Aachs%26aulast%3DHaggarty%26aufirst%3DS.%2BJ.%26aulast%3DKoeller%26aufirst%3DK.%2BM.%26aulast%3DWong%26aufirst%3DJ.%2BC.%26aulast%3DGrozinger%26aufirst%3DC.%2BM.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26atitle%3DDomain-selective%2520small-molecule%2520inhibitor%2520of%2520histone%2520deacetylase%25206%2520%2528HDAC6%2529-mediated%2520tubulin%2520deacetylation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2003%26volume%3D100%26spage%3D4389%26epage%3D4394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Hodawadekar, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marmorstein, R.</span><span> </span><span class="NLM_article-title">Chemistry of acetyl transfer by histone modifying enzymes: structure, mechanismand implications for effector design</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">5528</span><span class="NLM_x">–</span> <span class="NLM_lpage">5540</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2007&pages=5528-5540&author=S.+C.+Hodawadekarauthor=R.+Marmorstein&title=Chemistry+of+acetyl+transfer+by+histone+modifying+enzymes%3A+structure%2C+mechanismand+implications+for+effector+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHodawadekar%26aufirst%3DS.%2BC.%26aulast%3DMarmorstein%26aufirst%3DR.%26atitle%3DChemistry%2520of%2520acetyl%2520transfer%2520by%2520histone%2520modifying%2520enzymes%253A%2520structure%252C%2520mechanismand%2520implications%2520for%2520effector%2520design%26jtitle%3DOncogene%26date%3D2007%26volume%3D26%26spage%3D5528%26epage%3D5540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Rational Design of Non-Hydroxamate Histone Deacetylase Inhibitors</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">515</span><span class="NLM_x">–</span> <span class="NLM_lpage">526</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=515-526&author=T.+Suzukiauthor=N.+Miyata&title=Rational+Design+of+Non-Hydroxamate+Histone+Deacetylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DRational%2520Design%2520of%2520Non-Hydroxamate%2520Histone%2520Deacetylase%2520Inhibitors%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2006%26volume%3D6%26spage%3D515%26epage%3D526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Non-hydroxamate Histone Deacetylase Inhibitors</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2867</span><span class="NLM_x">–</span> <span class="NLM_lpage">2880</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.2174%2F092986705774454706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=16305476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1ShsrvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=2867-2880&author=T.+Suzukiauthor=N.+Miyata&title=Non-hydroxamate+Histone+Deacetylase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">Non-hydroxamate histone deacetylase inhibitors</span></div><div class="casAuthors">Suzuki, Takayoshi; Miyata, Naoki</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2867-2880</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  A no. of histone deacetylase (HDAC) inhibitors have been developed as anticancer agents and most of them are hydroxamic acid derivs., typified by suberoylanilide hydroxamic acid (SAHA), Trichostatin A (TSA) and NVP-LAQ824.  However, hydroxamic acids have been assocd. with poor pharmacokinetics and severe toxicity.  In addn., although isoenzyme-selective HDAC inhibitors are considered useful not only as tools for probing the biol. of an enzyme but as drugs with low toxicity, many of the hydroxamate HDAC inhibitors do not distinguish well among the HDAC isoenzymes.  Thus, there has been considerable interest in developing non-hydroxamate HDAC inhibitors.  To date, small fatty acids, o-aminoanilides, electrophilic ketones, N-formyl hydroxylamines, thiols and mercaptoamides have been reported as non-hydroxamate HDAC inhibitors, and some of them show antiproliferative activity comparable to hydroxamates.  Interestingly, hydroxamate HDAC inhibitors such as SAHA and TSA do not discriminate well among the HDAC isoenzymes whereas many non-hydroxamate HDAC inhibitors have shown selectivity.  These non-hydroxamate HDAC inhibitors should pave the way for the development of tools for biol. research and new medicines with few side effects.  In this review, we introduce non-hydroxamate HDAC inhibitors describing their design, enzyme inhibition, cancer cell growth inhibition and isoenzyme selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWm6vIRhSCELVg90H21EOLACvtfcHk0liEAi2LUd79DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1ShsrvK&md5=e36fdb1fdccf41ce542b10687b890218</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.2174%2F092986705774454706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986705774454706%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DNon-hydroxamate%2520Histone%2520Deacetylase%2520Inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2005%26volume%3D12%26spage%3D2867%26epage%3D2880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18a"><span><span class="NLM_label">(a) </span><div class="note"><p class="first last">For recent studies on hydroxamtes and benzamides, see for instance</p></div><span class="NLM_contrib-group">Anandan, S.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brokx, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bray, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, X.-Y.</span><span> </span><span class="NLM_article-title">Design and synthesis of thiazole-5-hydroxamic acids as novel histone deacetylase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">5995</span><span class="NLM_x">–</span> <span class="NLM_lpage">5999</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=5995-5999&author=S.-K.+Anandanauthor=J.+S.+Wardauthor=R.+D.+Brokxauthor=T.+Dennyauthor=M.+R.+Brayauthor=D.+V.+Patelauthor=X.-Y.+Xiao&title=Design+and+synthesis+of+thiazole-5-hydroxamic+acids+as+novel+histone+deacetylase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnandan%26aufirst%3DS.-K.%26aulast%3DWard%26aufirst%3DJ.%2BS.%26aulast%3DBrokx%26aufirst%3DR.%2BD.%26aulast%3DDenny%26aufirst%3DT.%26aulast%3DBray%26aufirst%3DM.%2BR.%26aulast%3DPatel%26aufirst%3DD.%2BV.%26aulast%3DXiao%26aufirst%3DX.-Y.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520thiazole-5-hydroxamic%2520acids%2520as%2520novel%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D5995%26epage%3D5999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Moradei, O. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallais, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frechette, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paquin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tessier, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leit, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fournel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonfils, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trachy-Bourget, M.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahil, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wand, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lefebvre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaisburg, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bestermann, J. M.</span><span> </span><span class="NLM_article-title">Novel Aminophenyl Benzamide-Type Histone Deacetylase Inhibitors with Enhanced Potency and Selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5543</span><span class="NLM_x">–</span> <span class="NLM_lpage">5546</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701079h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFKksLrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5543-5546&author=O.+M.+Moradeiauthor=T.+C.+Mallaisauthor=S.+Frechetteauthor=I.+Paquinauthor=P.+E.+Tessierauthor=S.+M.+Leitauthor=M.+Fournelauthor=C.+Bonfilsauthor=M.-C.+Trachy-Bourgetauthor=J.+Liuauthor=T.+P.+Yanauthor=A.+H.+Luauthor=J.+Rahilauthor=J.+Wandauthor=S.+Lefebvreauthor=Z.+Liauthor=A.+F.+Vaisburgauthor=J.+M.+Bestermann&title=Novel+Aminophenyl+Benzamide-Type+Histone+Deacetylase+Inhibitors+with+Enhanced+Potency+and+Selectivity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Aminophenyl Benzamide-Type Histone Deacetylase Inhibitors with Enhanced Potency and Selectivity</span></div><div class="casAuthors">Moradei, Oscar M.; Mallais, Tammy C.; Frechette, Sylvie; Paquin, Isabelle; Tessier, Pierre E.; Leit, Silvana M.; Fournel, Marielle; Bonfils, Claire; Trachy-Bourget, Marie-Claude; Liu, Jianhong; Yan, Theresa P.; Lu, Ai-Hua; Rahil, Jubrail; Wang, James; Lefebvre, Sylvain; Li, Zuomei; Vaisburg, Arkadii F.; Besterman, Jeffrey M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5543-5546</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Significant effort is being made to understand the role of HDAC isotypes in human cancer and to develop antitumor agents with better therapeutic windows.  A part of this endeavor was the exploration of the 14 Å internal cavity adjacent to the enzyme catalytic site, which led to the design and synthesis of compd. 4 (I) with the unusual bis(aryl)-type pharmacophore.  SAR studies around this lead resulted in optimization to potent, selective, nonhydroxamic acid HDAC inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlM848KF3mo7Vg90H21EOLACvtfcHk0liEAi2LUd79DQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFKksLrL&md5=17012416f4be84479762acac0cff5e6f</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1021%2Fjm701079h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701079h%26sid%3Dliteratum%253Aachs%26aulast%3DMoradei%26aufirst%3DO.%2BM.%26aulast%3DMallais%26aufirst%3DT.%2BC.%26aulast%3DFrechette%26aufirst%3DS.%26aulast%3DPaquin%26aufirst%3DI.%26aulast%3DTessier%26aufirst%3DP.%2BE.%26aulast%3DLeit%26aufirst%3DS.%2BM.%26aulast%3DFournel%26aufirst%3DM.%26aulast%3DBonfils%26aufirst%3DC.%26aulast%3DTrachy-Bourget%26aufirst%3DM.-C.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DT.%2BP.%26aulast%3DLu%26aufirst%3DA.%2BH.%26aulast%3DRahil%26aufirst%3DJ.%26aulast%3DWand%26aufirst%3DJ.%26aulast%3DLefebvre%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DVaisburg%26aufirst%3DA.%2BF.%26aulast%3DBestermann%26aufirst%3DJ.%2BM.%26atitle%3DNovel%2520Aminophenyl%2520Benzamide-Type%2520Histone%2520Deacetylase%2520Inhibitors%2520with%2520Enhanced%2520Potency%2520and%2520Selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5543%26epage%3D5546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hamblett, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Methot, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mampreian, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloman, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kral, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleming, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruz, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chenard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozerova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitz, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nazef, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harsch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dahlberg, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szewczak, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Secrist, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, T. A.</span><span> </span><span class="NLM_article-title">The discovery of 6-amino nicotinamides as potent and selective histone deacetylase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">5300</span><span class="NLM_x">–</span> <span class="NLM_lpage">5309</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=5300-5309&author=C.+L.+Hamblettauthor=J.+L.+Methotauthor=D.+M.+Mampreianauthor=D.+L.+Slomanauthor=M.+G.+Stantonauthor=A.+M.+Kralauthor=J.+C.+Flemingauthor=J.+C.+Cruzauthor=M.+Chenardauthor=N.+Ozerovaauthor=A.+M.+Hitzauthor=H.+Wangauthor=S.+V.+Deshmukhauthor=N.+Nazefauthor=A.+Harschauthor=B.+Hughesauthor=W.+K.+Dahlbergauthor=A.+A.+Szewczakauthor=R.+E.+Middletonauthor=R.+T.+Mosleyauthor=J.+P.+Secristauthor=T.+A.+Miller&title=The+discovery+of+6-amino+nicotinamides+as+potent+and+selective+histone+deacetylase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHamblett%26aufirst%3DC.%2BL.%26aulast%3DMethot%26aufirst%3DJ.%2BL.%26aulast%3DMampreian%26aufirst%3DD.%2BM.%26aulast%3DSloman%26aufirst%3DD.%2BL.%26aulast%3DStanton%26aufirst%3DM.%2BG.%26aulast%3DKral%26aufirst%3DA.%2BM.%26aulast%3DFleming%26aufirst%3DJ.%2BC.%26aulast%3DCruz%26aufirst%3DJ.%2BC.%26aulast%3DChenard%26aufirst%3DM.%26aulast%3DOzerova%26aufirst%3DN.%26aulast%3DHitz%26aufirst%3DA.%2BM.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DDeshmukh%26aufirst%3DS.%2BV.%26aulast%3DNazef%26aufirst%3DN.%26aulast%3DHarsch%26aufirst%3DA.%26aulast%3DHughes%26aufirst%3DB.%26aulast%3DDahlberg%26aufirst%3DW.%2BK.%26aulast%3DSzewczak%26aufirst%3DA.%2BA.%26aulast%3DMiddleton%26aufirst%3DR.%2BE.%26aulast%3DMosley%26aufirst%3DR.%2BT.%26aulast%3DSecrist%26aufirst%3DJ.%2BP.%26aulast%3DMiller%26aufirst%3DT.%2BA.%26atitle%3DThe%2520discovery%2520of%25206-amino%2520nicotinamides%2520as%2520potent%2520and%2520selective%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D5300%26epage%3D5309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouketsu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ninomiya, S.-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Thiol-based SAHA analogues as potent histone deacetylase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3313</span><span class="NLM_x">–</span> <span class="NLM_lpage">3317</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3313-3317&author=T.+Suzukiauthor=A.+Kouketsuauthor=A.+Matsuuraauthor=A.+Koharaauthor=S.-i.+Ninomiyaauthor=K.+Kohdaauthor=N.+Miyata&title=Thiol-based+SAHA+analogues+as+potent+histone+deacetylase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DKouketsu%26aufirst%3DA.%26aulast%3DMatsuura%26aufirst%3DA.%26aulast%3DKohara%26aufirst%3DA.%26aulast%3DNinomiya%26aufirst%3DS.-i.%26aulast%3DKohda%26aufirst%3DK.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DThiol-based%2520SAHA%2520analogues%2520as%2520potent%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3313%26epage%3D3317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Nishino, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jose, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebisusaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sumida, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, M.</span><span> </span><span class="NLM_article-title">Cyclic Tetrapeptides Bearing a Sulfhydryl Group Potently Inhibit Histone Deacetylases</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">5079</span><span class="NLM_x">–</span> <span class="NLM_lpage">5082</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol036098e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=5079-5082&author=N.+Nishinoauthor=B.+Joseauthor=S.+Okamuraauthor=S.+Ebisusakiauthor=T.+Katoauthor=Y.+Sumidaauthor=M.+Yoshida&title=Cyclic+Tetrapeptides+Bearing+a+Sulfhydryl+Group+Potently+Inhibit+Histone+Deacetylases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1021%2Fol036098e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol036098e%26sid%3Dliteratum%253Aachs%26aulast%3DNishino%26aufirst%3DN.%26aulast%3DJose%26aufirst%3DB.%26aulast%3DOkamura%26aufirst%3DS.%26aulast%3DEbisusaki%26aufirst%3DS.%26aulast%3DKato%26aufirst%3DT.%26aulast%3DSumida%26aufirst%3DY.%26aulast%3DYoshida%26aufirst%3DM.%26atitle%3DCyclic%2520Tetrapeptides%2520Bearing%2520a%2520Sulfhydryl%2520Group%2520Potently%2520Inhibit%2520Histone%2520Deacetylases%26jtitle%3DOrg.%2520Lett.%26date%3D2003%26volume%3D5%26spage%3D5079%26epage%3D5082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouketsu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Design, Synthesis, Structure−Selectivity Relationship, and Effect on Human Cancer Cells of a Novel Series of Histone Deacetylase 6-Selective Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5425</span><span class="NLM_x">–</span> <span class="NLM_lpage">5438</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm7009217" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5425-5438&author=Y.+Itohauthor=T.+Suzukiauthor=A.+Kouketsuauthor=N.+Suzukiauthor=S.+Maedaauthor=M.+Yoshidaauthor=H.+Nakagawaauthor=N.+Miyata&title=Design%2C+Synthesis%2C+Structure%E2%88%92Selectivity+Relationship%2C+and+Effect+on+Human+Cancer+Cells+of+a+Novel+Series+of+Histone+Deacetylase+6-Selective+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=10.1021%2Fjm7009217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm7009217%26sid%3Dliteratum%253Aachs%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DKouketsu%26aufirst%3DA.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DMaeda%26aufirst%3DS.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DDesign%252C%2520Synthesis%252C%2520Structure%25E2%2588%2592Selectivity%2520Relationship%252C%2520and%2520Effect%2520on%2520Human%2520Cancer%2520Cells%2520of%2520a%2520Novel%2520Series%2520of%2520Histone%2520Deacetylase%25206-Selective%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5425%26epage%3D5438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouketsu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurotaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Novel Inhibitors of Human Histone Deacetylases: Design, Synthesis, Enzyme Inhibition, and Cancer Cell Growth Inhibition of SAHA-Based Non-hydroxamates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1019</span><span class="NLM_x">–</span> <span class="NLM_lpage">1032</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049207j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1019-1032&author=T.+Suzukiauthor=Y.+Naganoauthor=A.+Kouketsuauthor=A.+Matsuuraauthor=S.+Maruyamaauthor=M.+Kurotakiauthor=H.+Nakagawaauthor=N.+Miyata&title=Novel+Inhibitors+of+Human+Histone+Deacetylases%3A+Design%2C+Synthesis%2C+Enzyme+Inhibition%2C+and+Cancer+Cell+Growth+Inhibition+of+SAHA-Based+Non-hydroxamates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm049207j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049207j%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DNagano%26aufirst%3DY.%26aulast%3DKouketsu%26aufirst%3DA.%26aulast%3DMatsuura%26aufirst%3DA.%26aulast%3DMaruyama%26aufirst%3DS.%26aulast%3DKurotaki%26aufirst%3DM.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DNovel%2520Inhibitors%2520of%2520Human%2520Histone%2520Deacetylases%253A%2520Design%252C%2520Synthesis%252C%2520Enzyme%2520Inhibition%252C%2520and%2520Cancer%2520Cell%2520Growth%2520Inhibition%2520of%2520SAHA-Based%2520Non-hydroxamates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1019%26epage%3D1032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Furumai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuyama, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, K-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishiyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komatsu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishino, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horinouchi, S.</span><span> </span><span class="NLM_article-title">FK228 (Depsipeptide) as a Natural Prodrug That Inhibits Class I Histone Deacetylases</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">4916</span><span class="NLM_x">–</span> <span class="NLM_lpage">4921</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=12208741" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD38Xmslylu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=4916-4921&author=R.+Furumaiauthor=A.+Matsuyamaauthor=N.+Kobashiauthor=K-H.+Leeauthor=M.+Nishiyamaauthor=H.+Nakajimaauthor=A.+Tanakaauthor=Y.+Komatsuauthor=N.+Nishinoauthor=M.+Yoshidaauthor=S.+Horinouchi&title=FK228+%28Depsipeptide%29+as+a+Natural+Prodrug+That+Inhibits+Class+I+Histone+Deacetylases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases</span></div><div class="casAuthors">Furumai, Ryohei; Matsuyama, Akihisa; Kobashi, Nobuyuki; Lee, Kun-Hyung; Nishiyama, Makoto; Nakajima, Hidenori; Tanaka, Akito; Komatsu, Yasuhiko; Nishino, Norikazu; Yoshida, Minoru; Horinouchi, Sueharu</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4916-4921</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">FK228 is a histone deacetylase (HDAC) inhibitor, the mol. mechanism of inhibition of which has been unknown.  Here we show that redn. of an intramol. disulfide bond of FK228 greatly enhanced its inhibitory activity and that the disulfide bond was rapidly reduced in cells by cellular reducing activity involving glutathione.  Computer modeling suggests that one of the sulfhydryl groups of the reduced form of FK228 (redFK) interacts with the active-site zinc, preventing the access of the substrate.  HDAC1 and HDAC2 were more strongly inhibited by redFK than HDAC4 and HDAC6.  RedFK was less active than FK228 in inhibiting in vivo HDAC activity, due to rapid inactivation in medium and serum.  Thus, FK228 serves as a stable prodrug to inhibit class I enzymes and is activated by redn. after uptake into the cells.  The glutathione-mediated activation also implicates its clin. usefulness for counteracting glutathione-mediated drug resistance in chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohcl-TJJMBcbVg90H21EOLACvtfcHk0li8yqbiEa-NvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xmslylu78%253D&md5=691ed84f8a35b1664b4bab770d69a194</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFurumai%26aufirst%3DR.%26aulast%3DMatsuyama%26aufirst%3DA.%26aulast%3DKobashi%26aufirst%3DN.%26aulast%3DLee%26aufirst%3DK-H.%26aulast%3DNishiyama%26aufirst%3DM.%26aulast%3DNakajima%26aufirst%3DH.%26aulast%3DTanaka%26aufirst%3DA.%26aulast%3DKomatsu%26aufirst%3DY.%26aulast%3DNishino%26aufirst%3DN.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DHorinouchi%26aufirst%3DS.%26atitle%3DFK228%2520%2528Depsipeptide%2529%2520as%2520a%2520Natural%2520Prodrug%2520That%2520Inhibits%2520Class%2520I%2520Histone%2520Deacetylases%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D62%26spage%3D4916%26epage%3D4921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yurek-George, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cecil, A. R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mo, A. H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shijun, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habens, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Packham, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganesan, A.</span><span> </span><span class="NLM_article-title">The First Biologically Active Synthetic Analogues of FK228, the Depsipeptide Histone Deacetylase Inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5720</span><span class="NLM_x">–</span> <span class="NLM_lpage">5726</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0703800" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1WmtL7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5720-5726&author=A.+Yurek-Georgeauthor=A.+R.+L.+Cecilauthor=A.+H.+K.+Moauthor=W.+Shijunauthor=H.+Rogersauthor=F.+Habensauthor=S.+Maedaauthor=M.+Yoshidaauthor=G.+Packhamauthor=A.+Ganesan&title=The+First+Biologically+Active+Synthetic+Analogues+of+FK228%2C+the+Depsipeptide+Histone+Deacetylase+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">The First Biologically Active Synthetic Analogues of FK228, the Depsipeptide Histone Deacetylase Inhibitor</span></div><div class="casAuthors">Yurek-George, Alexander; Cecil, Alexander Richard Liam; Mo, Alex Hon Kit; Wen, Shijun; Rogers, Helen; Habens, Fay; Maeda, Satoko; Yoshida, Minoru; Packham, Graham; Ganesan, A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5720-5726</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Macrocyclic peptide lactone analogs of the histone deacetylase (HDAC) inhibitor FK228 such as I (R = Me, Me2CH) are prepd.; their inhibition of human breast cancer cell line and of HDAC 1 and 6 is detd.  The dehydrobutyrine residue in FK228 is not essential and can be replaced by other residues such as D-valine without loss of HDAC inhibition.  Conformational restriction by the macrocyclic scaffold is important for HDAC inhibition; a linear peptide analog inhibits neither HDAC1 or HDAC6 and does not inhibit breast cancer cells.  The bridging disulfide of FK228 can be removed and one of its component cysteines replaced with an alanine residue with little or no loss in HDAC inhibition if the resultant thiol is protected (for example with an acetyl group).  The FK228 analogs are less effective at inhibiting HDAC6 (a class II HDAC) than HDAC1 (a class I HDAC).  The structure of I (R = Me) is detd. by X-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLSbpJiC7igbVg90H21EOLACvtfcHk0li8yqbiEa-NvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1WmtL7M&md5=7c44919259524c0d825e373c8466e536</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1021%2Fjm0703800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0703800%26sid%3Dliteratum%253Aachs%26aulast%3DYurek-George%26aufirst%3DA.%26aulast%3DCecil%26aufirst%3DA.%2BR.%2BL.%26aulast%3DMo%26aufirst%3DA.%2BH.%2BK.%26aulast%3DShijun%26aufirst%3DW.%26aulast%3DRogers%26aufirst%3DH.%26aulast%3DHabens%26aufirst%3DF.%26aulast%3DMaeda%26aufirst%3DS.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DPackham%26aufirst%3DG.%26aulast%3DGanesan%26aufirst%3DA.%26atitle%3DThe%2520First%2520Biologically%2520Active%2520Synthetic%2520Analogues%2520of%2520FK228%252C%2520the%2520Depsipeptide%2520Histone%2520Deacetylase%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5720%26epage%3D5726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Shivashimpi, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amagai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishino, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishino, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, M.</span><span> </span><span class="NLM_article-title">Molecular design of histone deacetylase inhibitors by aromatic ring shifting in chlamydocin framework</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">7830</span><span class="NLM_x">–</span> <span class="NLM_lpage">7839</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=7830-7839&author=G.+M.+Shivashimpiauthor=S.+Amagaiauthor=T.+Katoauthor=N.+Nishinoauthor=S.+Maedaauthor=T.+G.+Nishinoauthor=M.+Yoshida&title=Molecular+design+of+histone+deacetylase+inhibitors+by+aromatic+ring+shifting+in+chlamydocin+framework"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShivashimpi%26aufirst%3DG.%2BM.%26aulast%3DAmagai%26aufirst%3DS.%26aulast%3DKato%26aufirst%3DT.%26aulast%3DNishino%26aufirst%3DN.%26aulast%3DMaeda%26aufirst%3DS.%26aulast%3DNishino%26aufirst%3DT.%2BG.%26aulast%3DYoshida%26aufirst%3DM.%26atitle%3DMolecular%2520design%2520of%2520histone%2520deacetylase%2520inhibitors%2520by%2520aromatic%2520ring%2520shifting%2520in%2520chlamydocin%2520framework%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2007%26volume%3D15%26spage%3D7830%26epage%3D7839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hisakawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurotaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Identification of a potent and stable antiproliferative agent by the prodrug formation of a thiolate histone deacetylase inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1558</span><span class="NLM_x">–</span> <span class="NLM_lpage">1561</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1558-1561&author=T.+Suzukiauthor=S.+Hisakawaauthor=Y.+Itohauthor=S.+Maruyamaauthor=M.+Kurotakiauthor=H.+Nakagawaauthor=N.+Miyata&title=Identification+of+a+potent+and+stable+antiproliferative+agent+by+the+prodrug+formation+of+a+thiolate+histone+deacetylase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DHisakawa%26aufirst%3DS.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DMaruyama%26aufirst%3DS.%26aulast%3DKurotaki%26aufirst%3DM.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DIdentification%2520of%2520a%2520potent%2520and%2520stable%2520antiproliferative%2520agent%2520by%2520the%2520prodrug%2520formation%2520of%2520a%2520thiolate%2520histone%2520deacetylase%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1558%26epage%3D1561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouketsu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hisakawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Highly Potent and Selective Histone Deacetylase 6 Inhibitors Designed Based on a Small-Molecular Substrate</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4809</span><span class="NLM_x">–</span> <span class="NLM_lpage">4812</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060554y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4809-4812&author=T.+Suzukiauthor=A.+Kouketsuauthor=Y.+Itohauthor=S.+Hisakawaauthor=S.+Maedaauthor=M.+Yoshidaauthor=H.+Nakagawaauthor=N.+Miyata&title=Highly+Potent+and+Selective+Histone+Deacetylase+6+Inhibitors+Designed+Based+on+a+Small-Molecular+Substrate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=10.1021%2Fjm060554y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060554y%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DKouketsu%26aufirst%3DA.%26aulast%3DItoh%26aufirst%3DY.%26aulast%3DHisakawa%26aufirst%3DS.%26aulast%3DMaeda%26aufirst%3DS.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DHighly%2520Potent%2520and%2520Selective%2520Histone%2520Deacetylase%25206%2520Inhibitors%2520Designed%2520Based%2520on%2520a%2520Small-Molecular%2520Substrate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4809%26epage%3D4812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Anandan, S.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brokx, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bray, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, X.-X.</span><span> </span><span class="NLM_article-title">Mercaptoamide-based non-hydroxamic acid type histone deacetylase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1969</span><span class="NLM_x">–</span> <span class="NLM_lpage">1972</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1969-1972&author=S.-K.+Anandanauthor=J.+S.+Wardauthor=R.+D.+Brokxauthor=M.+R.+Brayauthor=D.+V.+Patelauthor=X.-X.+Xiao&title=Mercaptoamide-based+non-hydroxamic+acid+type+histone+deacetylase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnandan%26aufirst%3DS.-K.%26aulast%3DWard%26aufirst%3DJ.%2BS.%26aulast%3DBrokx%26aufirst%3DR.%2BD.%26aulast%3DBray%26aufirst%3DM.%2BR.%26aulast%3DPatel%26aufirst%3DD.%2BV.%26aulast%3DXiao%26aufirst%3DX.-X.%26atitle%3DMercaptoamide-based%2520non-hydroxamic%2520acid%2520type%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1969%26epage%3D1972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petukhov, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velena, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eliseeva, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dritschilo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span> </span><span class="NLM_article-title">Chemistry and biology of mercaptoacetamides as novel histone deacetylase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1389</span><span class="NLM_x">–</span> <span class="NLM_lpage">1392</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=1389-1392&author=B.+Chenauthor=P.+A.+Petukhovauthor=M.+Jungauthor=A.+Velenaauthor=E.+Eliseevaauthor=A.+Dritschiloauthor=A.+P.+Kozikowski&title=Chemistry+and+biology+of+mercaptoacetamides+as+novel+histone+deacetylase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DB.%26aulast%3DPetukhov%26aufirst%3DP.%2BA.%26aulast%3DJung%26aufirst%3DM.%26aulast%3DVelena%26aufirst%3DA.%26aulast%3DEliseeva%26aufirst%3DE.%26aulast%3DDritschilo%26aufirst%3DA.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DChemistry%2520and%2520biology%2520of%2520mercaptoacetamides%2520as%2520novel%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D1389%26epage%3D1392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuura, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kouketsu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakagawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyata, N.</span><span> </span><span class="NLM_article-title">Identification of a potent non-hydroxamate histone deacetylase inhibitor by mechanism-based drug design</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">–</span> <span class="NLM_lpage">335</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=331-335&author=T.+Suzukiauthor=A.+Matsuuraauthor=A.+Kouketsuauthor=H.+Nakagawaauthor=N.+Miyata&title=Identification+of+a+potent+non-hydroxamate+histone+deacetylase+inhibitor+by+mechanism-based+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DMatsuura%26aufirst%3DA.%26aulast%3DKouketsu%26aufirst%3DA.%26aulast%3DNakagawa%26aufirst%3DH.%26aulast%3DMiyata%26aufirst%3DN.%26atitle%3DIdentification%2520of%2520a%2520potent%2520non-hydroxamate%2520histone%2520deacetylase%2520inhibitor%2520by%2520mechanism-based%2520drug%2520design%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D331%26epage%3D335" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Gu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nusinzon, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. D.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horvarth, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silverman, R. B.</span><span> </span><span class="NLM_article-title">Carbonyl- and sulfur-containing analogs of suberoylanilide hydroxamic acid: Potent inhibition of histone deacetylases</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3320</span><span class="NLM_x">–</span> <span class="NLM_lpage">3329</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=3320-3329&author=W.+Guauthor=I.+Nusinzonauthor=R.+D.+Smithauthor=C.+M.+Horvarthauthor=R.+B.+Silverman&title=Carbonyl-+and+sulfur-containing+analogs+of+suberoylanilide+hydroxamic+acid%3A+Potent+inhibition+of+histone+deacetylases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGu%26aufirst%3DW.%26aulast%3DNusinzon%26aufirst%3DI.%26aulast%3DSmith%26aufirst%3DR.%2BD.%26aulast%3DHorvarth%26aufirst%3DC.%2BM.%26aulast%3DSilverman%26aufirst%3DR.%2BB.%26atitle%3DCarbonyl-%2520and%2520sulfur-containing%2520analogs%2520of%2520suberoylanilide%2520hydroxamic%2520acid%253A%2520Potent%2520inhibition%2520of%2520histone%2520deacetylases%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D3320%26epage%3D3329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Dehmel, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciossek, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinbrenner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zoche, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckers, T.</span><span> </span><span class="NLM_article-title">Trithiocarbonates—Exploration of a new head group for HDAC inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4746</span><span class="NLM_x">–</span> <span class="NLM_lpage">4752</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=4746-4752&author=F.+Dehmelauthor=T.+Ciossekauthor=T.+Maierauthor=S.+Weinbrennerauthor=B.+Schmidtauthor=M.+Zocheauthor=T.+Beckers&title=Trithiocarbonates%E2%80%94Exploration+of+a+new+head+group+for+HDAC+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDehmel%26aufirst%3DF.%26aulast%3DCiossek%26aufirst%3DT.%26aulast%3DMaier%26aufirst%3DT.%26aulast%3DWeinbrenner%26aufirst%3DS.%26aulast%3DSchmidt%26aufirst%3DB.%26aulast%3DZoche%26aufirst%3DM.%26aulast%3DBeckers%26aufirst%3DT.%26atitle%3DTrithiocarbonates%25E2%2580%2594Exploration%2520of%2520a%2520new%2520head%2520group%2520for%2520HDAC%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D4746%26epage%3D4752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Ciossek, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Julius, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wieland, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckers, T.</span><span> </span><span class="NLM_article-title">A homogeneous cellular histone deacetylase assay suitable for compound profiling and robotic screening</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">372</span><span class="NLM_x">, </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">81</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1016%2Fj.ab.2007.07.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=17868634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlajsbbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=372&publication_year=2008&pages=72-81&author=T.+Ciossekauthor=H.+Juliusauthor=H.+Wielandauthor=T.+Maierauthor=T.+Beckers&title=A+homogeneous+cellular+histone+deacetylase+assay+suitable+for+compound+profiling+and+robotic+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A homogeneous cellular histone deacetylase assay suitable for compound profiling and robotic screening</span></div><div class="casAuthors">Ciossek, Thomas; Julius, Heiko; Wieland, Heike; Maier, Thomas; Beckers, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">372</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">72-81</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Most cellular assays that quantify the efficacy of histone deacetylase (HDAC) inhibitors measure hyperacetylation of core histone proteins H3 and H4.  Here we describe a new approach, directly measuring cellular HDAC enzymic activity using the substrate Boc-K(Ac)-7-amino-4-methylcoumarin (AMC).  After penetration into HeLa cervical carcinoma or K562 chronic myeloid leukemia cells, the deacetylated product Boc-K-AMC is formed which, after cell lysis, is cleaved by trypsin, finally releasing the fluorophor AMC.  The cellular potency of suberoylanilide hydroxamic acid, LBH589, trichostatin A, and MS275 as well-known HDAC inhibitors was detd. using this assay.  IC50 values derived from concn.-effect curves correlated well with EC50 values derived from a cellomics array scan histone H3 hyperacetylation assay.  The cellular HDAC activity assay was adapted to a homogeneous format, fully compatible with robotic screening.  Concn.-effect curves generated on a Tecan Genesis Freedom workstation were highly reproducible with a signal-to-noise ratio of 5.7 and a Z' factor of 0.88, indicating a very robust assay.  Finally, a HDAC-inhibitor focused library was profiled in a medium-throughput screening campaign.  Inhibition of cellular HDAC activity correlated well with cytotoxicity and histone H3 hyperacetylation in HeLa cells and with inhibition of human recombinant HDAC1 in a biochem. assay.  Thus, by using Boc-K(Ac)-AMC as a cell-permeable HDAC substrate, the activity of various protein lysine-specific deacetylases including HDAC1-contg. complexes is measurable in intact cells in a simple and homogeneous manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwqcthSklVtbVg90H21EOLACvtfcHk0lim538KSgEw1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlajsbbE&md5=8ee83fa7270002c84108a915b9ba719e</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2007.07.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2007.07.024%26sid%3Dliteratum%253Aachs%26aulast%3DCiossek%26aufirst%3DT.%26aulast%3DJulius%26aufirst%3DH.%26aulast%3DWieland%26aufirst%3DH.%26aulast%3DMaier%26aufirst%3DT.%26aulast%3DBeckers%26aufirst%3DT.%26atitle%3DA%2520homogeneous%2520cellular%2520histone%2520deacetylase%2520assay%2520suitable%2520for%2520compound%2520profiling%2520and%2520robotic%2520screening%26jtitle%3DAnal.%2520Biochem.%26date%3D2008%26volume%3D372%26spage%3D72%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">O’Brien, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orton, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pognan, F.</span><span> </span><span class="NLM_article-title">Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">5421</span><span class="NLM_x">–</span> <span class="NLM_lpage">5426</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1046%2Fj.1432-1327.2000.01606.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=10951200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsVensbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=2000&pages=5421-5426&author=J.+O%E2%80%99Brienauthor=I.+Wilsonauthor=T.+Ortonauthor=F.+Pognan&title=Investigation+of+the+Alamar+Blue+%28resazurin%29+fluorescent+dye+for+the+assessment+of+mammalian+cell+cytotoxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity</span></div><div class="casAuthors">O'Brien, John; Wilson, Ian; Orton, Terry; Pognan, Francois</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5421-5426</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">The authors show here the identity of Alamar Blue as resazurin.  The "resazurin redn. test" has been used for about 50 yr to monitor bacterial and yeast contamination of milk, and also for assessing semen quality.  Resazurin (blue and nonfluorescent) is reduced to resorufin (pink and highly fluorescent) which is further reduced to hydroresorufin (uncolored and nonfluorescent).  It is still not known how this redn. occurs, intracellularly via enzyme activity or in the medium as a chem. reaction, although the reduced fluorescent form of Alamar Blue was found in the cytoplasm and of living cells nucleus of dead cells.  Recently, the dye has gained popularity as a very simple and versatile way of measuring cell proliferation and cytotoxicity.  This dye presents numerous advantages over other cytotoxicity or proliferation tests but the authors obsd. several drawbacks to the routine use of Alamar Blue.  Tests with several toxicants in different cell lines and rat primary hepatocytes have shown accumulation of the fluorescent product of Alamar Blue in the medium which could lead to an overestimation of cell population.  Also, the extensive redn. of Alamar Blue by metabolically active cells led to a final nonfluorescent product, and hence an underestimation of cellular activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3trjtqePmK7Vg90H21EOLACvtfcHk0lg-A7B01MMHdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsVensbY%253D&md5=7109c114d8d7d6e16f964d69f08f97fd</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1046%2Fj.1432-1327.2000.01606.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1432-1327.2000.01606.x%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DJ.%26aulast%3DWilson%26aufirst%3DI.%26aulast%3DOrton%26aufirst%3DT.%26aulast%3DPognan%26aufirst%3DF.%26atitle%3DInvestigation%2520of%2520the%2520Alamar%2520Blue%2520%2528resazurin%2529%2520fluorescent%2520dye%2520for%2520the%2520assessment%2520of%2520mammalian%2520cell%2520cytotoxicity%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D2000%26volume%3D267%26spage%3D5421%26epage%3D5426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Mahboobi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellmer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hocher, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garhammer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pongratz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciossek, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckers, T.</span><span> </span><span class="NLM_article-title">2-Aroylindoles and 2-aroylbenzofurans with <i>N</i>-hydroxyacrylamide substructures as a novel series of rationally designed histone deacetylase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4405</span><span class="NLM_x">–</span> <span class="NLM_lpage">4418</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0703136" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4405-4418&author=S.+Mahboobiauthor=A.+Sellmerauthor=H.+Hocherauthor=C.+Garhammerauthor=H.+Pongratzauthor=T.+Maierauthor=T.+Ciossekauthor=T.+Beckers&title=2-Aroylindoles+and+2-aroylbenzofurans+with+N-hydroxyacrylamide+substructures+as+a+novel+series+of+rationally+designed+histone+deacetylase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjm0703136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0703136%26sid%3Dliteratum%253Aachs%26aulast%3DMahboobi%26aufirst%3DS.%26aulast%3DSellmer%26aufirst%3DA.%26aulast%3DHocher%26aufirst%3DH.%26aulast%3DGarhammer%26aufirst%3DC.%26aulast%3DPongratz%26aufirst%3DH.%26aulast%3DMaier%26aufirst%3DT.%26aulast%3DCiossek%26aufirst%3DT.%26aulast%3DBeckers%26aufirst%3DT.%26atitle%3D2-Aroylindoles%2520and%25202-aroylbenzofurans%2520with%2520N-hydroxyacrylamide%2520substructures%2520as%2520a%2520novel%2520series%2520of%2520rationally%2520designed%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4405%26epage%3D4418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kao, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shabanowitz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phelan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazar, M. A.</span><span> </span><span class="NLM_article-title">A novel histone deacetylase pathway regulates mitosis by modulating Aurora B kinase activity</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2566</span><span class="NLM_x">–</span> <span class="NLM_lpage">2579</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1101%2Fgad.1455006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=16980585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVamsr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=2566-2579&author=Y.+Liauthor=G.+D.+Kaoauthor=B.+A.+Garciaauthor=J.+Shabanowitzauthor=D.+F.+Huntauthor=J.+Qinauthor=C.+Phelanauthor=M.+A.+Lazar&title=A+novel+histone+deacetylase+pathway+regulates+mitosis+by+modulating+Aurora+B+kinase+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A novel histone deacetylase pathway regulates mitosis by modulating Aurora B kinase activity</span></div><div class="casAuthors">Li, Yun; Kao, Gary D.; Garcia, Benjamin A.; Shabanowitz, Jeffrey; Hunt, Donald F.; Qin, Jun; Phelan, Caroline; Lazar, Mitchell A.</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2566-2579</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Histone deacetylase (HDAC) inhibitors perturb the cell cycle and have great potential as anti-cancer agents, but their mechanism of action is not well established.  HDACs classically function as repressors of gene expression, tethered to sequence-specific transcription factors.  Here we report that HDAC3 is a crit., transcription-independent regulator of mitosis.  HDAC3 forms a complex with A-Kinase-Anchoring Proteins AKAP95 and HA95, which are targeted to mitotic chromosomes.  Deacetylation of H3 in mitosis requires AKAP95/HA95 and HDAC3 and provides a hypoacetylated H3 tail that is the preferred substrate for Aurora B kinase.  Phosphorylation of H3S10 by Aurora B leads to dissocn. of HP1 proteins from methylated H3K9 residues on mitotic heterochromatin.  This transcription-independent pathway, involving interdependent changes in histone modification and protein assocn., is required for normal progression through mitosis and is an unexpected target of HDAC inhibitors, a class of drugs currently in clin. trials for treating cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkA181czLeGrVg90H21EOLACvtfcHk0ljEpM0U3VhWqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVamsr3J&md5=9abb518bd5f86ee9778ba9e0a724c8a9</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1101%2Fgad.1455006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.1455006%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DY.%26aulast%3DKao%26aufirst%3DG.%2BD.%26aulast%3DGarcia%26aufirst%3DB.%2BA.%26aulast%3DShabanowitz%26aufirst%3DJ.%26aulast%3DHunt%26aufirst%3DD.%2BF.%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DPhelan%26aufirst%3DC.%26aulast%3DLazar%26aufirst%3DM.%2BA.%26atitle%3DA%2520novel%2520histone%2520deacetylase%2520pathway%2520regulates%2520mitosis%2520by%2520modulating%2520Aurora%2520B%2520kinase%2520activity%26jtitle%3DGenes%2520Dev.%26date%3D2006%26volume%3D20%26spage%3D2566%26epage%3D2579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Dignam, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebovitz, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roeder, R. G.</span><span> </span><span class="NLM_article-title">Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1475</span><span class="NLM_x">–</span> <span class="NLM_lpage">1489</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1093%2Fnar%2F11.5.1475" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=6828386" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADyaL3sXhslCit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1983&pages=1475-1489&author=J.+D.+Dignamauthor=R.+M.+Lebovitzauthor=R.+G.+Roeder&title=Accurate+transcription+initiation+by+RNA+polymerase+II+in+a+soluble+extract+from+isolated+mammalian+nuclei"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei</span></div><div class="casAuthors">Dignam, John David; Lebovitz, Russell M.; Roeder, Robert G.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleic Acids Research</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1475-89</span>CODEN:
                <span class="NLM_cas:coden">NARHAD</span>;
        ISSN:<span class="NLM_cas:issn">0305-1048</span>.
    </div><div class="casAbstract">A new procedure was developed for prepg. exts. from nuclei of human tissue culture cells (HeLa cells) that directs accurate transcription initiation in vitro from promoters of class II by RNA polymerase II  [9014-24-8].  Conditions of extn. and assay were optimized for max. activity by using the major late promoter of adenovirus 2.  The ext. also directs accurate transcription initiation from other adenovirus promoters and cellular promoters.  The ext. also directs accurate transcription initiation from class III promoters (tRNA and adenovirus 2 VA).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpacSBbgqUIyrVg90H21EOLACvtfcHk0ljEpM0U3VhWqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXhslCit74%253D&md5=9a1031cfc1503d0179d166d9efe68ac5</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1093%2Fnar%2F11.5.1475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fnar%252F11.5.1475%26sid%3Dliteratum%253Aachs%26aulast%3DDignam%26aufirst%3DJ.%2BD.%26aulast%3DLebovitz%26aufirst%3DR.%2BM.%26aulast%3DRoeder%26aufirst%3DR.%2BG.%26atitle%3DAccurate%2520transcription%2520initiation%2520by%2520RNA%2520polymerase%2520II%2520in%2520a%2520soluble%2520extract%2520from%2520isolated%2520mammalian%2520nuclei%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D1983%26volume%3D11%26spage%3D1475%26epage%3D1489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Wegener, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wirsching, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riester, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwienhorst, A.</span><span> </span><span class="NLM_article-title">A fluorogenic histone deacetylase assay well suited for high-throughput activity screening</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm800093c&amp;key=10.1016%2FS1074-5521%2802%2900305-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm800093c&amp;key=12573699" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADC%252BD3sXps1Skuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=61-68&author=D.+Wegenerauthor=F.+Wirschingauthor=D.+Riesterauthor=A.+Schwienhorst&title=A+fluorogenic+histone+deacetylase+assay+well+suited+for+high-throughput+activity+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">A Fluorogenic Histone Deacetylase Assay Well Suited for High-Throughput Activity Screening</span></div><div class="casAuthors">Wegener, Dennis; Wirsching, Frank; Riester, Daniel; Schwienhorst, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-68</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Histone deacetylases (HDACs) are important enzymes for the transcriptional regulation of gene expression in eukaryotic cells.  Recent findings suggest that HDACs could be key targets for chemotherapeutic intervention in malignant diseases.  A convenient and sensitive fluorogenic assay for HDAC activity would therefore expedite studies of HDAC in transcriptional regulation and in vitro screening for drug discovery.  In this study, novel fluorogenic substrates of HDACs were synthesized with an ε-acetylated lysyl moiety and an adjacent MCA moiety at the C terminus of the peptide chain.  Upon deacetylation of the acetylated lysyl moiety, mols. became substrates for trypsin, which released highly fluorescent AMC mols. in a subsequent step of the assay.  The fluorescence increased in direct proportion to the amt. of deacetylated substrate mols., i.e., HDAC activity.  The nonisotopic, homogeneous assay is well suited for high-throughput HDAC inhibitor screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5ogyqEBSC3bVg90H21EOLACvtfcHk0ljEpM0U3VhWqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXps1Skuw%253D%253D&md5=eea350d8066f6ebd773ba50cc0211fdc</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2802%2900305-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252802%252900305-8%26sid%3Dliteratum%253Aachs%26aulast%3DWegener%26aufirst%3DD.%26aulast%3DWirsching%26aufirst%3DF.%26aulast%3DRiester%26aufirst%3DD.%26aulast%3DSchwienhorst%26aufirst%3DA.%26atitle%3DA%2520fluorogenic%2520histone%2520deacetylase%2520assay%2520well%2520suited%2520for%2520high-throughput%2520activity%2520screening%26jtitle%3DChem.%2520Biol.%26date%3D2003%26volume%3D10%26spage%3D61%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Ise, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heuser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, K.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">P-Glycoprotein-associated resistance to taxol and taxotere and its reversal by dexniguldipine-HCl, dexverapamil-HCl, or cyclosporin A</span> <span class="citation_source-journal">Int. J. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">951</span><span class="NLM_x">–</span> <span class="NLM_lpage">956</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm800093c&amp;key=1%3ACAS%3A528%3ADyaK28XjtVGkur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1996&pages=951-956&author=W.+Iseauthor=M.+Heuserauthor=K.+Sanders&title=P-Glycoprotein-associated+resistance+to+taxol+and+taxotere+and+its+reversal+by+dexniguldipine-HCl%2C+dexverapamil-HCl%2C+or+cyclosporin+A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">P-glycoprotein-associated resistance to taxol and taxotere and its reversal by dexniguldipine-HCl, dexverapamil-HCl, or cyclosporin A</span></div><div class="casAuthors">Ise, Wolfgang; Heuser, Margrit; Sanders, Karl Heinrich; Beck, James; Gekeler, Volker</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">951-956</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1019-6439</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Oncology</span>)
        </div><div class="casAbstract">A series of different human MDR (multidrug-resistant) cell lines including a HeLa-MDR1 transfectant which exhibit high overexpression of the MDR1/P-glycoprotein gene, but no enhanced expression of the MRP (multidrug resistance assocd. protein) gene, showed different ratios of relative resistances to the taxanes taxol and taxotere.  Using these cell lines the chemosensitizing efficacies of several structurally different chemosensitizers, i.e. the dihydropyridine dexniguldipine-HCl (B8509-035), its main pyridine metabolite M1 (B8909-008), the cyclic peptide cyclosporin A, or the phenylalkylamine dexverapamil-HCl, were examd. applying a 72 h tetrazolium based colorimetric MTT-assay, or a 96 h sulforhodamine B assay.  Remarkably, we obsd. in some instances that the modulating efficacy of a particular chemosensitizer was strongly dependent on the cell line used for experimentation.  Thus, dexniguldipine-HCl efficiently modulated taxane resistances of the ovarian carcinoma MDR cell line 2780AD in the submicromolar concn. range, whereas cyclosporin A and the other chemosensitizers were rather ineffective.  Dexniguldipine-HCl or cyclosporin A, however, both showed a similarly strong modulating activity on the HeLa-MDR1 transfectant in clear contrast to the effects obsd. using the pyridine B8909-008, or dexverapamil-HCl, resp., at the same final concns.  Our results point to addnl., as yet unidentified factors beyond the expression levels of P-glycoprotein which could contribute to the susceptibility of MDR cells to a combined treatment using taxanes and different chemosensitizing compds.  This result appears to be important considering the clin. application of chemosensitizers for combination therapy of tumors of different origin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpds9KBEh9B1rVg90H21EOLACvtfcHk0liVHUBt6H1kjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjtVGkur0%253D&md5=12bcb43223e88dd7295fd4309374a762</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIse%26aufirst%3DW.%26aulast%3DHeuser%26aufirst%3DM.%26aulast%3DSanders%26aufirst%3DK.%26atitle%3DP-Glycoprotein-associated%2520resistance%2520to%2520taxol%2520and%2520taxotere%2520and%2520its%2520reversal%2520by%2520dexniguldipine-HCl%252C%2520dexverapamil-HCl%252C%2520or%2520cyclosporin%2520A%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D1996%26volume%3D8%26spage%3D951%26epage%3D956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Schmidt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendelsohn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Z.</span><span> </span><span class="NLM_article-title">Differential modulation of paclitaxel-mediated apoptosis by p21waf1 and p27kip1</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2423</span><span class="NLM_x">–</span> <span class="NLM_lpage">2429</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2000&pages=2423-2429&author=M.+Schmidtauthor=Y.+Luauthor=B.+Liuauthor=M.+Fangauthor=J.+Mendelsohnauthor=Z.+Fan&title=Differential+modulation+of+paclitaxel-mediated+apoptosis+by+p21waf1+and+p27kip1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DM.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DFang%26aufirst%3DM.%26aulast%3DMendelsohn%26aufirst%3DJ.%26aulast%3DFan%26aufirst%3DZ.%26atitle%3DDifferential%2520modulation%2520of%2520paclitaxel-mediated%2520apoptosis%2520by%2520p21waf1%2520and%2520p27kip1%26jtitle%3DOncogene%26date%3D2000%26volume%3D19%26spage%3D2423%26epage%3D2429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-note1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i53"><a href="/doi/suppl/10.1021/jm800093c">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_57048"></div></div></div></div></div><hr /></hr><p class="last">All information about chemical synthesis and analytics of additional compounds as presented in the manuscript but not shown in the Experimental Section. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm800093c/suppl_file/jm800093c-file003.pdf">jm800093c-file003.pdf (1.69 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm800093c&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm800093c%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2008.51.issue-13%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm800093c" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"66e10278ab6c2440","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
